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ABSTRACT: 
 
The IBDV virus is icosahedral, ~70 nm in diameter and contains two dsRNA 
segments and five encoded mature proteins (VP1 to VP5). IBDV capsid is based on a 
single T=13 levo lattice and formed by 260 VP2 trimers disposed in 12 pentamers and 
120 hexamers.  
 
VP2 is synthezided as part of a polyprotein that is cotranslationally self-cleaved, 
releasing three polypeptides, namely pVP2 (the VP2 precursor), VP4 (the protease), and 
VP3 (a polypeptide with scaffolding activity among others). pVP2 (512 residues) 
undergoes subsequent processing events mediated by VP4 at three secondary 
alanyldipeptide targets (positions 487, 494 and 501). The resulting intermediates are 
further cleaved twice between residues Arg-452 and Arg-453 and between residues Ala-
441 and Phe-442 to yield VP2 and several C-terminal peptides (accountig for 71 
residues). Here, we have dilucidated the executor of the last pVP2→VP2 proteolytic 
maturation events associated with the pVP2 assembly into a procapsid-like structure. 
 
A cellular protease, a puromycin sensitive aminopeptidase (PSA) cleaves pVP2 
in the 452-453 scissile bond, and an autoproteolytic activity based on the Asp-431 is 
responsible of the last processing event. 
 
. The structural polymorphism of pVP2, is due to an amphipathic α-helix located 
at its C-terminal end which acts as a transient conformational switch. VP3, the other 
major protein, participates in capsid assembly by electrostatic interactions of its C-
terminal region with the molecular switch, acting as a molecular triggering factor. 
Moreover, it will exist an electrostatic interaction between the autocatalaytic residue 
(Asp-431) and the basic region of VP3 C-terminal domain, that may block the VP2 
cleavage by Asp-431 until the capsid has been correctly assembled. 
 
Together, all these results provide a better understanding of the multistep 
maturation process for the IBDV capsid. 
  
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
Capítulo 1——————————————————————————————— 
Los virus representan la vida reducida a su esencia. En realidad, no son poco 
más que material genético protegidos por una cubierta proteica o como Sir Peter 
Medawar una vez dijo, “un conjunto de malas noticias envueltas en proteína” (Medawar 
PB, 1983). 
Su principal característica es una absoluta dependencia hacia un hospedador, 
siendo un parásito obligado y representando una plaga para el resto de organismos. En 
1898, el científico holandés Beyerinck y los investigadores alemanes Loeffler y Frosch 
establecieron, basándose en experimentos de filtración, que los agentes causantes de 
ciertas enfermedades (de plantas y animales) eran más pequeños que todas las bacterias 
conocidas. Sólo dos años más tarde, la fiebre amarilla fue la primera enfermedad viral 
humana en ser determinada (Mayor Reed y asistentes, Armada Estadounidense, La 
Habana, 1900), y hasta la fecha más de 1938 especies virales pertenecientes a 287 
géneros y 73 familias han sido identificados (Fauquet y Fargette, 2005). Probablemente, 
los virus son tan antiguos como la vida en la Tierra, pero para el público general 
saltaron a la palestra con la pandemia del SIDA, los brotes del síndrome respiratorio 
severo agudo (SARS) y la gripe aviar. 
Las partículas virales compuestas por una cápsida proteica, envuelta o no por 
una membrana, y un ácido nucleico, están diseñadas para mover su genoma entre las 
células de un posible hospedador. Los genomas virales exhiben una gran diversidad, y 
pueden ser de cadena simple o doble de ADN, simple o doble de ARN, de polaridad 
negativa, positiva, o de ambos sentidos; con una topología circular o linear, y existir 
sólo un segmento o varios de ellos. La cubierta proteica proporciona una envuelta 
protectora para el ácido nucleico, y es la responsable de ciertas reacciones químicas 
necesarias para la maduración de la partícula viral y la entrada de la misma en la célula. 
Esta cápsida se forma por múltiples copias de productos génicos idénticos, lo cual 
minimiza la información génica que se requiere para su formación. Esta estrategia que 
reduce la cantidad de proteínas que se codifican, genera un problema en el ensamblaje 
de estos multímeros; con decenas, centenas o miles de subunidades, en un mismo marco 
biológico (Johnson y Speir, 1997). Las cápsidas virales representan un excelente marco 
de trabajo para el análisis de aspectos del ensamblaje de complejos macromoleculares 
así como del polimorfismo estructural y las conformaciones transitorias. Además, las 
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cápsidas complejas requieren a su vez, una o más proteínas auxiliares (de andamiaje, 
accesorias y proteolíticas). 
Crick y Watson, propusieron en 1956 que las cápsidas esféricas debían poseer 
geometría icosaédrica; ya que era el modo más efectivo de conseguir el máximo 
volumen con una pequeña proteína. Una corroboración experimental de esta hipótesis 
fue proporcionada por D.L.D. Caspar, quien notificó que los intensos reflejos 
observados en fotografías de rayos X del virus del enanismo ramificado del tomate 
(Tomato Bushy Stunt Virus-TBSV) correspondían a una disposición icosaédrica de 
orden cinco (Caspar, 1956). 
 
De los cuerpos platónicos (compuestos por subunidades idénticas), los 
icosaedros son los que poseen el mayor número de caras. Un icosaedro posee 20 caras 
formadas por triángulos equiláteros. Como cada cara posee una simetría de orden tres, 
el sólido resultante está formado por 60 unidades asimétricas idénticas. El icosaedro 
también se puede definir en términos de sus 532 puntos de simetría. Cada uno de los 
doce vértices icosaédricos coincide con un eje de simetría de orden cinco (5x12=60); los 
ejes de simetría van desde uno de orden cinco a través del centro del icosaedro y salen 
por la otra cara. Los ejes de orden tres pasan por el centro de las caras. Además, hay 30 
ejes de orden dos (2x30=60) que se determinan a través de los contactos arista-arista 
entre las caras del icosaedro. 
 
La ventaja de la geometría icosaédrica es que una secuencia relativamente corta 
de ARN/ADN puede codificar una proteína capaz de encapsidar el genoma completo. 
La teoría de la cuasiequivalencia describe como múltiplos de 60 proteínas se disponen 
en una simetría icosaédrica para poder crear volúmenes mayores (Caspar y Klug, 1962). 
El postulado fundamental de la cuasiequivalencia es que las proteínas de la cápsida viral 
pueden formar pentámeros y hexámeros usando los mismos contactos entre 
subunidades. El único requerimiento para formar la cara de un icosaedro es ser un 
triángulo equilátero con tres unidades asimétricas idénticas dispuestas con una simetría 
de orden tres. Usando una red hexagonal uno puede observar que hay una serie infinita 
de triángulos equiláteros que encierran un número integral de triángulos más pequeños 
denominado número de triangulación (T). El área de una unidad asimétrica para un 
triángulo con un vértice en el origen (0,0) y un segundo vértice en el punto (h, k) es: 
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T=h2+hk+k2. El tamaño del triángulo equilátero es proporcional al número de 
triangulación y cada partícula poseerá 60T subunidades, que se dispondrán como 12 
pentámeros y 10 (T-1) hexámeros (Fig. 1).  
 
Fig.1. Principios geométricos para la generación de superficies icosaédricas cuasi-equivalentes. Los 
hexámeros se consideran inicialmente planos (un conjunto de formas hexaméricas forman una superficie 
plana como la que se muestra) y los pentámeros se consideran convexos, introduciendo una curvatura en 
la superficie de los hexámeros cuando se insertan. La cápsida icosaédrica cerrada, se genera por la 
inserción de 12 pentámeros en posiciones apropiadas de la red hexamérica. Para construir un modelo de 
superficie cuasi-equivalente, una cara de un icosaedro se genera en la red hexagonal. El origen se 
reemplaza con un pentámero y el hexámero (h, k) se reemplaza por otro pentámero. El tercer hexámero 
que se reemplaza se identifica con el orden se simetría de orden 3 (por ejemplo, para completar el 
triángulo equilátero de una cara). La cara icosaédrica de una superficie T=3 se define por un triángulo de 
líneas naranjas (h=1, k=1). Existen dos posibles elecciones para una superficie T=7 marcadas en verde y 
azul (h=2, k=1 o h=1, k=2, siendo imágenes especulares), y se requiere el conocimiento de la disposición 
de hexámeros, pentámeros y la estereoisomería de la cápsida para su completa definición (adaptado de 
Johnson y Speir, 1997). 
 
La cuasisimetría surge debido a que las subunidades dentro de una unidad 
asimétrica no son equivalentes. En teoría, se pueden formar cápsidas cuasiequivalentes 
de cualquier tamaño y a veces distintos tipos de subunidades se utilizan para la 
formación de pentámeros y hexámeros, en cuyo caso se denomina 
pseudocuasiequivalencia y se define por un número P en lugar de T. 
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1.1. Diferentes mecanismos de control para el ensamblaje de la cápsida 
viral 
 
En cápsidas con un número de triangulación mayor de uno, las subunidades 
proteicas deben adoptar distintas conformaciones dependiendo de su ambiente 
estructural dentro de la cápsida; lo que significa que las distintas uniones entre las 
subunidades no son idénticas existiendo distintas clases de confórmeros (Caspar y Klug, 
1962). Estudios de estructurales de alta resolución han revelado algunas claves de cómo 
una proteína de la cápsida sabe la conformación que debe adoptar (Liddington y col., 
1991; Rossmann y Johnson, 1989) aunque el mecanismo todavía se entiende poco 
(Johnson y Speir, 1997). 
 
1.1.1. Control del cambio conformacional 
 
La información del cambio conformacional que se requiere para el ensamblaje 
de una cápsida T>1 es intrínseca a las subunidades en sí mismas, lo que frecuentemente 
permite la formación de cápsidas correctas en la ausencia de otras proteínas y está 
determinado por factores como las regiones proteicas flexibles (lazos y dominios 
amino- y carboxi-terminales), interacciones con el ARN, iones metálicos, pH y distintas 
combinaciones de todos ellos (Johnson, 1996). En algunos casos, sin embargo, se 
forman una gran variedad de estructuras aberrantes relacionadas con la cápsida 
dependiendo de ciertas condiciones fisiológicas (Krol y col., 1999; Salunke y col., 
1989; Savithri y Erickson, 1983; Schwartz y col., 2000). La restricción de esta 
flexibilidad inherente para que sólo las conformaciones apropiadas sean las que puedan 
ensamblarse, es algo muy importante en el proceso de ensamblaje casi tanto como la 
capacidad de generar variabilidad conformacional. 
 
Hay una conexión muy estrecha entre el plegamiento de una proteína y su 
ensamblaje. Las proteínas estructurales virales son frecuentemente bastante flexibles en 
solución y cada subunidad elige su disposición en base al estado conformacional de sus 
vecinos (Berger y col., 1994). 
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1.1.2. Proteínas formadoras de “cores” y de andamiaje 
 
Conforme la cápsida empieza a adquirir una mayor complejidad y el número de 
interacciones aumenta, la información adicional para constreñir las posibilidades 
conformacionales de la proteína de la cápsida y para asegurar la fidelidad en el proceso 
de ensamblaje también será mayor. Esta información, vendrá dada por una proteína que 
forma un “core” o que actúe como proteína de andamiaje. 
 
Un “core” es lo suficientemente simple para poder autoensamblarse sin ninguna 
información adicional. Una vez que el tamaño de la cápsida es especificado por el 
“core”, la simetría se determina por la disposición de los distintos multímeros de la 
proteína de la cápsida sobre este patrón (Berger y col., 1994), a pesar de que ciertas de 
estas interacciones sean relativamente no específicas (Grimes y col., 1998). Entre las 
proteínas mejor caracterizadas que cumplen esta función, se encuentra el precursor de la 
proteína VP22a de herpes simple tipo I, que interacciona con la proteína mayoritaria de 
la cápsida, VP5, a través de los últimos 25 residuos de su C-terminal. Esta interacción 
es esencial para el ensamblaje viral (Zhou y col., 1998). 
 
El término de “proteína de andamiaje” se refiere usualmente a aquella que juega 
un papel estructural esencial en ciertos episodios del ensamblaje, y que posteriormente 
es retirada, de modo análogo al papel de las chaperonas moleculares en plegamiento de 
proteínas. Las proteínas de andamiaje suelen compartir una organización estructural 
similar, incluyendo su forma alargada, y un dominio específico de interacción con la 
cápsida en su C-terminal. La proteína de andamiaje por sí misma no forma una 
estructura simétrica pero aparentemente proporciona suficiente información para 
constreñir la simetría de la cápsida ya que define el tamaño global de la cápsida externa, 
(Dokland, 1999); por ejemplo, la proteína de andamiaje gp0 es necesaria para la 
formación de cápsidas viables de bacteriófagos P2 y P4 (Chang y col., 2009). 
 
1.1.3. Cambios conformacionales mayores 
 
Mientras los cambios conformacionales “menores” proporcionan el mecanismo 
necesario para la generación de diversidad estructural que se requiere en la formación 
de cápsidas grandes; algunos virus son capaces de llegar más allá y sufren una 
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reorganización a gran escala de su estructura. El ejemplo más típico se encuentra en los 
bacteriófagos de doble cadena de ADN, cuya cápsida sufre una expansión (Conway y 
col., 1995; Dokland y Murialdo, 1993). La resolución de la precabeza II, uno de los 
intermedios de ensamblaje del bacteriófago HK07, a 3.65Å de resolución ha revelado 
un mecanismo de expansión sin precedentes que describe esta transición (Gertsman y 
col., 2009). 
 
1.1.4. Estructuras intermedias en el ensamblaje 
 
Se ha asumido que los virus se ensamblan a través de estructuras intermedias, 
que representan un subconjunto de la estructura final de la cápsida; ya que el ensamblaje 
a través de estos intermedios reduce el número de errores de manera dramática (Berget, 
1985). Ejemplos de virus que ensamblan a través de intermedios procápsidas son los 
herpesvirus (Newcomb y col., 2009) y bacteriófagos como T7 (Agirrezabala y col., 
2007). 
  
El proceso de ensamblaje se lleva a cabo a través de eventos separados de 
nucleación y crecimiento. De esta manera, el núcleo inicial que consiste en un 
subensamblaje específico va creciendo por la adición distintas subunidades y estructuras 
(Stehle y col., 1996). 
 
1.1.5. Procesamiento proteolítico 
 
Las proteasas pueden ser de origen celular o viral y juegan papeles esenciales en 
la replicación viral, incluyendo el ensamblaje coordinado y la maduración de los 
viriones (Hellen y Wimmer, 1992). La mayoría de estas enzimas pertenecen a una de 
estas tres clases (Ser, Cys o Asp) y están implicadas en dos funciones principales de la 
morfogénesis viral. La primera, es el corte proteolítico de grandes poliproteínas 
estructurales codificadas por retrovirus y virus de ARN, el cual es un prerrequisito para 
el ensamblaje de la partícula viral. La segunda función, es la maduración dependiente de 
ensamblaje de las partículas virales, que suele estar acompañada por la adquisición de la 
infectividad. Por ejemplo, en orthoretrovirus, la mayoría de las partículas que se liberan 
son inmaduras y una proteasa viral es la encargada de cortar la poliproteína Gag durante 
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o tras un tiempo corto tras el ensamblaje para permitir la maduración de las partículas 
(Adamson y Freed, 2007).  
 
Por otro lado, las proteasas celulares procesan a los precursores de las proteínas 
virales de una manera convencional después que estos hayan sido transportados a 
compartimentos vesiculares, como en infecciones por el virus de la hepatitis A, en el 
que las procápsidas inmaduras llegan a lisosomas tempranos en los que la proteasa 
celular, catepsina L, elimina el péptido 2A madurándose así la partícula (Morace y col., 
2008). Por el contrario, los cortes por proteasas virales son más complejos; y ocurren a 
través de una gran variedad de mecanismos facilitando el ensamblaje de estructuras 
virales complejas y la maduración post-ensamblaje del virión (Gallagher y Rueckert, 
1998). 
 
1.2. Familia Birnaviridae: el virus de la bursitis infecciosa 
 
La familia Birnaviridae forma una familia distintiva de virus de ARN de doble 
cadena (dsRNA) que infectan a distintas especies animales tan diferentes como 
vertebrados, moluscos, insectos y rotíferos (Delmas, 2004). Posee tres géneros 
diferentes: Aquabirnavirus, Entomobirnavirus y Avibirnavirus. Los miembros 
representativos de cada uno de ellos son; el virus de la necrosis pancreática infecciosa 
(IPNV); el virus Drosophila X (DrXV); y el virus de la bursitis infecciosa (IBDV), 
respectivamente (Fauquet y Fargette, 2005). La mayoría de los esfuerzos realizados en 
investigación se han centrado en IBDV (Muller y col., 2003), con interesantes 
propiedades de virulencia y responsable de importantes pérdidas económicas en la 
industria avícola. Otro birnavirus económicamente importante es IPNV que se 
encuentra en salmónidos y produce grandes pérdidas económicas en piscifactorías 
(Delmas, 2004).  
 
IBDV es el agente causal de la enfermedad de la bursitis infecciosa (IBD) que 
afecta a pollos jóvenes. Cuando IBD apareció en 1958, se designó como “enfermedad 
de Gumboro” ya que los primeros brotes se documentaron en Gumboro, Delaware, 
EEUU. Las infecciones con IBDV exacerban la infección con otros agentes etiológicos 
 11 
——————————————————————————————Introducción 
y reduce la capacidad de respuesta a la vacunación; produciéndose un gran impacto 
económico a nivel mundial en la industria avícola (van den Berg y col., 2000). 
Las células linfoides de la bolsa de Fabricio son las principales células diana de 
IBDV. Entre las tres y seis semanas tras la rotura del cascarón, la bolsa de Fabricio 
alcanza su máximo desarrollo, siendo en ese momento los pollos altamente susceptibles 
a la infección por el virus. La infección produce la depleción de linfocitos y la 
destrucción de la bolsa. En brotes clásicos, la mortalidad varía del 1 al 50%. También se 
ha observado una disminución en la producción de huevos con un deterioro en la 
calidad de los mismos, sobre todo de la cáscara y una inmunosupresión asociada a la 
infección con alta prevalencia de infecciones virales respiratorias y elevada mortalidad 
debida a airesaculitis y colisepticemia (Kaufer y Weiss, 1980).  
 
IBDV es resistente a todos los procedimientos tradicionales de desinfección 
como la inactivación química o por calor. Por el momento, el único método disponible 
para controlar la expansión de la enfermedad son programas intensivos de vacunación 
(Negash y col., 2004), a pesar de que el uso indiscriminado de vacunas atenuadas 
permitió la rápida diseminación del virus alrededor del mundo (Yamaguchi y col., 
1996). La búsqueda de nuevas estrategias para controlar y erradicar la enfermedad es 
nuestra prioridad, siendo especialmente importante en países en vía de desarrollo, donde 
la carne de pollo es la base proteica de la dieta. 
 
1.2.1. Serotipos de IBDV 
 
Hay dos tipos diferentes de serotipos de IBDV, I y II, que se distinguen por 
ensayos específicos de sero-neutralización (McFerran y col., 1980). El serotipo I 
incluye a aislados patogénicos en pollos domésticos, mientras que el serotipo II, 
presente en pavos no produce síntomas clínicos ni protección frente a los aislados de 
tipo I. Los aislados del serotipo I se subdividen en variantes clásica, antigénica y muy 
virulenta. IBDV de variante-antigénica sólo se ha documentado en Estados Unidos 
(desde 1985) y posee cambios simples de aminoácidos en una región específica de la 
proteína VP2 (región hipervariable), lo cual produce distintos fenotipos patológicos 
(Snyder, 1990). En Europa, desde 1988, se han descrito aislados de IBDV que han 
incrementado su virulencia (IBDV muy virulento [vvIBDV]) con la misma estructura 
antigénica que los aislados clásicos (Chettle y col., 1989). Diferencias en aminoácidos 
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entre las proteínas virales de aislados muy virulentos y clásicos se encontraron en todas 
las proteínas virales, aunque la mayoría de ellos se encontraban en la región 
hipervariable de VP2 (Brown y Skinner, 1996; Pitcovski y col., 1998). 
 
1.2.2. Organización genómica de IBDV 
 
El genoma de IBDV está formado por dos segmentos de ARN de doble cadena 
(dsRNA) de 3,2 kb (segmento A) y 2,8 kb (segmento B) (Muller y Nitschke, 1987a; 
Muller y col., 1979) con regiones no traducidas (UTR) en las regiones 5’ y 3’. Estudios 
de síntesis de ssRNA in vitro muestran que la ARN polimerasa sintetiza ssRNA viral de 
manera semi-conservativa por un mecanismo de desplazamiento de la cadena parental 
por la cadena naciente (Spies y col., 1987) (Fig. 2).  
 
El segmento A contiene dos marcos de lectura (open reading frame-ORF) 
parcialmente solapados. La ORF más pequeña codifica VP5 (15 kDa), un polipéptido 
no esencial, que está involucrado en la diseminación viral (Lombardo y col., 2000) e 
inhibe la apoptosis en los estadios iniciales de la infección viral (Liu y Vakharia, 2006). 
La ORF más grande codifica una poliproteína de 110 kDa que sufre un procesamiento 
proteolítico cotraduccional por la proteasa viral VP4, dando lugar a pVP2 (54.4 kDa), 
VP3 (29 kDa), y VP4 (26.7 kDa).  
 
Segmento B codifica VP1 (97.8 kDa), la polimerasa de RNA dependiente de 
RNA (RpRd) (Morgan y col., 1988; Muller y Nitschke, 1987b; von Einem y col., 2004) 
implicada en replicación viral. Como otras polimerasas dsRNA, VP1 cataliza la 
replicación y transcripción viral (Pan y col., 2007; Spies y col., 1987; Xu y col., 2004). 
Aunque la polimerización de ARN y la iniciación (“priming”) normalmente suponen 
diferentes componentes virales, en birnavirus la polimerasa es responsable de ambas 
actividades. VP1 se guanilida a sí misma actuando como “primer” para la síntesis de 
ARN (Dobos, 1993; Shwed y col., 2002; Spies y Muller, 1990; Xu y col., 2004).  
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Fig.2. Organización genómica de IBDV. El segmento A posee dos marcos abiertos de lectura (ORFs) 
parcialmente solapados, que codifican la proteína VP5 y la poliproteína viral, respectivamente. La 
poliproteína sufre un autoprocesamiento por la proteasa viral VP4, dando lugar a pVP2, VP3 y VP4. El 
C-terminal de pVP2 es posteriormente procesada produciendo la VP2 madura. El segmento B codifica la 
VP1, la polimerasa RNA dependiente de RNA. 
 
1.2.3. Estructura y morfogénesis de IBDV 
 
1.2.3.1. Componentes estructurales del virión de IBDV 
 
Las partículas infecciosas de IBDV, formadas por dos proteínas mayoritarias 
(VP2 y VP3) y dos minoritarias (VP1 y VP4), se ensamblan y se acumulan en el 
citoplasma (Fig. 3B). 
 
Las purificaciones virales dan lugar a seis poblaciones diferentes que comparten 
una composición proteica idéntica pero con un coeficiente de sedimentación mayor 
conforme la densidad de la partícula se incrementa. Análisis estequiométricos de su 
genoma indica que estas diferencias biofísicas se correlacionan con el número de 
segmentos de dsRNA que encapsida la partícula viral. Las partículas de IBDV con un 
mayor número de copias del genoma poseen mayores ratios de infectividad (Luque y 
col., 2009a). 
 
El virión posee una cápsida sencilla con un diámetro externo de 65-70nm 
formada por 260 subunidades triméricas cuasiequivalentes de pVP2/VP2 organizadas 
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con una arquitectura T=13l (levo) (Bottcher y col., 1997; Caston y col., 2001; Coulibaly 
y col., 2005). Los trímeros de (p)VP2 se organizan en 12 pentámeros y 120 hexámeros, 
con cinco conformaciones distintas (a-e). VP2 representa el principal marcador de 
virulencia y patogénesis y también induce anticuerpos neutralizantes (Brandt y col., 
2001) (Fig. 3A).  
 
 
Fig.3. Estructura de la cápsida. (A-B). Representaciones de superficie a 10 Å (Luque y col., 2001) de la 
superficie externa (A) e interna (B) de la cápsida de IBDV vista desde un eje de simetría de orden tres. 
Los cinco tipos distintos de capsómeros triméricos se indican por las letras a-e. Barra=100 Å. Los ejes de 
simetría se indican con números rojos. (C). Viriones purificados de IBDV por tinción negativa con 
acetato de uranilo. Barra=100nm. En el recuadro se muestra el análisis electroforético y la tinción de plata 
viriones maduros de IBDV (Lombardo 1999). Las proteínas estructurales se indican por una flecha: VP1 
(97.8 kDa), pVP2 (~54 kDa), VP2 (47 kDa), VP3 (29 kDa) y VP4 (26.7 kDa).  
 
pVP2 (512 residuos) es la forma precursora de la proteína de la cápsida VP2. 
Los 71 residuos finales del C-terminal de pVP2 son procesados proteolíticamente dando 
lugar al polipéptido maduro VP2 (47 kDa, 441 residuos). Se ha propuesto una 
maduración postraduccional en dos eventos distintos: procesamiento por VP4 en dianas 
secundarias de dipéptidos de alanina en las posiciones 487, 494 y 501 (generando como 
mínimo cuatro variantes distintas de pVP2) (Sanchez y Rodriguez, 1999), y el corte 
entre los residuos (441-442), que se discutirá más adelante. La maduración es necesaria 
para el correcto ensamblaje viral (Chevalier y col., 2002) y estos pequeños péptidos 
generados en este proceso permanecen asociados a las partículas virales (Da Costa y 
col., 2002), y poseen capacidad de desestabilización de membranas, con un posible 
papel en la internalización viral (Chevalier y col., 2005; Galloux y col., 2007). Además, 
una maduración post-ensamblaje similar de pVP2 se ha demostrado para IPNV 
(Villanueva y col., 2004). 
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VP3 es una proteína con múltiples funciones que actúa a distintos niveles del 
ciclo viral. VP3 es una proteína de andamiaje durante el ensamblaje viral, 
probablemente por la interacción con VP2, este hecho se discutirá posteriormente. VP3 
también interacciona con VP1 y dsRNA (Maraver y col., 2003a; Maraver y col., 2003b; 
Tacken y col., 2002). En realidad, la interacción de VP3 con VP1 es la responsable de la 
encapsidación de la polimerasa dentro de pseudopartículas virales (VLP) (Lombardo y 
col., 1999). La región de VP3 responsable de esta interacción se encuentra en un 
dominio de 16 aa con gran número de cargas eléctricas muy próximo al extremo C-
terminal de la proteína (Maraver y col., 2003a). Recientemente se ha demostrado que 
esta interacción desbloquea el sitio activo de la RdRp, actuando así como un 
transactivador transcripcional (Garriga et al., 2007). 
 
Por otro lado, el dominio de VP3 que interacciona con dsRNA se ha localizado 
por mutantes de deleción en 69 aa localizados muy cerca de la región N-terminal. 
Mediante ensayos in vitro, se demostró que la capacidad de unión a dsRNA era 
independiente de secuencia, consistente con una papel general de VP3 en estabilización 
del ARN viral (Kochan y col., 2003). VP1, VP3 y el genoma viral forman un complejo 
ribonucleoproteico (RNP) transcripcionalmente activo (Luque y col., 2009b). 
 
VP4 es una proteasa Lon Ser-Lys no canónica (Birghan y col., 2000), y su 
estructura atómica se ha determinado recientemente (Feldman y col., 2006; Lee y col., 
2007). A VP4 le falta el dominio ATPasa de las proteasas Lon, aunque su sitio catalítico 
es la diada Ser-652-Lys-692. VP4 actúa de manera cotraduccional y autocatalítica 
(Birghan y col., 2000). VP4 es un componente estructural del virión aunque su 
encapsidación es variable (Granzow y col., 1997; Luque y col., 2009a). En células 
infectadas por IBDV, VP4 forma estructuras tubulares (túbulos tipo-II) con un diámetro 
de 25 nm. 
 
1.2.3.2. Sistemas de expresión basados en virus para el análisis del ensamblaje de 
IBDV 
 
Una de las aproximaciones más exitosas para el entender el papel de las distintas 
proteínas en el ensamblaje del virión, ha sido el uso de sistemas de expresión 
heterólogos capaces de mimetizar la formación de VLP. 
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La expresión de la poliproteína de IBDV en células de mamíferos usando un 
virus vaccinia recombinante (rVV) da lugar al correcto procesamiento de la poliproteína 
y a la acumulación de una gran cantidad de VLP de forma y tamaño similar a los 
viriones (Fernandez-Arias y col., 1998; Lombardo y col., 1999), mediante este sistema 
también se han recuperado cápsidas más pequeñas con un número de triangulación T=7, 
con tres conformaciones distintas.  
 
La expresión de la poliproteína de IBDV en células de insecto mediante el 
sistema de expresión de baculovirus (rBV) también produce el procesamiento y la 
acumulación de pVP2, VP3 y VP4. Sin embargo, los ensamblados producidos son 
variables estructuralmente y la formación de VLP es bastante ineficiente. El uso de un 
vector de transferencia FastBac para generar un baculovirus que codifica la poliproteína 
produce estructuras tubulares rígidas (túbulos de tipo I), con diámetros de 50 nm 
(Martinez-Torrecuadrada y col., 2000). Estos túbulos, compuestos por pVP2, muestran 
una disposición hexagonal, similar a los observados en células infectadas por IBDV 
(Martinez-Torrecuadrada y col., 2000). Estos resultados indican que las células de 
insecto poseen algún factor(es) que interfieren negativamente con el ensamblaje de VLP 
(por ejemplo, proteínas celulares y/o el ambiente del hospedador), algunos de estos 
factores se discutirán más adelante. 
 
1.2.3.3. Polimorfismo estructural de la proteína de la cápsida de IBDV 
 
La expresión de formas maduras de VP2 usando distintos vectores basados en 
rBV resulta en la formación de partículas isométricas de 26 nm de diámetro (Caston y 
col., 2001; Coulibaly y col., 2005; Lee y col., 2003). Un examen de estas partículas 
subvirales (SVP) muestran que son estructuras dodecaméricas con un número de 
triangulación T=1, compuestas de 20 trímeros de VP2 (Caston y col., 2001) (Fig. 4A). 
Esto indica que los trímeros aislados de VP2, poseen la información intrínseca que se 
requiere para su ensamblaje en pentámeros pero no en hexámeros. Mientras la expresión 
de pVP2 produce estructuras tubulares poco ordenadas compuestas por hexámeros (Fig. 
4C and 4G), pero no posee la suficiente información para producir el patrón de 
interacciones complejas que se requiere para construir una cápsida T=13 (Caston y col., 
2001; Saugar y col., 2005). 
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Las diferencias de comportamiento en el ensamblaje de VP2 y pVP2 indican que 
la información que afecta a las interacciones entre subunidades está contenida dentro del 
dominio carboxi-terminal de pVP2 (pVP2CTD). Estos resultados sugieren que (i) 
pVP2CTD juega un papel importante en la determinación de las diferentes 
conformaciones de VP2, y (ii) la formación de la cápsida de IBDV requiere la 
interacción de VP2 con otros componentes virales. 
 
Fig.4. Polimorfismo estructural de la proteína de la cápsida VP2 en células de insecto. (A) SVPs T=1 
(B) cápsidas T=13 y (C) tubos rígidos purificados de células de insecto infectadas con rBVs que expresan 
la proteína madura VP2, la proteína quimérica HT-VP2-466 y la poliproteína. Barra=100nm. 
Reconstrucción tridimensional de (D) una SVP, (E) cápsida T=7, (F) cápsida T=13 y (G) tubo pVP2 a 26 
Å de resolución. Barra=10nm. 
 
El péptido 443-GFKDIIRAIR-452 de pVP2CTD, ausente en la proteína madura 
de VP2, forma una hélice-α anfipática. VP2 con esta hélice-α es capaz de ensamblar en 
cápsidas T=13 (Fig. 4B y 4F), pero sólo cuando se expresa conjuntamente con una 
proteína quimérica que expresa en el N-terminal la extensión de un Tag de histidinas 
(His tag) (Saugar y col., 2005). Con esta configuración, la hélice-α anfipática actúa 
como un interruptor molecular temporal (“molecular switch”). El His tag emula 
parcialmente la región C-terminal de VP3, que actúa como un efector molecular 
(“triggering factor”). Los últimos cinco aminoácidos del C-terminal de VP3 son 
homólogos al segmento ácido del His tag. No se han encontrado segmentos similares en 
la secuencia VP3. Estudios indirectos confirman la importancia del domino C-terminal 
de VP3 (Chevalier y col., 2004; Gonzalez y col., 2005; Maraver y col., 2003b); cuya 
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función es aquella de las proteínas de andamiaje canónicas (Coulibaly y col., 2005; 
Saugar y col., 2005) y además se ha demostrado que VP3 participa en la capacidad 
inherente de pVP2 para adquirir las distintas conformaciones a través de pVP2CTD 
(Ona y col., 2004). Una posible interacción electrostática entre la hélice-α anfipática de 
VP2 y la región ácida del dominio C-terminal de VP3 se desarrollará más adelante. 
 
1.2.3.4. Estructura atómica de VP2 y VP3: 
 
La estructura atómica de T=1 SVP se ha resuelto por cristalografía de rayos-X 
[PDB 1WCD, (Coulibaly et al., 2005); PDB 2GSY, (Garriga et al., 2006); PDB 2DF7, 
(Lee et al., 2006)]. La subunidad de VP2 se pliega en tres dominios denominados 
proyección (P), carcasa o “shell” (S) y base (B) (Fig. 5). Los dominios S y P son 
barriles-β con una topología “jelly roll”, orientada de tal manera que las láminas-β están 
orientadas tangencial y radialmente a la partícula esférica. El dominio B consiste en un 
conjunto de hélices-α que se forman de la extensión de los dominios amino- y carboxi-
terminal de VP2, localizados en la superficie interna de la cápsida (Fig. 5). Más allá de 
las interacciones laterales entre los trímeros de VP2, las SVP están estabilizadas por 
iones Ca2+ localizados en los ejes de simetría de orden tres e interaccionando con dos 
residuos ácidos Asp-31 y Asp-174, que agrega a las tres subunidades de cada trímero. 
Una mayor estabilización viene acompañada por una larga hélice C-terminal (α4) de la 
subunidad de VP2 que se proyecta más allá del “core” de la proteína, orientada a través 
del eje de simetría de orden tres a través del trímero vecino de VP2 (Garriga et al., 
2006). 
 
VP3 posee un papel de andamiaje y su capacidad de autoensamblaje es similar a 
la de muchas otras proteínas de andamiaje en bacteriófagos (Tacken y col., 2000). La 
estructura atómica de la región central de la proteína VP3 (Casanas y col., 2008) (Fig. 
5B) muestra dos dominios formados por hélices-α, cuya interacción forma 
aparentemente un dímero biológico. El uso de mutantes de deleción ha permitido 
señalar el dominio de oligomerización de VP3 entre los residuos 224 a 247, cerca del 
dominio C-terminal de la proteína (Maraver y col., 2003b) 
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Fig.5. Estructuras atómicas de VP2 y VP3. (A) Modelo tridimensional de la estructura de VP2 ( entrada 
PDB 2GSY) resuelta por difracción de rayos-X a 2.6 Å (Garriga et al., 2006). Los dominios P, S y B 
están coloreados en naranja, azul y verde respectivamente. (B) Representación de un dímero de VP3, 
(entrada PDB 2Z7J) resuelto por difracción de rayos-X a 2.4 Å (Casanas et al., 2008), con un protómero 
marcado en rojo y el segundo en gris. Uno de los iones de oro (amarillo) ocupa el eje de orden dos y 
también participa en interacciones protómero-protómero. 
 
1.3. Relaciones estructurales y funcionales de IBDV con virus ssRNA y 
dsRNA: 
  
La arquitectura de la cápsida de IBDV es similar a las cápsidas externas de otros 
virus dsRNA, con los que comparte una organización T=13l. Sin embargo, a excepción 
de los birnavirus, todos los virus dsRNA poseen un “core” interno con una arquitectura 
característica T=1, constituida por 120 subunidades en el que la unidad fundamental es 
el dímero. Esta organización es una notable excepción a la teoría de cuasiequivalencia y 
se denomina cápsida “T=2” (el cual es un número “prohibido”). Hasta hace poco, el 
core T=2, como unidad funcional involucrada en la transcripción, replicación y 
protección del dsRNA frente a los mecanismos de defensa del hospedador (Gouet y col., 
1999; Lawton y col., 1997; Prasad y Prevelige, 2003), se consideraba un componente 
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esencial de los virus dsRNA. Sin embargo, la existencia de los birnavirus claramente 
establece que el dsRNA puede replicarse sin la necesidad de esta estructura. 
 
Los birnavirus deben compensar esta falta de nucleocápsida T=2, usando otras 
alternativas entre sus componentes estructurales. En este contexto, la interacción entre 
VP3, VP1 y el dsRNA posee un papel fundamental en la organización funcional de la 
cápsida de IBDV a nivel morfogenético, transcripcional y replicativo (Ahlquist, 2005; 
Garriga y col., 2007; Luque y col., 2009b).  
 
También se han encontrado interesantes similitudes entre los birnavirus y los 
virus ssRNA, noda- y tetravirus. Estos dos grupos de virus poseen de igual manera, un 
genoma bisegmentado (Fauquet y Fargette, 2005), una permutación en sus RdRp 
(Gorbalenya y col., 2002), proteínas de la cápsida similares (Coulibaly y col., 2005) y 
una maduración proteolítica de la misma esencial para la adquisición de la infectividad 
viral (Gallagher y Rueckert, 1988; Schneemann y col., 1998; Zlotnick y col., 1994). 
 
Nudaurelia capensis ω virus (NωV) es el prototipo de los ω-tetraviruses; virus 
ARN de cadena simple (ss) y polaridad positiva, sin envoltura y con un número de 
triangulación T=4 y genoma bisegmentado. Los dos segmentos de ARN empaquetados 
en cada cápsida viral se componen de, ARN1 de 5,3 kb, el cual codifica la polimerasa 
ARN dependiente de ARN (RdRp), y ARN2 de 2,4 kb codificante para el precursor de 
la proteína de la cápsida, proteína-α (70-kDa).  Los tetravirus infectan exclusivamente a 
insectos del orden Lepidopteran. La expresión de proteína-α de NωV en el sistema 
recombinante de baculovirus, produce el ensamblaje espontáneo de un intermedio 
procápsida. Tras la acidificación del medio (pH 5.0) se produce un cambio 
conformacional a gran escala dando lugar a la cápsida madura (Canady y col., 2000), 
seguido del corte autoproteolítico de la proteína de la cápsida. Mutaciones puntuales en 
la Asn del sitio de corte (Asn-570-Phe-571) permite un cambio conformacional 
reversible procápsida-cápsida en función del pH (Taylor y col., 2002). Se ha propuesto 
como mecanismo de corte que el Glu-103 ejerce un ataque nucleofílico sobre Asn-570. 
Mutaciones en el residuo Glu-103 producen el corte de manera menos eficiente (Taylor 
y Johnson, 2005). 
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 Nodavirus es una familia de pequeños virus icosaédricos que infectan insectos, 
mamíferos y peces, que incluye a las especies Flock House Virus (FHV) y Black 
Beetle Virus (BBV) (Hendry, 1991; Kaesberg, 1987; Mori y col., 1992). La partícula 
viral consiste en 180 copias de la proteína de la cápsida y un genoma bisegmentado. El 
genoma viral sólo codifica tres proteínas: la proteína-α (precursora de la proteína de la 
cápsida) en el ARN2; ARN1 codifica la replicasa y una pequeña proteína de 12-kDa 
denominada B2, que inhibe ARN de interferencia en células de Drosophila (Li y col., 
2002). La cápsida de nodavirus posee una simetría icosaédrica con un número de 
triangulación T=3 que ensambla inicialmente en un provirión que madura por el corte 
autoproteolítico de la proteína-α,  dando lugar a la proteína-β, que forma la cápsida 
viral, y el péptido-γ, que permanece asociado en el interior de la cápsida (Gallagher y 
Rueckert, 1988). La maduración proteolítica es necesaria para la adquisición de la 
infectividad (Schneemann y col., 1992) y estabilización del virión (Gallagher y 
Rueckert, 1988). La reacción proteolítica dependiente del residuo Asp-75 lanza un 
ataque nucleofílico sobre Asn-363 del sitio de corte (Zlotnick y col., 1994). En ambos 
casos, el péptido-γ, similar en FHV y NωV, parece estar involucrado en las 
translocación del ARN a través de membranas al principio de la infección (Cheng y col., 
1994). También se ha demostrado el rescate de FHV defectivos en maduración y por 
tanto en infectividad con particulas similares a virus (VLP) maduras no infecciosas 
(Walukiewicz y col., 2008). 
Por otro lado, un análisis de comparación de secuencias demuestra que las RdRp 
de los tetra- y birnavirus pertenecen a las polimerasas ARN no canónicas definidas por 
una permutación en el dominio de la palma con un motivo C-A-B en lugar del canónico 
A-B-C (Gorbalenya y col., 2002). Estos resultados sugieren que las polimerasas ARN 
primigenias podrían haber presentado una organización del dominio de la palma no 
canónico, a partir del cual las canónicas podrían haber evolucionado, siendo las RdRp 
de birna- y tetravirus trazas evolutivas de este proceso. La resolución cristalográfica por 
rayos X de VP1 (Garriga y col., 2007; Pan y col., 2007) demuestra que la permutación 
en el dominio C está asociado al mecanismo de regulación de la actividad catalítica por 
su interacción con el dominio C-terminal de VP3 (Garriga y col., 2007). 
 
Adicionalmente, la proteína VP2 de los birnavirus es un híbrido estructural entre 
las proteínas de la cápsida de virus ssRNA de cadena positiva (noda- y tetravirus) y de 
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la cápsida T=13 de la familia Reoviridae (virus dsRNA) (Coulibaly y col., 2005). 
Mientras que el dominio S y B de VP2 posee una gran homología con sus equivalentes 
de la proteína de la cápsida de noda- y tetravirus, el dominio protuberante (P) de VP2 y 
de la proteína de la cápsida de reovirus T=13 son estructuralmente similares (Fig. 6). De 
hecho, en noda- y tetravirus así como en IBDV, las hélices-α que tapizan la superficie 
interna de la cápsida generan canales hidrofílicos en los ejes de simetría de orden cinco 
que podrían estar implicados en la translocación de las nuevas moléculas transcritas de 
ssRNA a través de la cápsida (Coulibaly y col., 2005; Garriga y col., 2006; Munshi y 
col., 1996); esta extrusión a través de los ejes pentaméricos es una estrategia que se ha 
demostrado para miembros de la familia Reoviridae  (Diprose y col., 2001; Lawton y 
col,1997).
 
Fig.6. Relación estructural entre las cápsidas proteicas de virus (+) ssRNA y dsRNA. Comparación 
estructural de la estructura cristalográfica de la proteína β de FHV, un nodavirus (PDB 2Q26), con VP2 
de IBDV (PDB 2GSY) y VP6 de rotavirus, un reovirus (PDB 1QHD). El código de color coincide con los 
aspectos estructurales similares entre las distintas familias Nodaviridae/Tetraviridae, Birnaviridae y 
Reoviridae representados en la parte superior. Las proteínas de la cápsida de nodavirus y birnavirus 
poseen una alta homología estructural (representada en azul) entre los dominios S y B. El dominio P de 
birnavius y reovirus es similar (en amarillo). Las cápsidas de nodavirus, birnavirus y reovirus contienen 
respectivamente, ssRNA desnudo, complejos filamentosos de dsRNA con VP3 (círculos naranjas) y VP1 
(triángulos rojos); nucleocápsidas T=2 (púrpura) con dsRNA ordenado y complejos transcripcionales. 
Adaptado de Alquist 2005. 
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Viruses represent life stripped to the bare essentials. They are one of the smallest 
and simplest infectious agents identified to date. Indeed they are little more than a piece 
of genetic material protected by a protein coat or as Sir Peter Medawar said-“a piece of 
bad news wrapped up in protein” (Medawar PB, 1983). 
The prime characteristic of viruses is their absolute dependence on a host for 
multiplication and, as such, they are obligate parasites and a plague to all living 
organisms. Back in 1898, the Dutch scientist Beyerinck and the German researchers 
Loeffler and Frosch established, based on filtration experiments, that the causative 
agents of certain plant and animal diseases were smaller than all known bacteria. 
Yellow fever was the first human viral disease to be recognized, two years later (Major 
Reed and assistants, US Army, Havanna, 1900). To date, more than 1938 virus species 
belonging to 287 genera of 73 families have been identified (Fauquet and Fargette, 
2005). Probably, viruses are as old as life on Earth, but a broad public awareness is only 
emerging now, in view of the current AIDS pandemic and the recent outbreaks of 
severe acute respiratory syndrome and avian influenza. 
Virus particles, composed of an enveloped or non-enveloped protein shell and 
nucleic acid, are designed to move its genome between cells of a susceptible host and 
between hosts. Viral genomes exhibit a great diversity; the different families have 
genomes formed by one double stranded DNA (dsDNA) or single-stranded DNA 
(ssDNA), dsRNA or ssRNA, with positive, negative or ambisense polarity, circular or 
linear topology and simple or multipartite genomes. The protein shell provides a 
protective coat for the nucleic acid, carries out required chemical reactions for particle 
maturation, and facilitates entry into the cell. Virus particles are always formed of 
multiples copies of identical gene products, minimizing the genetic information required 
for shell formation. This strategy reduces the burden of encoding a large protein but 
generates the new problem of assembling multimers, with tens, hundreds or thousands 
of subunits, in a biologically realistic time frame, being a paradigm in the optimization 
strategy of resources (Johnson and Speir, 1997). Viral capsids represent an excellent 
framework for the analysis of “built-in” features such as structural polymorphism and 
transient conformations. In addition, complex capsids may require one or more auxiliary 
proteins (scaffold, accessory, and proteolytic proteins) to trigger structural and 
functional changes. 
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Crick and Watson proposed icosahedral geometry for spherical capsids, 
reasoning that the most effective way of enclosing a large volume with a small protein 
is to arrange it in a regular geometric repeat, (Crick and Watson, 1956). An 
experimental corroboration for this hypothesis was provided by D.L.D. Caspar who 
noted that the arrangement of intense reflections in a X-ray photograph by bushy stunt 
virus corresponded to the arrangement of icosahedral five-folds (Caspar, 1956). Of the 
platonic solids (composed of identical faces), icosahedra have the largest number (20 
equilateral triangles). Since each facet has a three-fold symmetry, the resulting solid is 
formed by 60 identical asymmetric units. Icosahedra can also be defined in terms of 
their 532-point symmetry. Each of the twelve icosahedral vertexes is coincident with a 
five-fold symmetry axis (5x12=60); five-fold symmetry axes run through one five-fold 
axis, through the centre of the icosahedron, and out the other side. Moreover, there are 
30 two-fold axes (2x30=60) which run through the edge-edge contacts between facets. 
 
Icosahedral geometry (with 60 identical copies) allows that a relatively short 
RNA/DNA sequence could code for a protein capable of encapsidating the complete 
genome. The theory of quasi-equivalence describes how multiples of 60 monomers can 
be arranged with quasi-icosahedral symmetry to enclose an even larger volume (Caspar 
and Klug, 1962). The underlying postulate of quasi-equivalence is that the viral coat 
protein can form pentamers and hexamers using the same subunits contacts, but with 
slight conformational changes between structural subunits. The only requirement for an 
icosahedral facet is being an equilateral triangle with three identical asymmetric units 
arranged with three-fold symmetry. Using a hexagonal grid one can see that there are 
series of equilateral triangles that enclose an integral number of smaller triangles (the 
so-called triangulation number, T). The area of an asymmetric unit for a triangle with 
one vertex on the origin (0, 0) and a second vertex at a point (h, k) is: T=h2+hk+k2. The 
size of the equilateral triangle is proportional to the T number and each particle will 
contain 60T subunits. These will be arranged as 12 pentamers and 10 (T-1) hexamers 
(Fig.1). 
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Fig.1. Geometric principles for generating icosahedral quasi-equivalent surface lattices. Hexamers 
are initially considered planar (an array of hexamers forms a flat sheet as shown) and pentamers are 
considered convex, introducing curvature in the sheet of hexamers when they are inserted. The closed 
icosahedral shell, composed of hexamers and pentamers, is generated when by inserting 12 pentamers at 
appropriate positions in the hexamer net. To construct a model of a particular quasi-equivalent lattice, one 
face of an icosahedron is generated in the hexagonal net. The origin is replaced with a pentamer and the 
(h, k) hexamer is replaced by a pentamer. The third replaced hexamer is identified by 3-fold symmetry 
(i.e. complete the equilateral triangle of the face). The icosahedral face for a T=3 surface lattice is defined 
by the triangle in orange lines (h=1, k=1). Two possible T=7 lattice choices are also marked in green and 
blue (h=2, k=1 or h=1, k=2, these being mirror images of each other), and require knowledge of the 
arrangement of hexamers and pentamers and the enantiomorph of the lattice for a complete lattice 
definition (adapted from Johnson J.E. and Speir J.A, 1997).  
 
Quasi-equivalence arises because the subunits within an asymmetric unit are not 
fully equivalent. In theory, quasi-equivalent shells of any size can be formed. In other 
systems, different subunit polypeptides are also utilized for the formation of pentamers 
and hexamers; they are denominated as pseudoequivalent shell and defined and by a P 
number (pseudo-T number). 
 
1.1. Different control mechanisms for viral capsid assembly 
 
In capsids with T>1, the proteins subunits must adopt several different 
conformations depending on their different structural environments in the shell; that is, 
the bonding properties of subunits are not identical, and several classes of conformers 
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exist (Caspar and Klug, 1962). High-resolution structural studies have revealed some 
clues about how a capsid protein is able to know the conformation that must adopt 
(Liddington et al., 1991; Rossmann and Johnson, 1989) although the mechanism is still 
poorly understood (Johnson and Speir, 1997).  
  
1.1.1. Control of conformational switching 
 
The information for the conformational switching required for the assembly of a 
T>1 shell is intrinsic to the subunits themselves, which are often able to form 
morphologically correct shells in the absence of other proteins and are determined by 
factors like flexible protein regions (loops and N- and C-terminal domains), RNA 
interactions, metallic ions, pH and different combinations between all of them (Johnson, 
1996). In many cases, however, they form a variety of aberrant shell-related structures 
depending on the physiological conditions in a way (Krol et al., 1999; Salunke et al., 
1989; Savithri and Erickson, 1983; Schwartz et al., 2000). Restrict the inherent 
flexibility, in which only the appropriate conformations are formed, is as important to 
the assembly process as the generation of conformational variability.  
 
There is a close connection between protein folding and assembly. Viral 
structural proteins are often quite flexible in solution and each subunit chooses its 
conformation on the basis of the conformational state of its neighbours (Berger et al., 
1994).  
 
1.1.2. Cores and scaffolds 
 
As the size of the shell gets larger and interactions become numerous, additional 
information may be required to constrain the conformational possibilities of the capsid 
protein and to ensure the fidelity of the assembly process. This information might come 
from a scaffold or core proteins. 
 
The core itself is presumably simple enough to assemble without any additional 
information. Once the shell size is specified by the core, the symmetry may be governed 
by simple pattern formation (Berger et al., 1994), while core-shell interactions are 
relatively non-specific (Grimes et al., 1998). Among the best characterized of such 
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proteins is the precursor of the herpes simplex virus type I VP22a protein (Zhou et al., 
1998). PreVP22a interacts with the major capsid protein, VP5, through its C-terminal 25 
residues, and this interaction is essential for capsid assembly. 
 
The term “scaffolding protein” usually refers to a protein playing an essential 
structural role during assembly but is subsequently removed, analogous to the role of 
molecular chaperones in protein folding. Scaffolding proteins share a similar structural 
organization, including an elongated shape, and a specific capsid interaction domain at 
the C-terminus. The scaffolding protein itself does not form a symmetric structure, but 
apparently provides sufficient information to constrain the shell symmetry by defining 
the overall size of the outer shell, (Dokland, 1999), i.e. P2 internal scaffolding protein 
gp0 required for the formation of viable capsids of both P2 and P4 bacteriophages 
(Chang et al., 2009). 
 
1.1.3. Major conformational changes 
 
While conformational switching provides the mechanism for generating the 
structural diversity required to make large capsids, some virus capsids go further and 
undergo a large-scale reorganization of their entire structure. The typical example is 
found in the dsDNA phages which undergo capsid expansion, (Conway et al., 1995; 
Dokland and Murialdo, 1993). The resolution of prohead II, one of the intermediate 
assembly capsid of the lambda-like bacteriophage HK97, at 3.65Å resolution has 
unveiled an unprecedent expansion mechanism that describes the transition (Gertsman 
et al., 2009). 
 
1.1.4. Assembly intermediates and pathways 
 
It is assumed that viruses assemble via a pathway of intermediates, particularly 
for large and complex viruses, each consisting of a subset of the final capsid structure, 
forming a precursor particle- the provirion or procapsid. Assembly through 
intermediates reduces the errors dramatically (Berget, 1985). Examples of viruses that 
assemble through procapsids intermediates are herpesvirus (Newcomb et al., 2000) and 
bacteriophages, like T7 (Agirrezabala et al., 2007). 
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The assembly process proceeds through separate nucleation and growth events. 
Thus, the initial nucleus may consist of a specific subassembly whereas subsequent 
growth proceeds from other structures (Stehle et al., 1996). 
 
1.1.5. Proteolytic processing  
 
Proteases can be cellular and viral origin and play essential roles in viral 
replication, including the coordinated assembly and maturation of virions (Hellen and 
Wimmer, 1992). Most of these enzymes belong to one of three classes, Ser-, Cys- or 
Asp-proteases, and can play two general roles in viral morphogenesis. The first one is 
that of structural proteins encoded by retroviruses and many RNA viruses as part of 
large polyproteins. Their proteolytic release is a prerequisite for particle assembly. The 
second role is in assembly-dependent maturation, which is accompanied by the 
acquisition of infectivity. For instance, in orthoretroviruses, most of the newly released 
particles are “immature”; virus-encoded protease cleaves the Gag polyprotein during or 
soon after assembly to allow the transformation from immature to mature particles 
(Adamson and Freed, 2007). 
 
Host-encoded proteases cleave viral protein precursors in a conventional manner 
after the precursor polypeptides have been transported to vesicular compartments; i.e. 
during the course of Hepatitis A virus particle assembly, immature procapsids might be 
targeted to early lysosomes where they encounter cellular proteases including cathepsin 
L that remove 2A peptide and thereby fully mature the particles (Morace et al., 2008). 
In contrast, cleavage by viral proteases is more complex. It occurs by a variety of 
mechanisms facilitating the assembly of complex viral structures and the post-assembly 
maturation of the virion (Gallagher and Rueckert, 1988). 
 
1.2. Birnaviridae family: Infectious bursal disease virus 
 
The Birnaviridae family forms a distinct family of dsRNA viruses infecting 
animal species as different as vertebrates, molluscs, insects, and rotifers (Delmas, 2004). 
It groups three different genera: Aquabirnavirus, Entomobirnavirus and Avibirnavirus; 
and the representative members are: Infectious pancreatic necrosis virus (IPNV); 
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Drosophila X virus (DXV); and Infectious bursal disease virus (IBDV), respectively 
(Fauquet and Fargette, 2005). Most of the research efforts on birnaviruses have focused 
on IBDV (Muller et al., 2003), which shows interesting virulence properties and is 
responsible for important losses in the poultry industry. Another economically relevant 
birnavirus is IPNV, of salmonids that affects a wide variety of farmed fish species 
(Delmas, 2004).  
 
IBDV is the causative agent of the infectious bursal disease (IBD) that affects 
young chickens. When IBD appeared in chickens in 1959, the disease was designated as 
“Gumboro disease” after the geographic location of the first recorded outbreaks 
(Gumboro, Delaware, USA). Infections caused by IBDV may exacerbate the 
susceptibility to other pathogens, and reduce the chicken’s ability to respond to 
vaccination. This causes a severe economical impact on poultry industry worldwide 
(van den Berg et al., 2000). 
 
Lymphoid cells in the bursa of Fabricius (BF) are the main target cells of IBDV. 
Between 3 and 6 weeks after hatching, when the BF reaches maximum development, 
chickens are highly susceptible to the virus. Infection results in lymphoid depletion and 
the final destruction of the bursa as the predominant feature of the IBD pathogenesis. In 
the classical form of the outbreaks, the mortality rate may range from 1 to 50%. 
Depression in egg production and deterioration in eggshell and internal quality of eggs 
in commercial laying strain flocks are also observed. In addition to mortality, IBDV is 
immunosuppressive. Immunosuppression is denoted by a high prevalence of viral 
respiratory infections and elevated mortality due to airsacculitis and colisepticemia 
during the terminal third of the 6-8 week growing cycle (Kaufer and Weiss, 1980).  
 
IBDV has been described to be resistant to all the conventional disinfection 
procedures like chemical or heat inactivation. At the moment, the only available method 
to control the disease is the implementation of intensive vaccine programs (Negash et 
al., 2004). The indiscriminate use of attenuated vaccines has led to the rapid virus 
dissemination around the world (Yamaguchi et al., 1996). The search of new strategies 
to control and erradicate the disease is a flock farming priority. This is especially 
important in developing countries, in which chicken meat is the main protein source of 
the diet. 
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1.2.1. IBDV serotypes 
 
There are two different serotypes for IBDV, I and II that are distinguished by 
sero-neutralization assays (McFerran et al., 1980). Serotype I includes all the 
pathogenic isolates for domestic chickens, whereas serotype II isolates, mostly from 
turkeys, do not produce clinical symptoms or protection against type I isolates. 
Pathogenic serotype I isolates are subdivided into classical, antigenic-variant, and very 
virulent isolates. Antigenic-variant IBDV have only been reported in the United States 
(since 1985) and were found to have single amino acid changes in a specific region of 
the VP2 protein (the hyper variable region), leading to a different pathologic phenotype 
(Snyder, 1990). Since 1988 in Europe, (Chattel et al., 1989), there were reports 
describing IBDV isolates that had an enhanced virulence (very virulent IBDV [vivid]) 
while having the same antigenic structure as classical isolates. Amino acid differences 
between viral proteins of vivid and classical IBDV isolates were found scattered 
throughout all viral proteins, although most of them were found in the hyper variable 
region of VP2 (Brown and Skinner, 1996; Pitcovski et al., 1998). 
 
1.2.2. IBDV genomic organization 
 
The IBDV genome is formed by two segments of dsRNA of 3,2 kb (segment A) 
and 2,8 kb (segment B) (Muller and Nitschke, 1987a; Muller et al., 1979) with 
untranslated regions (UTR) at the 5’ and 3’ ends. In vitro ssRNA synthesis studies show 
that the RNA polymerase synthesizes viral ssRNA by a semi-conservative strand 
displacement mechanism, whereby the nascent strand displaces one of the parental 
strands (Spies et al., 1987) (Fig.2).  
 
Segment A contains two partially overlapping open reading frames (ORFs). The 
smaller ORF codes for VP5 (15 kDa), a non-essential polypeptide that is involved in 
virus dissemination (Lombardo et al., 2000), and inhibits apoptosis at the very early 
stage of virus infection (Liu and Vakharia, 2006). The larger ORF encodes a 110 kDa 
polyprotein that undergoes an auto-cleavage by the viral protease VP4, yielding the 
pVP2 (54.4 kDa), VP3 (29 kDa), and VP4 (26.7 kDa) polypeptides.  
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Fig.2. IBDV genomic organization. Segment A possesses two open reading frames (ORFs) partially 
overlapped, which codes for protein VP5 and viral polyprotein, respectively. The polyprotein undergoes 
an auto-cleavage by the viral protease VP4, yielding pVP2, VP3 and VP4. pVP2 C-terminal domain is 
removed during further processing, rendering the mature VP2. Segment B encodes for VP1, the viral 
RNA-dependent RNA polymerase.  
 
Segment B encodes VP1 (97.8 kDa), the viral RNA-dependent RNA 
polymerase (RpRd) (Morgan et al., 1988; Muller and Nitschke, 1987b; von Einem et al., 
2004) with different functions related to viral replication. Like other viral dsRNA 
polymerases, VP1 catalyzes transcription and viral genome replication (Garriga et al., 
2007; Pan et al., 2007; Spies et al., 1987; Xu et al., 2004). Although RNA 
polymerization and priming usually involve different viral components, in birnaviruses 
the polymerase is responsible for both activities. VP1 guanylylates itself acting as a 
primer for the RNA synthesis (Dobos, 1993; Shwed et al., 2002; Spies and Muller, 
1990; Xu et al., 2004).  
 
1.2.3. IBDV structure and morphogenesis 
 
1.2.3.1. Structural components of IBDV virion 
 
IBDV infectious particles assemble and accumulate in the cell cytoplasm, and 
consists of two major (VP2 and VP3) and two minor proteins (VP1 and VP4) (Fig.3B).  
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Virus purification renders six different populations sharing an identical protein 
composition but showing higher sedimentation coefficients as particle density increases. 
Biochemical analyses showed that these biophysical differences correlate with the 
number of dsRNA segments present within the viral capsid. IBDV particles with greater 
genome copy number (i.e. polyploid viruses) have higher infectivity rates (Luque et al., 
2009a). 
 
The virion has a single-shelled capsid with an external diameter of 65-70 nm 
formed of 260 quasi-equivalent pVP2/VP2 trimeric subunits, arranged with a T=13l 
(levo) architecture (Bottcher et al., 1997; Caston et al., 2001; Coulibaly et al., 2005). 
The (p) VP2 trimers are organized in 12 pentamers and 120 hexamers, and from a 
geometrical perspective, exist in five distinct conformations (a-e). VP2 represents the 
main marker for virulence and pathogenesis, and also induces neutralizing antibodies 
(Brandt et al., 2001) (Fig.3A). 
 
 
 
Fig.3. Capsid structure. (A-B). Surface-shaded representations at 10 Å (Luque et al., 2007) of the outer 
(A) and inner (B) surfaces of IBDV capsids viewed along a three-fold axis of icosahedral symmetry. The 
five different types of trimeric capsomers are indicated by letters a to e. Bar=100 Å. Icosahedral 
symmetry axes are indicated in red numbers. (C) IBDV purified virions negative stained with uranyle 
acetate. Bar=100nm. In the square, the electrophoretic analysis and silver staining of mature IBDV 
virions is shown (Lombardo 1999). Structural proteins are indicated by an arrow: VP1 (97.8 kDa), pVP2 
(~54 kDa), VP2 (47 kDa), VP3 (29 kDa) and VP4 (26.7 kDa).  
 
pVP2 (512 residues) is the precursor form of the capsid protein VP2; the C-
terminal 71 residues (pVP2 C-terminal domain, pVP2CTD), are removed, rendering the 
mature VP2 polypeptide (47 kDa, 441 residues). It has been proposed that the 
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postranslational maturation of pVP2 occurs by two different proteolytic events: 
processing by VP4 in secondary alanyldipeptide targets in position 487, 494 and 501 
(generating at least four different variants of pVP2) (Sanchez and Rodriguez, 1999), and 
a processing event between residues (441-442), as discussed below. The maturation is 
required for correct viral capsid assembly (Chevalier et al., 2002). The small pVP2-
based peptides generated remain associated to the viral particle (Da Costa et al., 2002), 
and possess membrane desestabilization capacity, which suggests their implication 
during viral internalization (Chevalier et al., 2005; Galloux et al., 2007). A similar post-
assembly pVP2 maturation pathway has also been demonstrated for IPNV (Villanueva 
et al., 2004). 
 
VP3 is a multi-tasking protein involved in numerous processes during viral 
cycle. VP3 acts as a scaffolding protein during virus assembly, probably interacting 
with VP2, as discussed below. In addition to its interaction with pVP2, VP3 interacts 
with VP1 and the dsRNA genome (Kochan et al., 2003; Maraver et al., 2003a; Maraver 
et al., 2003b; Tacken et al., 2002). Actually, the interaction of VP3 with VP1 is 
responsible for the encapsidation of the viral polymerase into VLP (Lombardo et al., 
1999). The region of VP3 responsible has been mapped within the highly charged 16 
amino-acid domain located near its C-terminus (Maraver et al., 2003a). Recently, it has 
been demonstrated that this interaction releases the inherent blockade of the active site 
of the viral RNA RdRP, thus acting as a transcriptional transactivator (Garriga et al., 
2007). 
 
Finally, the domain of VP3 that directs the dsRNA binding activity of the 
protein has been mapped by deletion mutagenesis to a 69 amino-acid region located 
near the N-terminus. Based on in vitro assays, it has been shown that the dsRNA 
binding activity is sequence independent, consistent with a general role for VP3 in 
stabilizing the viral RNA (Kochan et al., 2003), and protecting it from cellular RNases. 
VP1, VP3 and the virus genome form a transcriptionally active ribonucleoprotein 
complex (RNP) (Luque et al., 2009b). 
 
VP4 is a non-canonical Ser-Lys Lon protease (Birghan et al., 2000), and its 
atomic structure has been recently determined (Feldman et al., 2006; Lee et al., 2007). 
VP4 lacks the ATPase domain of the Lon proteases, although its catalytic site is the Ser-
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652-Lys-692 dyad. Moreover, VP4 acts in a cotranslational and autocatalytically 
manner (Birghan et al., 2000). VP4 protein is a true structural component of the virion 
although its encapsidation is highly variable (Granzow et al., 1997; Luque et al., 2009a). 
In IBDV-infected cells, VP4 forms tubular structures (so called, type II tubules) with a 
diameter of about 25 nm. 
 
1.2.3.2. Virus based expression systems to analyze IBDV capsid assembly 
 
One of the most successful approaches to understanding the role of IBDV 
proteins in particle assembly has been the use of heterologous expression systems 
capable of supporting VLP formation. 
 
Expression of the IBDV polyprotein in mammalian cells using inducible 
recombinant vaccinia virus vectors results in the correct processing of the polyprotein 
and the accumulation of abundant levels of VLP. The size and shape of these VLP are 
similar to those of authentic IBDV particles (Fernandez-Arias et al., 1998; Lombardo et 
al., 1999), thus, demonstrating the reliability of this expression system. Smaller capsids 
are also observed, representing a T=7 (Fig. 4E) arrangement of equivalent trimeric 
capsomers. Unlike the T=13 capsid, with its five classes of trimeric capsomers, the T=7 
icosahedron displays only three trimer classes. 
 
The expression of the IBDV polyprotein in insect cells using a baculovirus 
expression system also results in the processing and accumulation of pVP2, VP3 and 
VP4. However, the assemblies produced with this expression system are structurally 
varied and, in general, the formation of VLP is rather inefficient. The use of a FastBac 
transfer vector to generate a baculovirus encoding the polyprotein yields rigid tubular 
structures (type I tubules), with diameters of 50 nm (Martinez-Torrecuadrada et al., 
2000). These tubular structures, made up of pVP2, exhibit an equivalent hexagonal 
arrangement, similar to the type I tubules observed in IBDV-infected cells (Martinez-
Torrecuadrada et al., 2000). A comparable result has been obtained with other 
baculovirus-based constructs (Chevalier et al., 2002). Overexpression from other 
baculovirus systems leads to the assembly of VLP, flexible tubules, and intermediate 
assembly products formed by icosahedral caps elongated in tubules. All these structures 
consist of pVP2 and variable amounts of VP2 and VP3 (Martinez-Torrecuadrada et al., 
 36
Chapter 1—————————————————————————————— 
2000). These results with the baculovirus expression system support the idea that insect 
cells have important cellular factor(s) interfering negatively with VLP assembly (e.g. 
cellular proteins and/or host environment); some of these factors will be further 
discussed in the present report. 
 
1.2.3.3. Structural polymorphism of IBDV coat protein 
 
Expression of the mature form of VP2 using different baculovirus-based vectors 
results spontaneously in the formation of isometric particles of 26 nm diameter (Caston 
et al., 2001; Coulibaly et al., 2005; Lee et al., 2003). Analysis of these subviral particles 
(SVP) shows that they are dodecameric T=1 structures, composed of 20 trimers of VP2 
(Caston et al., 2001) (Fig. 4A and 4D). VP2 trimers alone posses the intrinsic 
information required for their assembly into pentameric, but not hexameric units. 
Whereas pVP2 expression leads to poorly ordered tubular structures with a hexagonal 
lattice (Fig. 4C and 4G), but lacks sufficient information to produce the complex 
interaction pattern required for building a T=13 capsid (Caston et al., 2001; Saugar et 
al., 2005). 
 
Differences in the assembly behaviour of VP2 and pVP2 suggest that 
information affecting inter-subunit interactions is contained within the pVP2 CTD or is 
induced by the interaction of pVP2 CTD with additional viral components. These 
results suggest that (i) the pVP2CTD plays an important role in determining different 
VP2 conformations, and (ii) IBDV capsid formation requires the interaction of VP2 
with other viral components.  
 
The pVP2CTD peptide 443-GFKDIIRAIR-452, absent in the mature protein 
VP2, forms an amphiphatic α-helix (Galloux et al., 2007; Saugar et al., 2005). pVP2 
intermediates containing this α-helix are able to assemble into the T=13 VLP (Fig. 4B 
and 4F), but only when expressed as a chimeric protein containing an N-terminal His 
tag extension (Saugar et al., 2005). In the context of this construct, the amphiphatic α-
helix acts as a temporal molecular switch, and the His tag acts as a molecular triggering 
factor, partially emulating the VP3 C-terminal region. The last five residues in the VP3 
C-terminal end are homologous to the acidic segment of the His tag. Indirect studies 
confirmed the importance and uniqueness of the VP3 C-terminal end (Chevalier et al., 
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2004; Gonzalez et al., 2005; Maraver et al., 2003b). The VP3 role is akin to those of 
canonical scaffolding proteins rather than an intrinsic component of the capsid 
(Coulibaly et al., 2005; Saugar et al., 2005). Effectively, VP3 participates in the inherent 
ability of pVP2 to acquire different conformations through the pVP2 C-terminal end 
(Ona et al., 2004) by a putative electrostatic interaction between the VP2 C-terminal 
domain and the VP3 Ct acidic region, will be discussed below. 
 
 
Fig.4. Structural polymorphism of VP2 coat protein in insect cells. (A) SVPs T=1 (B) T=13 capsids 
and (C) rigid tubes purified from insect cells infected by rBVs that express the mature protein VP2, the 
HT-VP2-466 chimeric protein and the polyprotein.Bar=100nm. 3DR of (D) a SVP, (E) T=7 capsid, (F) 
T=13 capsid and (G) pVP2 tube at 26 Å resolution. Bar=10nm. 
 
1.2.3.4. Atomic structures of VP2 and VP3: 
 
The atomic structure of the T=1 SVP has been solved by X-ray crystallography 
[PDB 1WCD, (Coulibaly et al., 2005); 2GSY, (Garriga et al., 2006); 2DF7, (Lee et al., 
2006)]. The VP2 subunit is folded into three domains named projection (P), shell (S), 
and base (B) (Fig.5A). Domains S and P are β-barrels with a jelly roll topology, 
oriented such that their β-strands are oriented tangentially and radially, respectively, to 
the spherical particle. The B domain consists of α-helices, formed from extensions of 
the N- and C-termini of VP2, facing the inner surface of the capsid (Fig.5B). Besides 
lateral interactions between the VP2 trimers, SVPs are stabilized by Ca 2+ ions located 
at the three-fold icosahedral axes that interact with the two acidic Asp-31 and Asp-174 
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residues, linking together the three subunits of each trimer. Further stabilization is 
accomplished by the long C-terminal helix (α4) of the VP2 subunit that is projected 
away from the core of the protein, oriented towards the three-fold axis of the 
neighbouring VP2 trimer (Garriga et al., 2006).  
 
VP3 has a scaffold role, consistent with the finding that VP3 is able to self-
assemble, as many bacteriophage scaffolding proteins do (Tacken et al., 2000). The 
atomic structure of the central region of the protein VP3 shows two domains formed by 
α-helices, whose interaction can form an apparently biological dimer (Casanas et al., 
2008) (Fig. 5B). The use of deletion mutants has allowed mapping of the VP3 
oligomerization domain between residues 224 to 247, near the C-terminal end of the 
protein (Maraver et al., 2003b). 
 
Fig.5. VP2 and VP3 atomic structures. (A) 3D model of VP2 structure (PDB entry 2GSY) resolved by 
X ray diffraction at 2.6 Å (Garriga et al., 2006). Domains P, S, and B are coloured orange, blue, and 
green, respectively. (B) Ribon plot of a VP3 dimer, (PDB entry 2Z7J) resolved by X-ray diffraction at 2.4 
Å (Casanas et al., 2008), with one protomer shown in red and the second one in grey. One of the gold ions 
(yellow) occupies the two-fold axis and also participates in protomer-protomer interactions. 
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1.3. IBDV structural and functional relationships with ssRNA and 
dsRNA viruses 
  
The IBDV capsid architecture is very similar to the outer capsids of many other 
dsRNA viruses sharing a T=13l organization. However, with the exception of 
birnaviruses, all dsRNA viruses posses an internal core with a characteristic T=1 
architecture, constituted by 120 subunits in which the fundamental unit is a dimer. This 
organization, a notable exception in the quasi-equivalence theory, is denominated 
“T=2” capsid (which is a “forbidden” number). Until recently, the T=2 core, was 
considered to be an essential component of all dsRNA viruses, as a functional unit 
involved in transcription, replication and protecting the dsRNA genome from host 
defence mechanism (Gouet et al., 1999; Lawton et al., 1997; Prasad and Prevelige, 
2003). However, the existence of birnaviruses clearly establishes a mechanism in which 
a segmented dsRNA genome can fully be accomplished in the absence of this T=2 shell.  
 
Birnaviruses should compensate the lack of the T=2 capsid by using some 
alternative structural components. In this context, the ribonucleoprotein complex 
formed by VP3, VP1 and viral dsRNA appears to exert a fundamental role in the 
functional organization of  IBDV capsid in a morphogenetic level as well as in the 
transcriptional and replication mechanisms (Ahlquist, 2005; Garriga et al., 2007; 
Hjalmarsson et al., 1999; Luque et al., 2009b). 
  
Interesting structural and functional similarities between birnaviruses and 
positive ssRNA virus such as noda- and tetraviruses have been found. These two virus 
groups posses a bisegmented genome (Fauquet and Fargette, 2005), a permutation in 
their RdRps (Gorbalenya et al., 2002), similar coat proteins (Coulibaly et al., 2005) and 
an autoproteolytic maturation step of the capsid protein essential for virus infectivity 
(Gallagher and Rueckert, 1988; Schneemann et al., 1998; Zlotnick et al., 1994).  
 
Nudaurelia capensis ω virus (NωV) is the prototype of the ω-tetraviruses; 
nonenveloped, positive sense ssRNA viruses with T=4 icosahedral symmetry and 
bipartite genomes. Both RNA segments are packaged in each viral capsid. RNA1 is 5.3 
kb and encodes the RNA-dependent RNA polymerase, while RNA2 is 2.4 kb and codes 
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for the 70-kDa coat protein precursor called α−protein. Tetraviruses exclusively infect 
insects of the Lepidopteran order. The expression of NωV RNA2 in a recombinant 
baculovirus system, yields a porous procapsid intermediate composed by 240 
chemically identical copies of protein-α. After acidification (pH 5.0) this intermediate 
undergoes a large-scale conformational change into the mature capsid (Canady et al., 
2000).  
 
The conformational change is followed by an autoproteolytic cleavage that 
requires an acidic environment (pH 5.0). The asparagine residue at the scissile bond 
(Asn-570-Phe-571) is required for cleavage and a point mutation allows the particles to 
undergo the conformational change from procapsid to capsid reversibly as a function of 
pH (Taylor et al., 2002). As a cleavage mechanism, it has been proposed that Glu-103 
participates in this reaction enabling to perform a nucleophilic attack on Asn-570 
(Taylor and Johnson, 2005). Intermediates formed by a protein containing mutations in 
the Glu-103 residue cleave significantly less efficient than the wild-type capsid (Taylor 
and Johnson, 2005). 
 
 Nodavirus is a family of small icosahedral viruses infecting insects, mammals 
and fish, which include Flock House Virus (FHV) and Black Beetle Virus (BBV) 
(Hendry, 1991; Kaesberg, 1987; Mori et al., 1992). The nodavirus particle consists of 
180 copies of the coat protein, which encapsidates a bipartite genome. RNA1 encodes 
protein A, a 112-kDa RdRp. A subgenomic RNA3 is produced from RNA1 in infected 
cells and encodes the 12-kDa B2 protein, which has been shown to inhibit RNAi in a 
drosophila cell line (Li et al., 2002). Finally, RNA2 encodes the 43-kDa capsid protein-
α (Hendry, 1991; Kaesberg, 1987). Nodavirus capsids (T=3 icosahedral symmetry) are 
initially assembled as provirions of α-protein, which undergoes a post-assembly 
cleavage leading the β-protein, that forms the virus capsid protein, and the γ-peptide that 
remains associated at the interior of the capsid, (Gallagher and Rueckert, 1988). This 
proteolytic maturation is required for the acquisition of infectivity (Schneemann et al., 
1992) and increases the virion stability (Gallagher and Rueckert, 1988). The proteolysis 
reaction occurs near the interior surface of the protein shell and is dependent on the 
Asp-75 residue, that triggers Asn-363 residue of the cleavage site by a nucleophilic 
attack (Zlotnick et al., 1994). In both cases the γ-peptide, which is similar in FHV and 
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NωV, seems to be involved in the RNA membrane translocation at the beginning of the 
infection (Cheng et al., 1994). It has been also demonstrated the rescue of maturation-
defective FHV infectivity with non-infectious mature virus-like particles (VLP) 
(Walukiewicz et al., 2008). 
 
On the other hand, sequence comparison analysis demonstrates that tetra- and 
birnaviruses polymerases belongs to the non-canonical RNA polymerases defined by a 
permutation in the palm domain with a C-A-B motif instead of the A-B-C canonical one 
(Gorbalenya et al., 2002). These results suggest that primigenic RdRp had a non-
canonical palm domain organization from which canonical RdRp could have evolved; 
being birna- and tetravirus RdRp evolutive traces of this process. Recently, the X-ray 
crystallographic resolution of VP1 (Garriga et al., 2007; Pan et al., 2007) demonstrated 
that the C motif permutation is associated to a catalytic activity regulation mechanism 
by its interaction with the VP3 C-terminal domain (Garriga et al., 2007).  
 
Birnaviruses VP2 protein is a structural hybrid between the capsid protein of 
positive ssRNA viruses (noda- and tetravirus) and the capsid protein T=13 of 
Reoviridae family (dsRNA viruses) (Coulibaly et al., 2005). Whereas the shell (S) and 
the base (B) domains of VP2 have a high structural homology with the capsid proteins 
of noda- and tetraviruses, its projection domain (P) is structurally homologous to that of 
reovirus T=13 capsid protein (Fig.6). α-helices surrounding the inner surface of the 
capsid in noda- and tetraviruses as well as in IBDV, generate hydrophilic channels in 
the five-fold symmetry axes that might be involved in the translocation of newly 
transcribed ssRNA (Coulibaly et al., 2005; Garriga et al., 2006; Munshi et al., 1996); 
the extrusion through the pentameric axes has been demonstrated for the Reoviridae 
family members (Diprose et al., 2001; Lawton et al., 1997).  
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Fig.6. Structural relationships between capsid proteins of (+) ssRNA and dsRNA viruses. Structural 
comparison of the crystallographic structure of protein β of FHV, a nodavirus (PDB 2Q26), with VP2 of 
IBDV (PDB 2GSY) and VP6 of rotavirus, a reovirus (PDB 1QHD). Colour code is coincident with 
comparative diagrams of main structural features of virions of families Nodaviridae/Tetraviridae, 
Birnaviridae and Reoviridae represented in the upper part. Capsid proteins of nodavirus and birnavirus 
posses a high structural homology (coloured in blue) between S and B domains. P domains of birnavirus 
and reovirus are similar (in yellow). Nodavirus, birnavirus and reovirus capsids contain, respectively, 
naked ssRNA; filamentous complexes of dsRNA with VP3 (orange circles) and VP1 (red triangles); T=2 
nucleocapsids (purple) with ordered dsRNA and transcriptional complexes. Adapted from Alquist 2005. 
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—————————————————————————————————Aims 
 
The general aim of this thesis is the characterization of the maturation process of 
IBDV capsid. In this context, the following topics were proposed: 
 
1. Analysis of the putative interaction between the pVP2 and VP3 C-
terminal ends involved in the structural polymorphism of the IBDV 
capsid protein. 
 
2. Characterization of the post-translational processing events for the 
precursor of the capsid protein and its implication in viral assembly. 
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3.1 Biological Material 
 
3.1.1 Prokaryotic cells  
 
E. coli DH5α (Raleigh E.A., 2003) was used for the amplification of 
recombinant plasmids. E. coli DH10-Bac (Luckow et al., 1993) has been utilized for the 
generation of baculovirus infective bacmids. 
 
3.1.2 Eukaryotic cells 
Expression experiments were carried out with BSC-40 mammalian cells, kidney 
epithelial cells from Cercopithecus aethiops (Brockman and Nathans, 1974) (ATCC, 
CRL-2761) or QM7 quail muscle cells (Antin and Ordahl, 1991) (ATCC, CRL-1962) 
for vaccinia recombinants (rVV) and IBDV infections, and Trichoplusia ni (H5) insect 
cells (Invitrogen), adapted for monolayer growth from the cellular line Sf9 of 
Spodoptera frugiperda (Vaughn et al., 1977) (ATCC, CRL-1711) for baculovirus 
recombinants (rBV) infections. For silencing assays, 293T cells, human epithelial 
kidney cells (DuBridge et al., 1987) (ATCC CRL-11268); and DF-1 cellular line, 
derived from Gallus gallus fibroblasts (Himly et al., 1998) (ATCC, CRL-12203) were 
used.  
BSC-40, QM7 and 293T cells were grown in Dulbecco’s modified Eagle’s 
medium (DMEM) (Dulbecco and Freeman, 1959) containing 10% fetal calf serum, 
penicillin (100 U/ml), streptomycin (100 µg/ml), gentamycin (50 µg/ml), fungizone (1 
µg/ml) and non-essential aminoacids at 37ºC. DF-1 cells were grown in the same 
medium but at 39ºC; silenced DF-1 cells are also maintained with puromycin 2µg/ml 
not to lose the retroviral gene. H5 cells were grown in TC-100 medium (Gibco-BRL) 
containing 10% fetal calf serum, penicillin (100 U/ml), streptomycin (100 µg/ml), 
gentamycin (50 µg/ml) and fungizone (1 µg/ml) at 28ºC.  
 
3.1.3 Plasmids 
 
pFastBac1 and pFastBacHT plasmids from Invitrogen company were utilized to 
generate rBVs. Both plasmids, heterologous genes are under control of the polyhedrin 
 51 
—————————————————————————Experimental procedures 
promoter and have specific sites for the recombinant gene transposition in the bacmid. 
pFastBacHT plasmid also possesses a Histidine tag (His tag) and a spacer region in the 
amino terminal extreme of the recombinant protein. 
 
pVOTE.2 plasmid (Ward et al., 1995) was kindly provided by Bernard Moss 
(NIH, Bethesda, Md.) and used for the generation of rVVs.  
 
The pRETROSUPER vector is derived from the Murine Embryonic Stem Cell 
virus (pMSCV). The pRETROSUPER vector contains the pSUPER short hairpin RNA 
(shRNA) expression cassette (Netherlands Cancer Institute, NKI/AvL).  
 
3.1.4 Viruses 
 
IBDV infections have been carried out with the Soroa isolate (Lombardo et al., 
1999), which was isolated from an infected chicken in the Soroa region (Cuba) and 
adapted to grow in chicken embrionary fibroblasts (CEF) primary cultures. Afterwards, 
it has been adapted to grow in different mammalian cells. 
 
 Generation of rBVs has been made from a baculovirus (BV) FastBac 
(Invitrogen). This virus was generated by genetic manipulation from a field isolate of 
the polyhedrosis virus Autographa californica (AcPHV). 
 
To construct rVVs, genes of interest are inserted into pVOTE.2 transfer vectors. 
The latter are then transfected into BSC-40 cells infected with a vaccinia virus that 
encodes the T7 RNA polymerase and lac repressor, VT7lacIO. Recombinant virus 
isolation is facilitated by mycophenolic acid selection. The expression of our protein is 
induced by the addition of upon addition of isopropyl-β-D-thiogalactopyranoside 
(IPTG) (Ward et al., 1995).  
rVV VT7LacOI/POLY, and rBV FB/VP2-452, FB/VP2-501 and FB/HTVP2-
466 were previously described (Caston et al., 2001; Lombardo et al., 1999; Saugar et 
al., 2005).  
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3.1.5 Antibodies 
 
During this study, rabbit anti-VP2 and VP3 sera, previously described 
(Lombardo et al. 1999; Sánchez and Rodríguez 1999), have been used. Commercial 
antibody against His tag (Sigma) has been also applied.  
 
3.2 Manipulation and generation of recombinant vectors 
 
 3.2.1 PCR 
 
Reactions were carried out in a final volume of 50 µl with 0.2 mM dNTPs, 200 
ng of each primer, 2 ng of  DNA template, 20 mM Tris-HCl pH 8.8, 10 nM KCl, 2 mM 
MgSO4, 10 mM (NH)4SO2, 0.1% Triton X-100 y 2 U of DNA polymerase Vent (New 
England Biolabs). As amplification protocol the current method was used: 1 min at 
94ºC; 30 cycles of 40 sec at 92ºC, 40 sec at 60ºC and 1 min 30 sec at 75ºC; 5 min at 
75ºC. 
 
3.2.2 DNA fragments ligation reactions 
 
Reactions were carried out in a final volume of 15 µl en a buffer composed by 
50 mM Tris-HCl pH 7.8, 10 mM MgCl2, 10 mM DTT, 1mM ATP, 25 µg/ml BSA; 
using 200 ng/ml of each DNA fragment and 200 U of T4 DNA ligase (New England 
Biolabs) during 16 hours at 16ºC. 
 
3.2.3 Enzymatic restriction reactions 
 
New England Biolabs, Roche and Fermentas enzymes were used following the 
manufacturer’s guidelines. 
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3.2.4 Generation of recombinant plasmids 
 
3.2.4.1. Plasticity domain of the C-terminal of pVP2 
 
pFB/HTVP2-466 (Saugar et al., 2005) and pFB/POLY (Ona et al., 2004) 
plasmids were used as a template for PCR synthesis to generate rBV/∆2-10HTVP2-466 
and rBV/∆11-25HTVP2-466. PCR was performed with 5’ (5’-
GCGCAGATCTATGGATTACG ATATCCCAACGACC for rBV/∆2-10HTVP2-466 
and 5’-CGCAGATCTATGTCNTAYTAYCAYCAYCAYCAYCAYCAYATGGGATC 
TATGACAAACCTGTCAGATCAA for rBV/∆11-25HTVP2-466) and common 3’end 
primer (5’-GCGCAAGCTTAGGCAGGTGGGAACAATGTGG). BglII-HindIII-
digested PCR fragments were cloned into FastBac BamH1-HindIII polylinker sites for 
protein expression.  
 
pFB/CtVP3-VP2466 fusion was constructed by generation of two overlapping 
PCR fragments. The first one using pVOTE.2/VP3 (Kochan et al., 2003) as a template 
in combination with primers 5’-GCGCCGGTCCGAAACCATGGGTCGGCTGGGCC 
GCTGGATCAGG and 5’-GTCTCTGATGAGGACCTTGAGATCCCAACGACCGAA 
AACCTG. The second fragment was generated using primers 5’-CAGGTTTTCGGT 
CGTTGGGATCTCAAGGTCCTCATCAGAGACGG and 5’-AAGACAATTAGCCC 
TG, and pFB/HTVP2-466 (Saugar et al., 2005) as a template. PCR overlap extension 
was carried out with primers 5’-GCGCCGGTCCGAAACCATGGGTCGGCTGGGCC 
GCTGGATCAGG and 5’-AAGACAATTAGCCCTG. The resulting DNA fragment 
was digested with RsrII and used to replace the original RsrII fragment of the 
pFB/HTVP2-466 plasmid.  
 
Using PCR overlap extension four different mutants for pFB/HTVP2-466 were 
generated containing the following single mutations: D11R and D13R in the His tag, 
K445D and R449D in VP2. PCR reactions were carried out using the pFB/HTVP2-466 
plasmid as template, and the set of mutator primers (Table 1) in combination with 
primers 5’-GTATTTTACTGTTTTCGTAACAG and 5’-AAGACAATTAGCCCTG for 
the His tag mutations and 5’-GGCCGCAAACAATGGGCTGACG and 5’- 
GCGCAAGCTTAGGCAGGTGGGAACAATGTGG for the α-helix of pVP2 
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mutations. The resulting DNA fragments were digested with RsrII for the His tag, and 
BamH1 and HindIII for the α-helix of pVP2, and replaced the original sequences of the 
pFB/HTVP2-466 plasmid. Double mutants, D11R/K445D, D11R/R449D, 
D13R/K445D and D13R/R449D, were generated by ligation of the corresponding 
mutated BamH1/HindIII α-helix fragment into the single mutant His tag plasmid. 
In a similar way, four different mutants for pFB/CtVP3-VP2466 were generated 
containing the following single mutations: D13R (Asp-252) and D15R (Asp-254) of 
VP3 C-terminal domain; K445D and R449D for VP2. PCR reactions were carried out 
using the pFB/CtVP3-VP2466 plasmid as template, and the set of mutator primers 
(Table 1) in combination with primers previously described for the His tag mutations 
and the α-helix of pVP2 mutations. The resulting DNA fragments were digested with 
RsrII for the CtVP3, and BamH1 and HindIII for the α-helix of pVP2, and replaced the 
original sequences of the pFB/CtVP3-VP2466 plasmid. Double mutants, D13R/K445D, 
D13R/R449D, D15R/K445D and D15R/R449D, were generated similarly to the double 
mutations in pFB/HTVP2-466 previously described. 
 
Table 1. Synthetic oligonucleotides used to generate constructs used in “Plasticity domain of the C 
terminal of pVP2”. 
Name Sequence (5’-3’) 
pFB/HTVP2-466D11R CACCATCACCATCACCGTTACGATATCCCAACG 
pFB/HTVP2-466D11Rc CGTTGGGATATCGTAACGGTGATGGTGATGG 
pFB/HTVP2-466D13R CACCATCACGATTACCGTATCCCAACGACCG 
pFB/HTVP2-466D13Rc CGGTCGTTGGGATACGGTAATCGTG ATG G 
pFB/HTVP2-466K445D 
pFB/CtVP3-VP2466-K445D 
GGAGCATTCGGCTTCGACGACATAATCCGG G 
pFB/HTVP2-466K445Dc 
pFB/CtVP3-VP2466-K445Dc 
CCCGGATTATGTCGTCGAAGCCGAATG TCC 
pFB/HTVP2-466R449D 
pFB/CtVP3-VP2466-R449D 
CAAAGACATAATCGACGCCATAAGGAGGATAGC 
pFB/HTVP2-466R449Dc 
pFB/CtVP3-VP2466-R449Dc 
TCCTCCTTATGGCGTCGATTATGTCTTTGAAGC 
pFB/CtVP3-VP2466-D13R ATCAGGACCGTCTCTCGTGAGGACCTTGAGATCCC 
pFB/CtVP3-VP2466-D13Rc GATCTCAAGGTCCTCACGAGAGACGGTCCTGATCC 
pFB/CtVP3-VP2466-D15R ACCGTCTCTGATGAGCGCCTTGAGATCCCAACG 
pFB/CtVP3-VP2466-D15Rc CGTTGGGATCTCAAGGCGCTCATCAGAGACGG 
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Using PCR overlap extension three mutant polyprotein genes were constructed 
containing the following single mutations in the VP3 C-terminal domain: R248D, 
R245D and R242D. PCR reactions were carried out using the polyprotein gene, cloned 
in the pVOTE.2/POLY plasmid as template, and the set of mutator primers (Table 2) in 
combination with primers 5’-GCGCGCATGCAGAGAAGAGCCGGTTGGCA and 5’-
GCGCGCTCAGCGGTGGCAGCAGCCA for VP3 C-terminal domain. Primers 5’-
GATGCCATCACAAGCCTCAGC and 5’-CGCAGTCGAGGTTGTGTGCAC were 
used for D431R. The resulting DNA fragments were digested with NdeI and SphI for 
D431N or SphI and BlpI for VP3 mutants, and used to replace the original NdeI-SphI or 
SphI-BlpI fragment in the pVOTE.2/POLY plasmid. For double or triple mutants in 
D431 and VP3 C-terminal, SphI-BlpI resulting DNA containing mutations in VP3 was 
used to replace the original fragment in pVOTE.2/D431R. 
 
Table 2. Synthetic oligonucleotides used to generate constructs used in “Implication of the catalytic 
residue in viral assembly”. 
Name Sequence (5’-3’) 
pVOTE.POLYR248D TGGTGATCTGGGCCGCTGGATC 
pVOTE.POLYR248D c GATCCAGCGGCCCAGATCACC 
pVOTE.POLYR245D TGGGCGATTGGATCAGGACC 
pVOTE.POLYR245D c GGTCCTGATCCAATCGCC 
pVOTE.POLYR242D GGATCGATACCGTCTCTGATG 
pVOTE.POLYR242D c CATCAGAGACGGTATCGATCC 
 
3.2.4.2. Maturation of pVP2 
 
Using PCR overlap extension five mutant pVP2 genes were constructed 
containing the following single and double mutations: A441G, F442G, A441G/F442G, 
D431N and D391N. PCR reactions were carried out using the pVP2 gene, cloned in the 
pFB/POLY plasmid as template, and the set of mutator primers (Table 3) in 
combination with primers 5’-GCCATCACAAGCCTCAGCGTTGG and 5’-GTGCAC 
CGCGGAGTACCCCAG for A441G, F442G and A441G/F442G. Primers 5’-GATGC 
CATCACAAGCCTCAGC and 5’-CGCAGTCGAGGTTGTGTGCAC were used for 
D431N and D391N. The resulting DNA fragments were digested with NdeI and SphI 
and used to replace the original NdeI-SphI fragment of the pVOTE.2/POLY plasmid. 
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Table 3. Synthetic oligonucleotides used to generate constructs used in “Maturation of pVP2”. 
 
Name Sequence (5’-3’) 
pVOTE.POLYA441G GAAGATTGCAGGAGGATTCGGCTTC 
pVOTE.POLYA441G c GAAGCCGAATCCTCCTGCAATCTTC 
pVOTE.POLYF442G GAAGATTGCAGGAGCAGGCGGCTTCAAAGAC 
pVOTE.POLYF442G c GTCTTTGAAGCCGCCTGCTCCTGCAATCTTC 
pVOTE.POLYA441G/F442G CCTGAAGATTGCAGGAGGAGGCGGCTTCAAAGACATAATCC 
pVOTE.POLYA441G/F442G c GGATTATGTCTTTGAAGCCGCCTCCTCCTGCAATCTTCAGG 
pVOTE.POLYD391N GTTACAGAATACGGCCGATTTAATCCAGGAGCCATGAACTACAC 
pVOTE.POLYD391N c GTGTAGTTCATGGCTCCTGGATTAAATCGGCCGTATTCTGTAAC 
pVOTE.POLYD431N GTGAATACTTCATGGAGGTGGCCAATCTCAACTCTCCCCTGAAGATTG
pVOTE.POLYD431N c CAATCTTCAGGGGAGAGTTGAGATTGGCCACCTCCATGAAGTATTCAC
 
3.2.4.3. Implication of the catalytic residue in the viral assembly 
  
FB/VP2-452 and FB/VP2-501 were previously described (Caston et al., 2001; 
Saugar et al., 2005). The pVOTE.2/D431N and pVOTE.2/D391N plasmids were used 
as a template for PCR synthesis to generate rBV/VP2-452D431N, rBV/VP2-452D391N 
and rBV/VP2-501D431N. PCR was performed with common 5’ and 3’end primer (5’-
GCGCAGATCTATGACAAACCTGTCAGATCAAACCC and 5’-GCGCAAGCTTA 
CCTTATGGCCCGGATTATGTCTTTGAAGC). BglII-HindIII-digested PCR 
fragments were cloned into FastBac BamH1-HindIII polylinker sites for protein 
expression.  
 
3.2.4.4. The role of a cellular protease 
 
From cDNA of DT40 cells, cytosol alanylaminopeptidase or puromycin 
sensitive aminopeptidase (PSA) cellular protease was amplified using primers 5’-
GCGCAGATCTCCGGCCAAGC and 5’-GCGCAAGCTTTCAGTTACCTGTGGC. 
BglII-HindIII-digested PCR fragments were cloned into pFastBac HTb BamH1- HindIII 
polylinker sites for protein expression.  
 
Using PCR overlap extension two mutant pVP2 genes were constructed 
containing the following single mutations: R452A and R453A. PCR reactions were 
carried out using the polyprotein gene, cloned in the pVOTE.2/POLY plasmid as 
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template, and the set of mutator primers (Table 4) in combination with primers 5’-
GATGCCATCACAAGCCTCAGC and 5’-CGCAGTCGAGGTTGTGTGCAC. The 
resulting DNA fragments were digested with SacI and SalI and used to replace the 
original SacI-SalI fragment in the pFastBac/POLY plasmid.  
 
Table 4. Synthetic oligonucleotides used to generate constructs used in “The role of a cellular protease”. 
 
Name Sequence (5’-3’) 
pFastBac/POLY R452A GACATAATCCGG GCCATAGCG AGG ATAGCTGTG CCG GTG 
pFastBac/POLY R452A c CACCGG CACAGCTATCCTCGCTATGGCCCG GATTATGTC 
pFastBac/POLY R453A CATAATCCG GGCCATAAG GGCGATAGCTGTGCCGGTGGTC 
pFastBac/POLY R453A c GACCACCGG CACAGCTATCGCCCTTATGGCCCG GATTATG 
 
3.2.5 Generation of recombinant baculoviruses 
 
rBVs have been generated by the Bac-to-Bac (Invitrogen) system following the 
manufacturer’s protocols. This method is based in the recombinant genes transposition 
into a vector (bacmid) that is propagated in E.coli DH10-Bac (Luckow et al., 1993).  
 
First, our interest sequence is cloned in a donator plasmid (pFastBac), which is 
used to transform DH10-Bac bacteria, where the recombinant gen transposition is going 
to occur. Once recombinant bacmids have been selected, they are used to generate rBVs 
by H5 cells transfection. Finally, rBVs are amplified by the infection of H5 cells, with 
the supernatant of cells previously transfected.  
 
3.2.6. Generation of recombinant vaccinia viruses 
 
To generate rVVs, BSC-40 cells are infected with the VT7LacOI virus at a 0,05 
multiplicity of infection (MOI). After an hour, these cells are transfected with pVOTE 
plasmids with our gene of interest, using lipofectamine (Gibco BRL). Plasmids can 
recombine with the wt vaccinia virus by haemaglutinin (HA) sequences. After 72hp.i 
recombinant viruses are selected three times by the addition of mycophenolic acid. 
Mycophenolic acid inhibits the inosine-monophophatedehydrogenase enzyme 
provoking purine nucleotides depletion. Only viruses that have been recombined with 
the transfection vector will include in their genome the E. coli gpt 
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(phosphoribosyltransferase) gen, which in xanthine and hypoxanthine presence can 
produce puric nucleotides. rVVs are amplified in BSC-40 cells.  
 
3.2.7. Generation of DF1 silenced cells 
 
The PSA short hairpin (sh) oligonucleotides were first cloned in pRETRO-
SUPER. pRETRO-SUPER vector was digested with BglII and HindIII, and the annealed 
oligonucleotides targeting the cellular protease, 5’-GATCCCCGGCAACTTTTGATA 
TTTCATTCAAGAGATGAAATATCAAAAGTTGCCTTTTTGGAAA and 5’-AGC 
TTTTCCAAAAAGGCAACTTTTGATATTTCATCTCTTGAATGAAATATCAAA 
AGTTGCCGGG for sh1; 5’-GATCCCCAACCTGGTGGAAGTCAAGTTTCAAGA 
GAACTTGACTTCCACCAGGTTTTTTTGGAAA and 5’-AGCTTTTCCAAAAAA 
ACCTGGTGGAAGTCAAGTTCTCTTGAAACTTGACTTCCACCAGGTTGGG 
for sh2; 5’-GATCCCCGGAAAGTTTGCATTAGAGGTTCAAGAGACCTCTAAT 
GCAAACTTTCCTTTTTGGAAA and 5’-AGCTTTTCCAAAAAGGAAAGTTTGC 
ATTAGAGGTCTCTTGAACCTCTAATGCAAACTTTCCGGG for sh3; were 
ligated with the vector, yielding pRETRO-SUPER-sh1, pRETRO-SUPER-sh2 and 
pRETRO-SUPER-sh3. The 19-mer PSA targeting sequence in the oligonucleotide is 
indicated in bold. The hairpin oligonucleotides for the SUPER RNAi™ library are 
cloned downstream of the polymerase III Histone H1-RNA promoter (H1).  
 
Upon transfection using lipofectamine (Gibco BRL) of pRETRO-SUPER-sh1, 
sh2, sh3 and an empty plasmid as positive control for non-silencing of the protein, into 
packaging cell line 293T with pCL-anfo as a helper plasmid, pRETROSUPER 
expresses a transcript containing the viral packaging signal, the H1-shRNA cassette and 
the puromycin resistance gene. At 48 hours post transfection, we collect the supernatant, 
which should be filter through a 0.45 µm filter, and then is added to DF1 recipient cells. 
The infection of DF1 cells with the retrovirus-containing supernatant is made three 
times in 24 hours with the addition of polybrene at 4µg/ml or 8µg/ml. Then the 
selection of silenced cells starts with the addition of 2µg/ml of puromycin. Selection 
will take between two and three days. 
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3.2.8. Reverse genetic analysis 
DNA fragments containing cDNA versions corresponding to the complete 
positive strand RNAs of to the IBDV Soroa strain segments A and B, fused to the T7 
bacteriophage promoter (in 5’ position with respect of the IBDV cDNAs) and a cDNA 
corresponding to the hepatitis delta virus ribozyme (in 3’ position with respect of the 
IBDV cDNAs) sequences were generated by in vitro gene synthesis (Genescript Co.), 
and inserted into the multiple cloning site of the pUC57 cloning plasmid 
(GenBank/EMBL). These plasmids were named pT7-SA-Rz and pT7-SB-Rz, containing 
the cDNA corresponding to segment A and B, respectively. 
Plasmid pVOTE/D431N, described above, was digested with SphI and NdeI, and 
ligated to pT7-SA-Rz previously digested with the same enzymes. The resulting 
plasmid, pT7-SA (D431N)-Rz, was sequenced to determine the correctness of its 
sequence. 
QM7 cells were transfected with a combination of either pT7-SA-Rz and pT7-
SB-Rz or pT7-SA (D431N)-Rz and pT7-SB-Rz, respectively, using lipofectamine 
(Gibco BRL). At 6 h after transfection, cultures were infected with 1 PFU/cell of 
VT7LacOI, an rVV inducible expressing the T7 RNA polymerase. After infection, 
cultures were maintained at 37ºC in DMEM containing 10% FCS supplemented with 
1mM IPTG. At 72 h pi, cultures were harvested, and subjected to three freeze-thawing 
cycles. After removing cell debris by low speed centrifugation, supernatants were 
recovered and passed through 0.1 µm filters (Millipore) to eliminate contaminant rVV 
particles, and used to infect fresh QM7 cell monolayers. Infections were performed in 
triplicate with undiluted and 10-1 to 10-5 serial dilutions of the initial stocks. A set of 
infected cells was used to determine the IBDV titre at 72 hp.i. Another set was 
harvested at 72 hp.i., and the corresponding extracts analyzed for the presence of VP1 
and VP2 proteins. The absence of contaminant infecting rVV particles was also 
monitored by Western blot, using the mAbC3. The third set was also harvested at 72 
hp.i., and used to collect cells originally infected with the undiluted stocks. These 
samples were subjected to three freeze-thawing cycles, and the procedure described 
above was repeated; thus allowing the analysis of the initial virus stock and two 
subsequent virus amplification rounds. 
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3.3 Infections and protein expression 
 
3.3.1 rBV infection 
 
H5 cells confluent cultures were infected with a MOI of 1 to 5 plaque forming 
units per cell (pfu/cell) of the corresponding rBV in minimal volume. After an hour of 
adsorption, the inocule was released and TC-100 medium supplemented with 2% FCS 
was added. 
 
3.3.2 rVV infection 
 
BSC-40 and QM7 cells confluent cultures were infected with a MOI of 2 
pfu/cell of the corresponding rVV in minimal volume. After an hour of adsorption, the 
inocule was released and DMEM medium supplemented with 2% FCS, and IPTG 1M to 
a final concentration of 2mM was added. 
 
3.3.3 IBDV infection 
 
For IBDV virions purification, QM7 cell cultures were infected at a 70-80% 
confluence with a MOI of 1-2 pfu/cell in a minimal volume. After an hour of 
adsorption, the inocule was released and DMEM medium supplemented with 2% FCS 
was added. Culture supernatant was collected at 48-72 hp.i. depending on the cytopathic 
effect (CPE) observed.  
 
For IBDV stock production, the same procedure was followed using a MOI of 
0.02-0.05 pfu/cell and collecting supernatants at 72-96 hp.i.depending on the CPE. 
 
3.3.4 IBDV Titration 
 
Viral titres were determined by immunostaining assays against the capsid 
protein VP2. QM7 cell monolayers were infected at a 50-60% cell confluence with 
higher virus dilutions. After the adsorption hour, the inocule was released and DMEM 
supplemented with 2%FCS was added. At 72 hp.i cells were fixed by a methanol- 
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acetone solution (1:1) during 2 minutes at room temperature. Cells were incubated with 
an anti-VP2 antibody during 1hour and 30 minutes and a posterior incubation with a 
secondary antibody conjuged with peroxidase (GE Healthcare). Lysis plaques were 
developed when the substrate H2O2/3, 3’-diaminobenzidine (Sigma) in the presence of 
NiSO4 was added. Titres were determined by lysis plaques counting. 
 
3.3.5 rVV Titration 
 
Viral titres were determined by lysis plaques assays. BSC-40 confluent cell 
monolayers were infected with higher virus dilutions. After the adsorption hour, the 
inocule was released and DMEM supplemented with 2%FCS was added. At 48 hp.i 
cells were fixed by a 10% formaldehyde solution during 2 minutes at room temperature 
and stained with a 2% violet crystal solution. Titres were determined by lysis plaques 
counting. 
3.4 Purification of IBDV polyprotein-derived structures 
QM7 and H5 cells (2-5x108 cells) were infected with appropriate rVV or rBV 
(MOI 1-5pfu/cell). At 72 hp.i. in rVV assays and at 48 hp.i. in rBV assays, cells were 
harvested, lysed in PES buffer (25 mM piperazine-N, N’-bis (2-ethanesulfonic acid), pH 
6.2, 150 mM NaCl, and 20 mM CaCl2) plus 1% IGEPAL CA-630 (Sigma) and 1% of 
proteases inhibitor (Complete Mini, Roche) on ice during 30 min. The lysate was 
clarified by centrifugation at 3,000 r.p.m. (1,000xg) during 10 min in a swing 5624 rotor 
(Hettich Zentrifugen). The supernatant was processed on a 25% sucrose cushion at 
37,000 r.p.m. (170,000xg) during 2h 30 min in a SW41 rotor (Beckman-Coulter Inc). 
The pellet was resuspended in PES buffer and centrifuged in a microfuge at 13,000 
r.p.m. (16,000xg) during 1 min and the supernatant processed in a linear 20-50% 
sucrose gradient at 40,000 r.p.m. (200,000xg) during 45 min in a SW41 rotor 
(Beckman-Coulter Inc). The particulate material containing polyprotein-derived 
structures was fractionated in 12 and concentrated 20-fold by ultracentrifugation at 
50,000 r.p.m. (240,000xg) during 2 hours in a SW55 rotor (Beckman-Coulter Inc). All 
purification steps were made at 4ºC. 
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3.5 Biochemical analysis 
 
3.5.1 Electrophoretic analysis in denaturing polyacrylamide gels 
 
Infected cell extracts (25 µl) or concentrated sucrose gradient fractions (10 µl) 
were added to Laemmli’s sample buffer (62.5 mM Tris-HCl pH 6.8, 1% SDS, 0.06% 
bromophenol blue, 25% glycerol and 10 mM DTT) to a 1x final concentration and 
heated at 100ºC for 3 min. Electrophoresis was performed in 11% polyacrylamide gels 
(37.5:1). 
 
Afterwards, gels were electrotransferred to nytrocellulose membranes or stained 
with a 2% Coomassie blue solution in 10% methanol and 10% acetic acid. 
 
3.5.2 Electrotransference and immunodetection (Western Blot) 
 
Following PAGE, gels were blotted at 200 mA for 90 min onto nitrocellulose 
membranes (Protan) using a semi-dry blotter (Bio-Rad). Before the transference gels 
and membranes were incubated during 10 min in Tris 48 mM, glycine 39 mM, SDS 
0.0375 % (p/v), methanol 20 % (v/v) buffer. Membranes were saturated in a blocking 
solution (5% powder skimmed milk in phosphate saline buffer (PBS)) during 30 min at 
room temperature. And then incubated with a diluted primary antibody (α-VP2 1:1000; 
α-VP3 1:1000; α-His 1:1000) in blocking solution during 2 hours at room temperature. 
After washing membranes three times with PBS, were incubated with a goat secondary 
antibody conjugated with peroxidase (GE Healthcare) diluted 1:5000 in blocking 
solution. Membranes were washed three times with PBS during 10 min and developed 
by the commercial chemiluminescent method ECL (GE Healthcare) or by the addition 
of 4-chloro-1-naphtol with 0,025% of H2O2. 
3.5.3 Immunoprecipitation (IP) of VP2 
QM7 cell monolayers were infected with the corresponding rVV at a MOI of 2 
pfu/cell and maintained in the presence of IPTG. At 18 hp.i., cells were washed twice 
and metabolically labeled with methionine-free DMEM containing 125 µCi/ml of 
[35S]Met and IPTG for 1h. After this period, cells were washed three times with DMEM 
 63 
—————————————————————————Experimental procedures 
containing a 10 fold concentration of cold methionine and then maintained in DMEM 
supplemented with IPTG and 2% FCS. At 0, 24, 48, 72 h post-labelling, cells were 
harvested, washed twice with PBS, and resuspended in lysis buffer (50 mM Tris [pH 
7.5], 100 mM NaCl, 5 mM EDTA, 0.5% IGEPAL CA-630). IPs were carried out with 
protein A-Sepharose CL-4B (Pharmacia Biotech AB, Uppsala, Sweden) after incubation 
of the extracts with specific rabbit anti-VP2 antisera. Immunoprecipitated samples were 
resuspended in Laemmli sample buffer to a 1x final concentration, subjected to 11% 
SDS-PAGE followed by autoradiography. 
3.6. Microscopy 
 
3.6.1. Electron microscopy 
 
2-5 µl samples of concentrated sucrose gradient fractions were applied to glow-
discharged (K100X, Emitech) carbon-coated grids for 2 min and negatively stained with 
2% aqueous uranyl acetate. Micrographs (Kodak SO-163) were recorded with a JEOL 
1200 EXII electron microscope operating at 100kV at a nominal magnification of 
40,000x. 
 
3.6.2. Immunofluorescence and confocal laser scanning microscopy analysis 
 
 DF1 silenced cells and H5 cells seeded onto glass coverlips were infected with 
IBDV and rBVs, respectively, at a MOI of 1 PFU/cell. Cells were washed twice with 
phosphate-buffered saline at 30 hp.i for DF1 cells and at 48hp.i for H5 cells and then 
fixed in methanol-acetone (1:1) for 5min. After fixation, coverlips were airdried, 
blocked in phosphate-buffered saline containing 20% fetal calf serum for 1h and 
incubated with rabbit anti-VP2 and mouse anti-His tag specific sera, followed by 
incubation with goat anti-rabbit Ig coupled to Alexa 488 (green) and goat anti-mouse Ig 
coupled to Alexa 594 (red) for H5 cells; for DF1 cells only a rabbit anti-VP2 followed 
by a goat anti-rabbit Ig coupled to Alexa 488 (green) were used. Cell nuclei were 
stained with ToPro-3. Fluorescent signals detected by CLSM were recorded separately 
by using appropriate filters. Samples were visualized by epifluorescence using a Zeiss 
Axiovert 200 microscope equipped with a Bio-Rad Radiance 2100 confocal system. 
Images were captured using the Laser Sharp software package (Bio-Rad). 
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3.7 Crystallization and data collection 
 
Cubic crystals belonging to space group P213 (a=b=c=326.72 Å) were obtained 
by the vapour diffusion method in hanging drops at room temperature by mixing 2 
volumes of VP2-452D431N derived SVP (1.6 mg/ml) and 1 volume of the reservoir 
solution, containing 14 to 17% PEG 4K, 0.1 M TRIS pH 9.0 and 5% isopropanol. 
Crystals were transferred to a cryoprotecting solution containing 20% glycerol in the 
crystallization buffer and incubated 1 minute before they were flash frozen by 
immersion in liquid nitrogen. X-ray data were collected from a single crystal using 
synchrotron radiation at the ESRF, Grenoble, France (beamline ID14-2), to 3.1 Å 
resolution. Diffraction images were processed using MOSFLM (Leslie, 1991) and 
internally scaled with SCALA (Evans, 1994). 
3.7.1 Structure refinement 
Crystals of D431N-mutated SVP were isomorphous to the previously obtained 
of native VP2 SVPs [PDB code 2GSY, (Garriga et al., 2006)]. The initial maps for 
D431N-mutant were obtained after a rigid body fitting of the coordinates of native 
SVPs (PDB code 2GSY) to the new unit cell. The D431N mutation and other subtle 
changes were manually rebuilt using Coot (Emsley, 2004) and the structure was then 
refined with CNS (Brünger, 1998), using the twentyfold non crystallographic symmetry 
as a restraint. 
The final refinement statistics are summarized in Table 5. 
 
 
 
 
 
 
 
 65 
—————————————————————————Experimental procedures 
Table 5. Data collection and refinement statistics. 
Data collection D431N 
          Space group P213 
          Cell dimensions 
          a=b=c (Å)  
 
326.72 
          Wavelength 0.933 
          Resolution (Å) 50-3.1 
          Rsym 0.12 
          I/σI 9.3 
          Completeness (%) 99.0 
          Redundancy 5.3 
Refinement  
          Resolution (Å) 20.0-3.1 
          No. Reflections 187110 
          Cutoff 3σF 
          Rwork/Rfree 0.28/0.28 
          No. Residues  
             Protein 428 
             Ligand/ion 1 
             Water - 
          Averaged B-factors 26.7 
          R.m.s. deviations  
             Bond lengths (Å) 0.006 
             Bond angles (º) 0.803 
 
3.7.2. Protein structure accession number 
The coordinates and structure factors have been deposited into the Protein Data 
Bank (accession no. 3FBM). 
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3.8. Quantitative real time polymerase chain reaction (qRT-PCR) 
 
3.8.1. Total cellular RNA extraction 
 
In the determination of the presence or not of the PSA in different cell lines, as 
well as in the qRT-PCR to check the quantity of the cellular protease in the silenced 
cells, cells were lysed directly in a culture dish by adding 1ml of TRIzol LS Reagent 
(Invitrogen). The homogenized samples were incubated for 5 min at room temperature 
to permit the complete dissociation of nucleoprotein complexes and 0.2 ml of 
chloroform was added. Samples were centrifuged at 12,000x g for 15 min at 4ºC and the 
upper aqueous phase was recovered, where RNA remained. RNA was precipitated by 
mixing with isopropyl alcohol for 10 minutes and centrifuged at 12,000x g for 10 min at 
4ºC. The RNA pellet was washed once with 75% ethanol and then resuspended in 100µl 
of DEPC water. The RNA concentration and the relation 260/280 nm were determined 
by a spectrophotometer Nano-Drop ND-1000 (NanoDrop Technologies, Wilmingon, 
DE; USA). RNA integrity was checked in a 1% agarose gel. 
 
3.8.2. RNA Purification and cDNA synthesis 
 
Total RNA was treated with DNase I RNases-free (Qiagen) for 10 min at room 
temperature to eliminate contaminant genomic DNA. Afterwards, the RNA was purified 
by RNeasy Mini Kit (Qiagen) following manufacturers’ guidelines. 
 
cDNA synthesis was made from 1µg of total RNA in a reaction total volume of 
20µl with 1X PCR Buffer II (Applied Biosystems), 5mM MgCl2, 1mM dNTP, 1U/µl 
RNase inhibitor (RNasin, Promega), 2.5 U/µl of MuLV reverse transcriptase (Applied 
Biosystems), 5mM of random primers (Gibco) and DEPC water.  
 
3.8.3. Oligonucleotides design 
 
To detect PSA transcripts levels, a pair of oligonucleotides were used which 
originated an amplification product of 143pb.(Table 6) As a control, a pair of 
oligonucleotides which generates an amplification product of 154 pb of the 
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glyceraldehide-3-phosphate dehidrogenase (GAPDH) enzyme Gallus gallus gen was 
used (Table 6). In all cases, oligonucleotides were designed using “Primer Express 2.0” 
program (Applied Biosystems, Foster City, CA, USA). 
 
Table 6. Primers used in qRT-PCR reactions.  
Name Sequence (5’-3’) 
GAPDH (Gallus gallus) ATGGTGAAAGTCGGAGTCAACG 
GAPDH (Gallus gallus) c GACAGTGCCCTTGAAGTGTC 
PSA (Gallus gallus) TGCCTTAGACAACAGTCATCC 
 PSA(Gallus gallus) c TCCGAAAGTCCTCATCACCA 
 
3.8.4. Conditions and analysis of qRT-PCR 
 
PCR reactions were carried out in 96-multiwell (Applied Biosystems). Transcript 
levels were determined by qRT-PCR using the real time 7300 PCR system (Applied 
Biosystems) and SYBRGreen (Applied Biosystems) as a detector. Reactions were made 
in a final volume of 20µl in which 10µl was PCR master mix “Power SYBR Green 
PCR” 2x (where “AmpliTaq Gold”, dNTPs and “SYBR Green” are included), 250nM 
of the 5’ and 3’ specific oligonucleotide, 1µL of the 1:10 cDNA dilution and water. 
After the enzyme activation at 95ºC for 10 min, amplification was carried out during 40 
2- steps cycles: i) 95ºC for 15 sec for the denaturalization of the dhDNA, and ii) 60ºC 
for 1 min for the hybridization and product extension. Negative controls were included 
and reactions were made by triplicate. 
 
 Data were analyzed by qBase Plus (BioGazelle) program. Expression levels 
were calculated using the standard curve method and normalized using GAPDH gen as 
a reference control.  
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3.9. Computer programs 
 
3.9.1. Sequence alignment 
 
For the alignment of different IBDV isolates and different cytosol 
alanylaminopeptidases from several organisms, the Clustal W 2.0 program was used.  
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4.1. Plasticity domain of the pVP2 C-terminal end 
 
VP2 is synthesized as a 512 residue precursor, pVP2, which undergoes a variety 
of defined C-terminal processing events to render the mature VP2 (441 residues). The 
molecular switch controlling VP2 polymorphism resides within the C-terminal 71 
residues, which are removed when its function has been completed. Previous results 
obtained in our laboratory (Saugar et al., 2005) indicated that the VP2 molecular switch 
is located in the temporally bound 443-GFKDIIRAIR-452 segment that is organized as 
an amphipathic α-helix (Fig.7). The hydrophilic side of this α-helix is built of three 
basic and an acidic residues and an interaction with other proteins is possible. 
 
Fig.7.VP3 and VP2 polypeptide segments involved in structural polymorphism of VP2. In the upper 
panel, VP3 C-terminal and His tag sequences are aligned based on their polarity. Basic residues are 
represented in blue and acid ones in red. The His tag is composed of six canonical His and a spacer arm 
corresponding to residues Asp-11 until Ser-28, from which the VP2 sequence would start. VP3-Ct end is 
shown in the opposite direction, from C-terminal to N-terminal domain respect to the polyprotein 
sequence and the last residue (Glu-17) is indicated by a line, after that, part of the spacer arm of the His 
tag has been introduced .The C-terminal VP2 sequence is shown in the middle. The amphiphatic α-helix 
(443-453 residues) is shown as helix-α5; helices-α6, α7 and α8 were determined by NMR analysis 
(Galloux et al., 2007). A helical wheel representation of the amphiphatic α-helix is shown at the bottom. 
Group colour key is indicated. All residues that are going to be mutated are marked by a number. 
 
Previous results from our laboratory showed that, in the absence of VP3, 
efficient T=13 capsid-like assembly is dependent upon the presence of a His tag located 
at the VP2 N-terminus, indicating that the His tag mimics the VP3 function, acting as a 
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triggering factor, during virion assembly (Saugar et al., 2005). We compared the His tag 
and VP3 sequences to search for an explanation to this observation. The acid character 
of the last five residues in the VP3 C-terminus align well with an equivalent region of 
the His tag (Fig.7). A charge complementarity with the proposed α−helix is evident, 
tempting us to suggest that electrostatic interactions may be the initial event in the 
adoption of different pVP2 conformational states. Both acid segments in the His tag and 
the VP3 C-terminal residues are preceded by a basic segment that might also have an 
additional function. This electrostatic interaction has been postulated to be transmitted 
to the rest of VP2, inducing the correct conformational change (Saugar et al., 2005). 
 
4.1.1. The role of the basic and acid segments of the His tag in T=13 VLP assembly 
 
To analyze whether the basic region of the His tag is necessary for the correct 
assembly of the T=13 VLP, different deletion mutants were made in the HT-VP2-466 
recombinant polypeptide. HT-VP2-466 in the baculovirus system, which banded at the 
middle of a sucrose gradient, is able to assemble into structures morphologically similar 
to T=13 infectious particles with minor differences in the outermost and the inner 
surface of the capsid (Fig.8A). This chimeric VP2 polypeptide possesses two elements 
required for a correct T=13 assembly, the VP2 amphiphatic α-helix and the His tag 
emulating VP3 C-terminus. Different experiments were carried out to determine the 
implication of the basic and the acid regions. Two different deletion mutants were 
generated in the baculovirus system. The rBV/HT-VP2-466∆2-10 expresses the 
chimeric VP2 protein lacking residues 2-10; this region includes six basic residues of 
the His tag (Fig.7 and Fig.8B); in HT-VP2466∆11-25, the deletion removed the acid 
region, residues 11-25, which mimic VP3 Ct acid region (Fig.7 and Fig.8C). Cell 
extracts infected with these rBVs were analyzed by sucrose gradient and 
ultracentrifugation, and EM analysis by negative staining. As shown in Fig. 8B and 8C, 
expression of the HT-VP2-466∆2-10 gene results in the assembly of large tubular 
structures, whereas the HT-VP2-466∆11-25 construct assembles as T=1 SVP were 
recovered. The formation of T=13 capsid assemblies is prevented for both deletion 
mutants, suggesting that basic and acid residues are required for the proper T=13 VLP 
assembly. 
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Fig.8. The role of the basic segment of the His tag in capsid assembly. (A) Wild type HTVP2-466 
assemblies were purified by ultracentrifugation on sucrose gradients. Gradients were collected into 12 
fractions, concentrated by ultracentrifugation, and analyzed by SDS-PAGE and Coomassie staining. The 
direction of sedimentation was right to left, with fraction 12 representing the gradient top. The image 
shown on the right corresponds to a representative electron microscopy micrograph (negative staining) of 
wild-type HTVP2-466 capsids, present at the middle and the top gradient fractions. (B) Mutant HTVP2-
466-∆2-10 and (C) HTVP2-466-∆11-25 assemblies were analyzed as described above. The image shown 
on the right corresponds to a representative electron microscopy micrograph (negative staining) of the 
middle and upper fractions. Bars = 100 nm. 
 
 
 
 
 
 
 75 
————————————————————————————————Results 
4.1.2. The emulation of VP3 C-terminal domain by the His tag 
 
To definitely confirm whether the His tag functionally emulate the VP3, the His tag 
was exchanged by VP3 C-terminal region, including basic residues domain. This was 
generated in rBVs expressing VP2-456 and VP2-466, as their homologues BV/HT-
VP2-466 and BV/HT-VP2-456, were previously determined to be able to assemble in 
T=13 capsids indistinguishable of IBDV virions by electron microscopy.  
 
BV/Ct-VP3-VP2-456 and BV/Ct-VP3-VP2-466 were harvested and at 48h.pi. 
analyzed by sucrose gradient and ultracentrifugation. As it can be observed in Fig. 9A 
and B, this change permits the correct assembly of T=13 VLP in both cases, indicating 
that the His tag is clearly emulating VP3 C-terminal domain. 
 
Fig. 9. The emulation of VP3 C-terminal domain by the His tag. (A) CtVP3-VP2-456 and (B) CtVP3-
VP2-466 assemblies were purified by ultracentrifugation on sucrose gradients. Gradients were collected 
into 12 fractions, concentrated by ultracentrifugation, and analyzed by SDS-PAGE and Coomassie 
staining. The direction of sedimentation was right to left, with fraction 12 representing the gradient top. 
Images shown correspond to a representative electron microscopy micrograph (negative staining) of 
structure recovered at the middle gradient fractions. Bars=100 nm. 
 
To further test these results; different point mutants were generated in the rVV 
polyprotein system (Lombardo et al., 1999) which allows the efficient assembly and 
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accumulation of VLPs. In comparison with the basic region of the His tag, three 
different arginine residues were replaced in VP3 C-terminal domain (Arg-248, Arg-245, 
and Arg-242), by aspartic acid (relative positions are shown in the scheme, Fig. 7). 
With this approach the charge of every residue potentially involved in this interaction 
was replaced by a residue with an opposite ionic character. The loss of the ability to 
assembly in T=13 VLP, of different rVVs would indicate that the altered residue is 
probably implicated in viral capsid formation. 
 
The analysis of the different single mutants, rVV/PolyR248D, rVV/PolyR245D 
and rVV/PolyR242D by sucrose gradient and ultracentrifugation (Fig. 10A, 10B and 
10C), shows that Arg-248 of VP3 Ct domain change does not alter the proper assembly 
of T=13 VLPs, similar to viral capsids. Furthermore, results of the biochemical analysis 
were similar to those obtained with the wild-type polyprotein. The R245D mutation 
renders a wild-type biochemical pattern, structures observed are more labile and highly 
prone to collapse, than wild-type T=13 capsids. The R242D mutant leads to the 
accumulation of structures in the upper fraction of the gradient, the electron microscopy 
analysis showed the presence of capsid-like structures smaller than T=13, probably 
corresponding to T=7 VLP. These results with the rVV system indicate that within the 
basic region of VP3, basic residues Arg-245 and Arg-242 are essential and probably 
implicated in IBDV capsid assembly probably by an electrostatic interaction with a non-
determined region of VP2. 
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Fig. 10. The role of the basic segment of VP3 C-t ends in viral assembly. (A) VT7/POLYR3D 
assemblies were purified by ultracentrifugation on sucrose gradients. Gradients were collected into 12 
fractions, concentrated by ultracentrifugation, and analyzed by SDSPAGE and Western blot using anti-
VP2 and anti-VP3 serum. The direction of sedimentation was right to left, with fraction 12 representing 
the gradient top. The image shown on the right corresponds to a representative electron microscopy 
micrograph (negative staining). (B)VT7/POLYR6D and (C) VT7/POLYR9D assemblies were analyzed 
as described. Bars=100 nm. 
 
4.1.3. Interaction between VP3-based triggering factor and the pVP2 molecular 
switch 
 
The acid character of VP3 C-terminal domain is necessary for the correct 
assembly of T=13 VLP and its role in viral assembly tempts to suggest the hypothesis of 
an electrostatic interaction with VP2 amphiphatic α−helix, where some basic residues 
are located. These electrostatic interactions may be the initial event in the adoption of 
different pVP2 conformational states.  
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To dilucidate if there is any electrostatic interaction between VP3 acid residues 
and the VP2 amphiphatic α-helix, different point mutations were generated in HT-VP2-
466 and CtVP3-VP2-466 recombinant genes. First, Lys-445 or Arg-449 was replaced 
by aspartic acid residues, in the amphiphatic α-helix. Second, Asp-11 and Asp-13 
located in the spacer arm of the His tag, were replaced by two Arg residues, in BV/HT-
VP2466. A similar approach was carried out for BV/CtVP3-VP2-466 in which Asp-13 
(VP3 Asp-252) or Asp-15 (VP3 Asp-254) of VP3 DEDLE region, were exchanged by 
Arg residues. The modification of charged residues potentially involved in the 
electrostatic interaction, by a residue with the opposite ionic character would eventually 
lose the ability to assembly in T=13 capsids. With this hypothesis the recovery of capsid 
formation would be provided by the generation of double mutants, in which the 
electrostatic change has been compensated; e.g. in HT-VP2-466, in which Asp-13 has 
been mutated to a Arg residue, could be eventually compensated by the change of Arg-
449 by Asp residue (a summary of all single mutants and double combinations 
generated is shown in Fig. 11). 
     
Fig. 11. Analysis of a possible interaction between the acid regions of VP3 C-terminal domain with 
basic residues of the amphiphatic α-helix 442-453. The proposed charge complementarity between the 
amphipathic α-helix and the last five residues of VP3 C-terminal region (upper panel) (or the aligned 
VP3 similar region of the His tag) (lower panel) used in this study are shown. VP3 and His tag sequences 
are shown in the opposite direction, from C-terminal to N-terminal ends. Residue mutated in each case is 
shown in black and the different double combinations can be followed by arrows. 
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H5 insect cells were infected by single mutants, and at 48 hp.i corresponding 
extracts were harvested and used for the isolation of IBDV derived assemblies using a 
sucrose gradient-based purification protocol followed by electron microscopy and 
biochemical analysis with Coomassie staining. The analysis of single mutants shows 
that mutations on the amphiphatic α−helix of VP2, in BV/HT-VP2-466 and BV/CtVP3-
VP2-466 chimeric proteins, prevent the formation of T=13 capsids. Particulated 
material is accumulated at the bottom part of the gradient and by electron microscopy 
only large tubular structures with an hexagonal lattice are observed (Fig. 12 and 14B). 
When any acid residues of VP3 C-terminus or His tag spacer arm is replaced, the 
structure that could be recovered are mostly T=1 SVP accumulated at the upper gradient 
fractions (Fig. 12 and 14C). This suggests that all mutated residues are potentially 
involved in T=13 correct assembly, probably by their implication in stabilizing the 
electrostatic interaction. 
 
Fig. 12. Analysis of single mutants. Single mutants assemblies were purified by ultracentrifugation on 
sucrose gradients. Gradients were collected into 12 fractions, concentrated by ultracentrifugation, and 
analyzed by SDS-PAGE and Coomassie staining. The direction of sedimentation was right to left, with 
fraction 12 representing the gradient top. The kind of assemblies that are yielded with each mutant is 
indicating on the right side. 
 
Double mutations in rBVs were carried out in order to rescue the proper T=13 
capsid assembly. Mutants in the Ct region of VP3 or His tag in which one Asp residue 
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was replaced by Arg, were compensated with Lys-445 and Arg-449 mutations, and vice 
versa (Fig. 11). H5 insect cells infected by these rBVs and their corresponding extracts 
harvested and used for the isolation of IBDV derived assemblies. Mutants HTD11R-
VP2-466R449D, HTD13R-VP2-466K445D, CtVP3/D13R-VP2466K445D, 
CtVP3/D13R-VP2466R449D, CtVP3/D15R-VP2466K445D, accumulate particulated 
material at the bottom fractions of the gradient, which was composed of tubular 
structures with a hexagonal lattice. Whilst the recovery of T=13 capsids was 
consistently observed when HT/D13R-VP2-466 and CtVP3/D15R-VP2466 were 
conjugated with R449D (Fig. 13), where VLP in the middle gradient fractions are 
observed by electron microscopy. T=13 capsids are also obtained with mutant 
HT/D11R-VP2-466K445D (Fig. 13 and 14A). 
 
 
Fig. 13. Analysis of double mutants. Double mutants assemblies were purified by ultracentrifugation on 
sucrose gradients. Gradients were collected into 12 fractions, concentrated by ultracentrifugation, and 
analyzed by SDS-PAGE and Coomassie staining. The direction of sedimentation was right to left, with 
fraction 12 representing the gradient top. The kind of assemblies that are yielded with each mutant is 
indicating on the right side. 
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Fig. 14. Representative EM micrographs (negative staining) of (A) T=13 capsids of HTD13R-VP2-
466R449D mutant, squared IBDV virions, (B) rigid tubules with an hexagonal lattice of CtVP3D13R 
mutant and (C) T=1 SVPs of the same mutant. Bars = 100 nm. 
 
Taken together, the results of these analyses suggest that all mutated residues are 
implicated in the correct assembly of T=13 capsids probably due to a temporary 
electrostatic interaction between the acid region of the triggering factor, the VP3 C-
terminus and the His tag, and the VP2 amphiphatic α-helix. As result of mutant 
analyses, in which T=13 VLP are only recovered in mutants HT/D13R-VP2-466R449, 
CtVP3/D15R-VP2-466R449D and HT/D11R-VP2-466K445D, it can be dilucidiate that 
this temporary electrostatic bond corresponds to an interaction between Arg-449 of the 
amphiphatic α-helix with Asp-254 of VP3 Ct domain and possibly between residues 
Lys-445 of VP2 with Asp-252 of VP3 in the context of the chimeric proteins analyzed. 
 
4.2. Maturation of pVP2
4.2.1. VP2 candidates as catalytic residues for autoproteolysis  
VP2 S and B domains share a high degree of structural similarity with noda- and 
tetravirus β-protein. Both coat protein precursors, pVP2 and α-protein; suffer an ulterior 
proteolytic event which confers stability and infectivity to the virion by rearrangement 
of the procapsid intermediate. As cleavage sites are deeply buried inside the capsid 
shell, and thus sheltered from possible attacks by cellular proteases. It has been 
described for noda- and tetravirus that the coat proteins is processed by an 
autoproteolytic event mediated by an acid residue (Taylor and Johnson, 2005; Zlotnick 
et al., 1994). 
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Searching for possible candidates in VP2, its atomic structure was fitted into the 
three-dimensional cryo-electron microscopy map of IBDV T=1 SVP allowing to 
identify at least two conformations for its C-terminal region (molecular swapping) 
(Luque et al., 2007). These structural considerations suggested that Asp391 and/or 
Asp431 might be good catalytic candidates capable to trigger a hydrolytic cleavage 
either on its own scissile bond or on that from a neighbouring pVP2 molecule (Fig. 15). 
 
Fig. 15. Conformational flexibility of VP2 C-terminal α-helix around its cleavage site. (A) Bottom 
view, facing the inner surface of the viral capsid, of the VP2 protein X-ray model (PDB entry 2GSY). α-
helices (1-4) of domain B (green) are indicated for a VP2 chain; the candidate catalytic residues Asp-391 
and Asp-431 are also indicated. α3 and α4 helices of the closer neighbouring VP2 chain (magenta) that 
projects towards the three-fold axis of the trimer are shown and, to simplify the view, only its Asp-391 
residue is indicated. The locations of five-fold, three-fold, and two-fold axes of icosahedral symmetry are 
indicated (B) Same as panel A, but the C-terminal α4 helices of VP2 chains were remodelled after fitting 
the X-ray model into an equivalent cryo-electron microscopy map (Luque et al., 2007). 
Furthermore, some indirect evidences suggest that a maturation and 
rearrangement process may be required similar to noda- and tetravirus for the correct 
IBDV assembly. The IBDV polyprotein expressed by an inducible rVV provided an 
excellent framework to analyze IBDV maturation. The use of this system allows the 
accumulation of pVP2 and VP2, and the efficient assembly of VLP, structurally 
undistinguishable from IBDV virions at 72hp.i., whereas at 48 hp.i the expression of 
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rVV/Poly only collapsed structures can be recovered when is purified by the same 
purification protocol; although biochemical analysis of purified fractions by WB and 
Coomassie staining, at different post-infection hours are similar (Fig. 16) (Caston, 2008; 
Lombardo et al., 1999). 
 
Fig. 16. Maturation intermediates (A) VT7/Poly at 48 hp.i. assemblies were purified by 
ultracentrifugation on sucrose gradients. Gradients were collected into 12 fractions, concentrated by 
ultracentrifugation, and analyzed by SDSPAGE and Western blot using anti-VP2. The direction of 
sedimentation was right to left, with fraction 12 representing the gradient top. The image shown on the 
right corresponds to a representative electron microscopy micrograph (negative staining) of partially 
collapsed structures present at middle fractions. (B) VT7/Poly at 72 hp.i. assemblies were analyzed as 
described above. The image shown on the right corresponds to a representative electron microscopy 
micrograph (negative staining) of T=13 capsid like structures in the middle fractions. Bars=100 nm. 
4.2.2. Effect of mutations on VP2 Asp-431 and Asp-391 
(p)VP2 residues D391 and D431 appeared to be likely candidates to trigger a 
nucleophilic attack on the pVP2 441-442 scissile bond. Two single-point mutant 
versions of the IBDV polyprotein gene were generated and used to construct the 
corresponding rVV, called VT7LacOI/D431N and VT7LacOI/D391N, respectively, in 
which Asp residues under study were replaced by Asn residues. Cultures infected with 
these two rVV were harvested at different times postinfection (pi, 24, 48, and 72 h), and 
the corresponding extracts analyzed by Western blot using VP2-specific serum. As a 
control for this experiment, cultures were also infected with VT7LacOI/POLY, a rVV 
expressing the wild-type polyprotein gene (Lombardo et al., 1999). 
Although expression of wild-type and D391N polyproteins led to accumulation 
of both pVP2 and VP2 polypeptides, samples from cells expressing polyprotein D431N 
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showed equivalent pVP2 levels but did not contain detectable VP2 (Fig. 17A). These 
results, strongly suggesting that the D431N substitution specifically abrogates pVP2 
proteolytic processing, were further confirmed using an alternative experimental 
approach. QM7 cells were infected with the three described rVV and, at 19 h pi, the 
cultures were metabolically labelled with [35S] methionine for 1h. Thereafter, cultures 
were extensively washed and incubated with fresh medium supplemented with an 
excess of cold methionine. At different times postlabeling (0, 24, 48 and 72 h), cells 
were harvested, and the corresponding extracts subjected to IP using anti-VP2 
antiserum. The results of this analysis (Fig. 17B) demonstrate that whilst in cells 
infected with VT7LacOI/POLY and VT7LacOI/D391N-infected cells, the pVP2 
polypeptide is progressively processed to mature VP2, the pVP2 polypeptide encoded 
by VT7LacOI/D431N remains intact for the duration of the experiment (72 h after its 
synthesis). Taken together, these results demonstrate that the conservative D431N 
substitution causes a complete blockade on pVP2→VP2 proteolytic maturation. 
 
Fig. 17. Effect of conservative mutations of residues Asp-431 and Asp-391 on pVP2/VP2 proteolytic 
maturation. (A) Western blot analysis of proteins expressed in cells infected with rVV 
VT7LacOI/POLY, VT7LacOI/D431N or VT7LacOI/D391N, respectively. Infected cultures were 
harvested at 24, 48 and 72 h pi, respectively. The corresponding extracts were subjected to SDS-PAGE 
and Western blot using anti-VP2 serum. (B) QM7 cells infected with rVV VT7LacOI/POLY, 
VT7LacOI/D431N or VT7LacOI/D391N were metabolically pulse-labelled with [35S]Met for 1h at 19 h 
pi. The radioactivity was chased with by adding fresh medium containing an excess of cold methionine. 
Cultures were harvested at 0, 24, 48 and 72 h post-labelling, and the corresponding extracts 
immunoprecipitated using anti-VP2 serum. The resulting samples were subjected to SDS-PAGE followed 
by autoradiography. Molecular weight markers (expressed in kDa, left) and bands corresponding to 
proteins pVP2 and VP2 (right) are indicated. 
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4.2.3. Decrease of IBDV infectivity by D431N substitution
In view of the results described above, it was important to assess the relevance 
of the D431 on IBDV infectivity. This analysis was carried out using a reverse genetics 
approach using plasmids pT7_SA_Rz and B pT7_SB_Rz containing the cDNA 
sequences corresponding to IBDV segments A and B, respectively, and plasmid 
pT7_SA/D431N_Rz, harbouring a mutant version of segment A containing the D431N 
substitution. 
The results obtained demonstrate that the D431N substitution completely 
abolishes the production of an infectious IBDV progeny (Table 7). Western blot 
analysis indicated that cells transfected with plasmids pT7_SA/D431N_Rz and 
pT7_SB_Rz, and infected with a rVV expressing the T7 polymerase, failed to trigger 
the assembly of infectious IBDV. This finding, in agreement with the observations 
described above, highlights the critical importance of the VP2 D431N residue on IBDV 
infectivity. 
Table 7. Virus titres obtained by reverse genetics.  
Coinfections  Virus titres (pfu/ml)  
 First round Second round Third round 
pT7-SA-Rz/             
pT7-SB-Rz 
                       
1.3+0.5x102
                        
9.0+1.3x104
                          
6.0+1.5x107
pT7-SA(D431N)-Rz/ 
pT7-SB-Rz 
                                         
0 
                                         
0 
                                              
0 
 
4.2.4. pVP2 an intramolecular proteolytic processing 
To get a better understanding of the pVP2 maturation mechanism, it was 
important to determine whether the pVP2→VP2 cleavage is the result of an intra- (cis-
cleavage) or intermolecular (trans-cleavage) event. 
To discriminate between these two possibilities, a polyprotein mutant containing 
an intact D431 residue but resistant to self-proteolytic processing was required. Such 
mutant would be used for co-expression analysis with the polyprotein D431N mutant to 
provide the pVP2→VP2 proteolytic activity in trans. With this aim, three polyprotein 
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genes, containing one or two amino acid substitutions affecting either one or both amino 
acid at the pVP2 scissile bond (Ala-441-Phe-442), were generated. The mutant genes 
contain the following substitutions: i)A441G; ii) F442G; and iii) A441G/F442G. 
Mutant genes were then inserted within the VV genome giving rise to rVV 
VT7LacOI/A441G, VT7LacOI/F442G and VT7LacOI/A441G/F442G, respectively. 
The effect of the described mutations on pVP2 processing was analyzed by Western 
blot and pulse-chase/IP analysis. As shown in Fig. 18, whilst single substitutions cause 
a major but partial pVP2→VP2 blockade, the double mutation, A441G/F442G, 
completely abolishes pVP2 processing. Accordingly, this mutant gene was selected for 
subsequent experiments. 
 
Fig. 18. Analysis of the pVP2 cleavage site Ala 441-Phe 442. (A) Western blot analysis of proteins 
expressed in cells infected with rVV VT7LacOI/POLY, VT7LacOI/A441G, VT7LacOI/F442G and 
VT7LacOI/A441G/F442G, respectively. Infected cultures were harvested at 24, 48 and 72 h pi. (B) QM7 
cells were infected with different recombinants VT7LacOI/A441G, VT7LacOI/F442G or 
VT7LacOI/A441G/F442G were pulse-labelled with [35S] Met for 1h at 19 h pi. The radioactivity was 
chased with by adding with fresh medium containing an excess of cold methionine. Cultures were 
harvested at 0, 24, 48 and 72 h post-labeling, and the corresponding extracts immunoprecipitated using 
anti-VP2 serum. The resulting samples were subjected to SDS-PAGE followed by autoradiography. 
Molecular weight markers (expressed in kDa, left) and bands corresponding to proteins pVP2 and VP2 
(right) are indicated. 
Next, cells were coinfected with VT7LacOI/POLY and VT7LacOI/D431N, 
VT7LacOI/POLY and VT7LacOI/A441G/F442G, or VT7LacOI/D431N and 
VT7LacOI/A441G/F442G. Cultures were harvested at 48 and 72 h pi, and the 
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corresponding extracts analyzed by Western blot. As shown in Fig. 19, the presence of 
mature VP2 was exclusively detected in samples from cells expressing the wt 
polyprotein gene that provides both the catalytic D431 residue and the intact cleavage 
site. Coinfection with VT7LacOI/D431N and VT7LacOI/A441G/F442G showed that 
pVP2-D431N remains uncleaved and is not proteolytically processed in trans by the 
wild-type pVP2, thus strongly suggesting that pVP2 processing is the result of a 
monomolecular cis-cleavage reaction. 
 
Fig. 19. pVP2 intramolecular proteolytic processing. Western blot analysis of proteins expressed in 
QM7 cells coinfected with VT7LacOI/POLY and VT7LacOI/D431N, VT7LacOI/POLY and 
VT7LacOI/A441G/F442G, or VT7LacOI/A441G/F442G and VT7LacOI/D431N, respectively. Infected 
cultures were harvested at 48 and 72 h pi, re4spectively. A scheme indicating the combinations of rVV 
used in this experiment (mutated positions are crossed out) is shown at the bottom. 
 
4.3.Implication of the catalytic D431 in viral assembly 
4.3.1. Influence of pVP2→VP2 maturation blockade on assembly of IBDV-
particles  
IPNV morphogenesis involves the assembly of provirions containing a high 
proportion of pVP2 molecules. Provirion maturation appears to be associated to pVP2 
proteolytic processing (Villanueva et al., 2004). Hence, it seemed feasible that blocking 
pVP2→VP2 processing might favor the accumulation and isolation of IBDV provirions. 
To test this possibility, QM7 cultures were infected with VT7LacOI/POLY or 
VT7LacOI/D431N, respectively. Expression of the IBDV polyprotein in avian cells 
using an inducible rVV results in the accumulation of abundant levels of VLP with 
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similar size and shape to those of authentic IBDV particles (Lombardo et al., 1999). 
Remarkably, the assemblies produced with the rBV system in insect cells were 
nevertheless structurally varied, and in general, the formation of IBDV-like particles 
was rather inefficient. Insect cells might, therefore, have an important cellular factor(s) 
that interferes negatively with VLP assembly (e.g. cellular proteins and/or host 
environment). Cultures harvested at two different times (36 and 72 h pi), and the 
corresponding extracts used for the isolation of IBDV derived assemblies using a 
sucrose gradient-based purification protocol followed by electron microscopy and 
Western blot analyses of the collected fractions. As described previously, extracts from 
cells infected with the rVV expressing the wild-type polyprotein gene contained 
abundant icosahedral VLPs with a relatively high VP2/pVP2 ratio (Lombardo et al., 
1999). In contrast, no IBDV-derived assemblies were detected in samples from 
VT7LacOI/ D431N-infected cells. 
The use of gentler extraction conditions and/or alternative purification protocols 
yielded similar results. The same results were observed with extracts from cells infected 
with the three rVVs expressing polyprotein genes containing mutations on the pVP2 
cleavage site described above (data not shown). 
4.3.2. The assembly of D431N VP2 trimers 
VP2 trimers constitute the building block of the IBDV-related icosahedral 
capsids with different triangulation numbers (T) as well as different tubular structures 
with helical symmetry (Luque et al., 2007; Saugar et al., 2005). Therefore, it seemed 
likely that the results described above might be caused by a deficiency on trimer 
assembly induced by a putative VP2 conformational change generated as a result of the 
D431N mutation. Such conformational change might prevent both the assembly of 
IBDV provirions and the subsequent pVP2 proteolytic processing event.  
Expression of chimerical VP2 genes in insect cells leads to the spontaneous 
assembly of T=1 SVP, built by 20 VP2 trimers arranged into pentamers (Caston et al., 
2001; Coulibaly et al., 2005; Lee et al., 2006). We have exploited this system to 
determine the effect of the D431N mutation on the assembly of VP2 trimers. A VP2 
gene with the N-terminal 452 residues harbouring the D431N substitution was 
generated, VP2-452_D431N, inserted into the pFastBac1 transfer vector, and then used 
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to generate the corresponding recombinant baculovirus (rBV), rBV/VP2-452_D431N. 
Extracts from cells infected with rBV/VP2-452_D431N were used for SVP purification. 
As shown in Fig. 20, expression of the VP2-452D431N gene results in the assembly of 
T=1 SVP undistinguishable under electron microscopy from those assembled by wild-
type protein. 
 
Fig. 20. VP2 with the D431N substitution assembles as T=1 subviral particleVP2 trimers. (A) Wild 
type VP2-452 SVP were purified by ultracentrifugation on sucrose gradients. Gradients were collected 
into 12 fractions, concentrated by ultracentrifugation, and analyzed by SDS-PAGE and Western blot 
using anti- VP2 serum. The direction of sedimentation was right to left, with fraction 12 representing the 
gradient top. The image shown on the right corresponds to a representative electron microscopy 
micrograph (negative staining) of wild-type SVP, present at the upper gradient fractions. (B) Mutant 
VP2-452-D431N assemblies were analyzed as described above. The image shown on the right 
corresponds to a representative electron microscopy micrograph (negative staining) of mutant VP2-452-
D431N SVP present at the upper gradient fractions. Bars=100 nm. 
The possibility nevertheless existed that the mutation D431N might somehow 
affect the formation of VP2 hexamers formed by VP2 trimers. To analyze this 
possibility we took advantage of a previous observation. We have shown that 
expression of VP2 long forms in a rBV expression system leads to the assembly of 
tubular structures formed exclusively by hexamers built by pVP2 intermediate precursor 
trimers (Caston et al., 2001; Saugar et al., 2005). Therefore, the D431N gene was 
subcloned into pFB/VP2-501, and the resulting plasmid, pFB/VP2-501_D431N, used to 
generate the corresponding rBV. As shown in Fig. 21, expression of VP2-501_D431N 
in insect cells results in the assembly of rigid tubules with an identical morphology to 
that of tubules purified from cells expressing wild-type VP2-501 gene. The results of 
this series of experiments demonstrate that the D431N substitution does prevent neither 
trimer assembly nor the subsequent formation of pentamers and hexamers. 
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Fig. 21. pVP2 variant with the D431N substitution assembles as tubular assemblies with hexagonal 
symmetry. (A) Wild type pVP2-501 assemblies were purified by ultracentrifugation on sucrose 
gradients. Gradients were collected into 12 fractions, concentrated by ultracentrifugation, and analyzed by 
SDSPAGE and Western blot using anti-VP2 serum. The direction of sedimentation was right to left, with 
fraction 12 representing the gradient top. The image shown on the right corresponds to a representative 
electron microscopy micrograph (negative staining) of wild-type tubular structures present at the lower 
fractions. (B) Mutant pVP2-501-D431N assemblies were analyzed as described above. The image shown 
on the right corresponds to a representative electron microscopy micrograph (negative staining) of pVP2- 
501-D431N rigid tubules at the lower fractions. Bars=100 nm. 
Finally, to rule out the possibility that the D431N substitution might induce 
conformational changes on the VP2 polypeptide undetectable by electron microscopy, 
the crystal structure of VP2-452_D431N-derived SVP was determined at 3.1 Å 
resolution. The root mean square deviation (rmsd) of the superimposition of all 428 
equivalent C-α atoms from VP2, in the structures of native and D431N SVP is 0.20 Å, 
showing that these structures are essentially identical in conformation. This similarity is 
also maintained within the flexible linker, between helices α3 and α4 (residues 428-
435), containing the D431N mutation (Fig. 22). 
 91 
————————————————————————————————Results 
 
Fig. 22. Structure of the VP2 D431N T=1 SVP monomer. Ribbon diagrams of wild-type (yellow) and 
mutant D431N (blue) VP2 proteins. The superposition was performed using all the 428 residues of both 
molecules. On the right, electron density map of the VP2 C-terminal boxed region around residue 
Asp431. Residues from Val429 to Pro435 are shown as sticks and explicitly labelled every two residues. 
4.3.3. D431N substitution in the context of HT-VP2-466 chimeric protein 
The point mutation in the catalytic residue Asp-431 prevents T=13 VLP 
formation, although this change allows the correct assembly of VP2 pentamers and 
hexamers. To rule out the possibility that this might be due to a putative blockade of an 
interaction with another viral protein, the D431N mutation was placed in the HT-VP2-
466 construct previously described system (Saugar et al., 2005). The expression of this 
wild-type recombinant yields efficient T=13 VLP (Fig. 23A) by the interaction of the 
His tag with the C-terminal of VP2. Unexpectedly, the results obtained with the HT-
VP2-466-D431N shows that the formation of T=13 VLP is prevented whilst the only 
structure that could be rescued were small capsids similar to T=1 SVPs (Fig. 23B). 
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Fig. 23. D431N substitution in the context of HT-VP2-466 chimeric protein. (A) Wild type HTVP2-
466 assemblies were purified by ultracentrifugation on sucrose gradients. Gradients were collected into 
12 fractions, concentrated by ultracentrifugation, and analyzed by SDS-PAGE and Coomassie staining. 
The direction of sedimentation was right to left, with fraction 12 representing the gradient top. The image 
shown on the right corresponds to a representative electron microscopy micrograph (negative staining) of 
wild-type HTVP2-466 capsids, present at the middle and the top gradient fractions. (B) Mutant HTVP2-
466-D431N assemblies were analyzed as described above. The image shown on the right corresponds to a 
representative electron microscopy micrograph (negative staining) of the upper fractions. Bars = 100 nm. 
 
In an attempt to explain this observation, Asp-431, in addition to its proteolytic 
role, should be involved in other aspects that preclude T=13 particle assembly. 
 
4.4.The role of a cellular protease 
 
4.4.1. The VP2-452 intermediate is required for IBDV correct assembly 
 
Polyprotein expression in insect cells with rBV vectors leads to an extremely 
inefficient VLP assembly (Chevalier et al., 2002; Martinez-Torrecuadrada et al., 2000). 
In particular, the use of IBDV polyprotein-derived rBVs results in the exclusive 
assembly of large tubule-like structures formed by hexamers of pVP2 trimers (Da Costa 
et al., 2002; Martinez-Torrecuadrada et al., 2000) identical to type I tubules isolated 
from IBDV-infected cells. 
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IBDV capsid is composed of pentamers and hexamers of (p) VP2 coat protein 
trimers; hexamers are provided by rBV/Poly, the other component necessary for a 
theoretical assembly of a VLP is the finding of a donor for pentamers. As previously 
described, short forms of VP2 spontaneously assemble into SVP, composed exclusively 
by pentameric units. Thus, it was rationalized that coinfections of rBV/Poly and rBV 
expressing short forms of VP2, i.e. VP2-441 (Saugar et al., 2005) or VP2-452, could 
eventually yield T=13 VLP. Additionally, the use of different short forms of VP2 could 
provide information about the requirement of the VP2 amphiphatic α-helix for T=13 
capsid assembly. 
  
 We carried out different infections and coinfections in insect cells rBV/Poly, 
rBV/Poly and rBV/VP2-452, rBV/Poly and rBV/VP2-441. Extracts were harvested at 
48hp.i and subjected to purification by sucrose gradient and ultracentrifugation and the 
resulting assemblies were analyzed. The infection with a rBV that express the wild-type 
Poly leads to the accumulation of particulated material in the bottom part of the gradient 
corresponding to large tubes (Fig. 24A). The coinfection of this rBV/Poly and the 
rBV/VP2-441 allows the detection of structures along the gradient. The bottom 
fractions contain tubular elements and in the upper fractions T=1 capsids. The middle 
fractions, where T=13 VLP are expected to migrate, T=1 SVP aggregations are 
observed, due to the sticky characteristic of VP2 P domain (Fig. 24B). On the other 
hand, the coinfection of rBV/Poly with a rBV/VP2-452 allows the accumulation of 
tubules, T=1 capsids, and in the middle fractions the presence of T=13 VLP. Not only 
the 452-VP2 form can be detected in these fractions, but also the VP2-441 form 
showing that these capsids were correctly processed because they could render the 
mature form of VP2. Also, it should be noticed that two different VP3 forms could be 
detected (Fig. 24C, framed in a red square). Polyprotein expression in insect cells leads 
to the accumulation of two VP3 species with different electrophoretic mobilities: a 29-
kDa product, which is the wild type protein; and a truncated 27-kDa product, produced 
by proteolytic cleavage at the C-terminal end of the protein, probably generated by a 
cellular protease(s) (Maraver et al., 2003). In our results, there is a high amount of VP3 
wild type accumulation probably because it has been protected from the cellular 
proteases by after encapsidation. 
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Fig. 24. VP2-452 form is required for IBDV correct assembly. (A) Wild type rBV/POLY assemblies 
were purified by ultracentrifugation on sucrose gradients. Gradients were collected into 12 fractions, 
concentrated by ultracentrifugation, and analyzed by SDSPAGE and Western blot using anti-VP2 and 
anti-VP3 serum. The direction of sedimentation was right to left, with fraction 12 representing the 
gradient top. The image shown on the right corresponds to a representative electron microscopy 
micrograph (negative staining) of wild-type tubular structures present at the lower fractions. (B) 
Coinfection rBV/POLY and rBV/VP2-441 and (C) coinfection rBV/POLY and rBV/VP2-452 assemblies 
were analyzed as described above. The image shown on the right corresponds to a representative electron 
microscopy micrograph (negative staining) of the middle fractions. Bars=100 nm. 
 
Some previous results obtained in our laboratory, in which the Arg-452 and Arg-
453 of VP2 were replaced by alanine residues in a rVV expressing the polyprotein (Fig. 
25A) shows that Arg-452 residue is essential for VP2 assembly, as it can be observed 
by confocal analysis, where VP2 and VP3 are not interacting with themselves and any 
recognizable structure is visualized (Fig. 25B). Whereas the mutation of Arg-453 leads 
to the assembly of large tubules, in which VP2 and VP3 are colocalizing, but any 
viroplasmatic structure is detected (Fig. 25B). 
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Fig. 25. The presence of an intermediate band. (A) Western blot analysis of VP2 expressed in BSC-40 
cells infected with the different rVV mutants: VT7/POLY, VT7/POLYR452A, VT7/POLYR453A and 
VT7/POLYR452AR453A. Infected cultures were harvested at 24, 48 and 72 h.pi. (B) Digital confocal 
images of BSC-40 cells infected with three different rVVs. At 48 hp.i, cells were fixed and incubated 
with rabbit anti-VP2 and rat anti-VP3 followed by incubation with goat anti-rabbit immunoglobulin 
coupled to Alexa-488 (green) and goat anti-rat immunoglobulin coupled to Alexa-594 (red). 
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 These results strongly suggest that the presence of VP2-452 forms in the viral 
capsid are essential for the correct T=13 assembly, probably conforming the capsid 
pentamers and by its interaction with the scaffolding protein VP3. 
 
A band migrating between pVP2 (512aa) and VP2 (441aa) can be observed in 
SDS-PAGE (Fig. 26), when QM7 cell extracts are analyzed after having been infected 
with IBDV at 48 hp.i. Furthermore, this band is specifically recognized by anti-VP2 
serum and co-migrates with the band corresponding to the (VP2 452aa) form, 
suggesting that the mature virion could eventually contain small amounts of this VP2 
molecular form.  
 
Fig. 26. The presence of an intermediate band. Western blot analysis of VP2 expressed in QM7 cells 
infected with IBDV. Infected cultures were harvested at 8, 12, 24, 30 and 48 h. pi. Bands corresponding 
to VP2-441aa and VP2-452aa are also shown. The intermediate band is indicated by an arrow. Molecular 
weight markers (expressed in kDa, left) and bands corresponding to proteins pVP2 and VP2 (right) are 
indicated. 
 
4.4.2. Searching for the VP2-452 origin 
 
 Although the presence of a VP2-452 form is necessary for the correct assembly 
of the T=13 capsid in the context of rBV, the origin of this VP2 form remains unclear. 
Whereas the viral protease VP4 has as catalytic targets at alanine dipeptides (Sanchez 
and Rodriguez, 1999), the autocatalytic residue Asp-431 is also excluded since its 
scissile bond is located in the Ala-441-Phe-442. As no more viral protease activities 
have been reported, we thought about the possibility of a cellular protease involved in 
the cleavage of the Arg-452-Arg-453 dipeptide. To ascertain whether possible 
candidates were described in the literature, we scanned the Merops protease database 
(Sanger Institute UK) (Rawlings et al., 2008). A list of candidates is shown in Table 8. 
The cytosol alanylaminopeptidase, also known as puromycin sensitive aminopeptidase 
(PSA), was selected for further studies. PSA was first described in Gallus gallus when 
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full length cDNAs from chicken bursal lymphocytes were analyzed. Interestingly, these 
bursal lymphocytes are the cell target of IBDV (Caldwell et al., 2005). 
 
Table 8. Several candidates as cellular proteases. 
Protease name: Cleavage site: 
1.Trypsin 1 Peptide Arg+ Arg Peptide 
2.Cathepsin L Peptide Arg+ Arg Peptide 
3.Trytase beta Peptide Arg+ Arg Peptide 
4.Kallikrein 1 Peptide Arg+ Arg Peptide 
5.Thrombin Peptide Arg+ Arg Peptide 
6.Plasmin Peptide Arg+ Arg Peptide 
7.Lactoferrin Peptide Arg+ Arg Peptide 
8.Intestinal Arg-specific endopeptidase Peptide Arg+ Arg Peptide 
9.Puromycin sensitive aminopeptidase 
(PSA) 
Arg+ Arg 
 
PSA is an ubiquitous 100 kDa, Zn+2 metallopeptidase. It has been proposed that 
plays a role in a number of essential cellular processes including neuropeptides 
metabolism (Hersh and McKelvy, 1981; Hersh et al., 1980), processing of antigenic 
peptides for presentation on MHC Class I molecules (Stoltze et al., 2000) and 
hydrolysis of proteasomal products (Botbol and Scornik, 1983; Saric et al., 2004). This 
protease exhibits a broad specifity against various N-terminal residues with some 
preference for basic and hydrophobic amino acids (Constam et al., 1995; Johnson and 
Hersh, 1990; Stoltze et al., 2000).  
 
4.4.3. Determination of the presence of the PSA in different IBDV- susceptible cell 
lines 
 
 We first determined the presence of the PSA in different cell lines routinely used 
in the laboratory that support correct T=13 capsid assembly. For the detection of 
mRNAs of PSA, primers were designed against highly conserved regions of this 
protein, determined by the alignment of PSA sequence from Homo sapiens sapiens, Pan 
troglodytes and Gallus gallus (Fig. 27A). 
 
 RNA from different cell lines was extracted. Different cell lines tested were: 
DT40 cells (bursal lymphocytes as positive control); DF1 cells (chicken fibroblasts); 
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QM7 (quail muscle cells); BSC 40 (green monkey kidney epithelial cells) as 
susceptible to allow the correct assembly of the capsid and H5 insect cells as a possible 
candidate for a negative control since VLPs assembly is highly inefficient. cDNAs were 
generated by reverse transcription with random primers and a later PCR was set up with 
the conserved region primers. This analysis showed that the mRNAs corresponding to 
PSA were present in all the cell lines in which IBDV can correctly assemble apart from 
H5 insect cells (Fig. 27B). 
 
Fig. 27. Determination of the presence of PSA in different cell lines. (A) Alignment of the DNA 
sequence of PSA of three different organisms (Pan troglodytes accession number, NC-006484, Homo 
sapiens accession number AJ132583 and Gallus gallus accession number AJ851657). Highlighted in blue 
highly conserved domains used for oligonucleotides design. (B) Agarose gel of the PCR to determine the 
presence or absence of the cellular protease in different cell lines, DT40, DF1, QM7, BSC-40 and H5, 
respectively. As molecular weight marker 1-kb ladder.  
 
4.4.4. Coexpression of PSA in H5 insect cells and its implication in VLP assembly 
 
 PSA can not be detected in H5 insect cells. To analyze its function when it is 
expressed in insect cells, a new rBV was generated (rBV/PSA). To clone the protease, 
DT40 cDNA was amplified by flanking primers in a PCR reaction and then inserted in a 
pFastBac vector which expressed a His tag. This would allow detecting the protein by 
immunological techniques and its ulterior purification if necessary. 
 
H5 insect cells were infected with a rBV/Poly and by immunofluorescence 
analysis at 48 hp.i, a tubular pattern of VP2 coat protein is observed (Fig. 28A). When 
H5 are coinfected with rBV/Poly and rBV/PSA, the distribution of VP2 becomes more 
diffuse similar to the typical pattern exhibited when viroplasms are formed (Ona et al., 
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2004), suggesting that the coat protein is not completely assembled in tubes (Fig. 28B). 
These assembles were purified by sucrose gradient and ultracentrifugation at 72 hp.i and 
different fractions obtained were analyzed by WB and electron microscopy. The 
comparison of biochemical patterns observed in the purification of IBDV-derived 
structures of rBV/Poly or the co-infection rBV/Poly-rBV/PSA revealed some 
differences. Whilst with rBV/Poly infection, the particulated material, exclusively 
composed by pVP2, is accumulated in the bottom part of the gradient (Fig. 28C); in the 
coinfection rBV/Poly and rBV/PSA, the mature form of VP2 (VP2-441) and a non-
truncated VP3 specimen can be detected in the middle fractions suggesting the presence 
of capsids(Fig. 28D). By electron microscopy differences are more noticeable, 
structures observed with rBV/Poly, as expected, are pVP2 rigid tubes with an hexagonal 
lattice (Fig. 28C), whereas in middle fractions of the co-infection rBV/Poly-rBV/PSA 
some particles with a size and morphology similar to genuine T=13 virion particles can 
be purify, although some of them are partially collapsed probably due to its fragility 
(Fig. 28D). 
 100 
Chapter 4——————————————————————————————— 
 
Fig. 28. Implication of PSA in IBDV capsid assembly when is expressed in H5 insect cells. (A and B) 
Digital confocal images of H5 cells infected with two different rBVs. At 48 hp.i, cells were fixed and 
incubated with rabbit anti-VP2 and mouse anti-His tag followed by incubation with goat anti-rabbit 
immunoglobulin coupled to Alexa-488 (green) and goat anti-mouse immunoglobulin coupled to Alexa-
594 (red). (A). H5 insect cells infected with rBV/Poly and (B) H5 insect cells infected with rBV/Poly and 
rBV/HT-PSA. (C) Wild type rBV/POLY assemblies were purified by ultracentrifugation on sucrose 
gradients. Gradients were collected into 12 fractions, concentrated by ultracentrifugation, and analyzed by 
SDSPAGE and Western blot using anti-His tag, anti-VP2 and anti-VP3 serum. The direction of 
sedimentation was right to left, with fraction 12 representing the gradient top. The image shown on the 
right corresponds to a representative electron microscopy micrograph (negative staining) of wild-type 
tubular structures present at the lower fractions. (D) Coinfection of rBV/POLY and rBV/His tag-PSA; the 
image shown on the right corresponds to a representative electron microscopy of the middle fractions, 
where VLP purified are shown with an arrow. VP3 recovered inside the capsids are squared in red 
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 Furthermore, to confirm the target of this cellular protease at the Arg-452-Arg-
453, different mutants in the polyprotein gene were carried out. Arg-452 or Arg-453 
was mutated to Ala residues. Insect cells were infected with the corresponding 
rBV/Poly R452A and rBV/PolyR453A Cultures harvested at 72hp.i, and the 
corresponding extracts used for the isolation of IBDV derived assemblies using a 
sucrose-gradient purification protocol. Any particulated material was recovered from 
rBV/PolyR452A infection. rBV/PolyR453A biochemical analysis shows a similar 
pattern to rBV/Poly, i.e., rigid tubules indistinguishable from rBV/Poly ones are 
observed by electron microscopy and confocal analysis (Fig. 29A and 29C). 
Coinfection of rBV/PolyR453A with rBV/PSA prevents the formation of capsid like 
structures. The biochemical pattern does not change regarding the non-protease added, 
and by electron microscopy and immunofluorescence analysis only large tubular 
structures are visualized (Fig. 29B and 29D). 
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Fig. 29. Implication of PSA in IBDV capsid assembly when is expressed in H5 insect cells. (A and B) 
Digital confocal images of H5 cells infected with two different rBVs. At 48 hp.i, cells were fixed and 
incubated with rabbit anti-VP2 and mouse anti-His tag followed by incubation with goat anti-rabbit 
immunoglobulin coupled to Alexa-488 (green) and goat anti-mouse immunoglobulin coupled to Alexa-
594 (red). (A). H5 insect cells infected with rBV/PolyR453A and (B) H5 insect cells infected with 
rBV/PolyR453A and rBV/HT-PSA. (C) rBV/PolyR453A assemblies were purified by ultracentrifugation 
on sucrose gradients. Gradients were collected into 12 fractions, concentrated by ultracentrifugation, and 
analyzed by SDSPAGE and Western blot using anti-His tag, anti-VP2 and anti-VP3 serum. The direction 
of sedimentation was right to left, with fraction 12 representing the gradient top. The image shown on the 
right corresponds to a representative electron microscopy micrograph (negative staining) of tubular 
structures present at the lower fractions. (D)Coinfection of rBV/POLYR453A and rBV/His tag-PSA. 
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 These results suggest that the formation of T=13 VLP can be rescued in the 
baculovirus system, when PSA cellular protease, naturally absent in these cells, is 
expressed. There is also strong evidence, although a structural change is not excluded, 
that the cleavage site of the PSA cellular protease are the basic residues, Arg-452-Arg-
453. 
 
4.4.5. The role of the cellular protease in viral infection context 
 
4.4.5.1. Silencing of PSA in DF1 cells 
 
 To analyze the influence of the PSA in the context of IBDV real infection, some 
silencing experiments were carried out in DF1 cells (chicken fibroblasts). Four different 
retroviruses were generated, three of them with a sequence of short hairpin RNA 
(shRNA) susceptible to be cleaved by siRNA induced silencing complex (RISC 
complex), called DF1-sh1, DF1-sh2 and DF1-sh3, and an empty vector used as a 
positive control for the cellular protease, referred as DF1 control cells. Retroviruses 
used in this study contain a puromycin resistance gene. Thus stably silenced cells were 
established by the addition of the antibiotic to the media. To quantify the inhibitory 
effect of the shRNAs, a quantitative real time PCR (qRT PCR) with specific primers for 
the cellular protease was performed. As an internal control, the gen coding for the 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Gallus gallus was used. 
 
 As observed in Fig. 30, the inhibitory effect of siRNAs ranged near 90% in 
DF1-sh1 and DF1-sh3, whereas the amount of GAPDH is maintained in a constant level 
in all cell lines. 
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Fig. 30. Silencing of PSA in DF1 cells. Quantitative real time PCR (qRT PCR) to quantify the inhibitory 
effect of shRNAs in silenced cells (DF1-control, DF1-sh1 and DF1-sh3) for PSA. Bars have been scaled 
to a maximum of one and error deviations are also shown for each one. (A) Quantification by qRT PCR 
of the amount of GAPDH cDNA for each cell line. (B) Quantification by qRT PCR of the amount of PSA 
for silenced cells. 
 
4.4.5.2. Effect of silencing in IBDV infection 
 
 Silenced cell lines were infected with IBDV at MOI 0.05 pfu/cell. At 30 hp.i 
cells were fixed and analyzed by immunofluorescence with an anti-VP2 antiserum. All 
DF1-control cells are infected, showing a characteristic viroplasmatic pattern in their 
cytoplasm (Fig. 31). In contrast with DF1-control cells, a small amount of DF1-sh1 and 
DF1-sh3 cells are susceptible to be infected by IBDV (Fig. 31).  
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Fig. 31. Effect of silencing in IBDV infection. Digital confocal images of silenced cells infected with 
IBDV. At 30hp.i, cells were fixed and incubated with rabbit anti-VP2 followed by incubation with goat 
anti-rabbit immunoglobulin coupled to Alexa 488 (green). 
 
At 48 hp.i silenced cells were infected with IBDV at MOI 0.05 pfu/cell, in the 
absence and presence of puromycin. Puromycin antibiotic has been described to be an 
inhibitor of PSA at low concentrations (Fidler et al., 1978). Cells were harvested and 
analyzed by Western Blot with an anti-VP2 antiserum. An accumulation of pVP2 and a 
prevention of the cleavage pVP2→VP2 can be observed in all infected silenced cells, 
probably because the coat protein has not been properly assembled in viral capsids (Fig. 
32). This effect was more noticeable in the presence of puromycin (Fig. 32). 
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Fig. 32. Effect of silencing in IBDV infection. Western blot analysis of proteins using an anti-VP2 
antiserum expressed in DF1 silenced cells infected with IBDV. Infected cultures were harvested at 48 h.pi 
in the absence and presence of puromycin (which is marked as puro).  
 
 To analyze the viability and production of IBDV virions in silenced cells. They 
were infected by IBDV, in the absence and presence of puromycin, at MOI 2 pfu/cells. 
The supernatant was collected at 12 hp.i and titrated by serial dilutions in QM7 cells. 
Viral titres were determined by an immunostaining assay against VP2 capsid protein. 
Viral titres reduction was dramatically high in DF1-sh1 and DF1-sh3 silenced cells, 
almost reaching a 90% (Fig. 33). It exists a clearly correlation between the silencing 
obtained by each cellular type and its capacity in viral production (Fig. 33). DF1-control 
cells were clearly affected by the addition of puromycin to the media, where viral titre 
was reduced to a half respect to the one obtained by DF1-control cells without antibiotic 
treatment. 
 
Fig. 33. Effect of silencing in IBDV infection: IBDV titration. Silenced cells were infected by IBDV in 
the absence or presence of puromycin. At 12hp.i supernatants were collected and titrated by serial 
dilutions in QM7 cells. Titres were determined by immunostaining and counting of plaque formation 
units. For each cell line bars in violet are for non-puromycin and in magenta for the addition of the 
antibiotic. 
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 It seems that a previous cleavage of pVP2 by this cellular protease is required 
for a correct IBDV production. A drastic reduction of PSA, by silencing experiments 
prevents IBDV progeny in a 90%. As it has been previously suggested, the cleavage of 
pVP2 on Arg-452 would donate short forms of VP2 that could assembly spontaneously 
in pentamers. As they have not lose their amphiphatic α-helix yet, they could interact 
with VP3 conforming a first nucleation factor of the whole capsid by the addition of the 
hexamers of pVP2. 
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5. INSIGHTS IN IBDV ASSEMBLY: 
 
Structural polymorphism and transient conformations are common in multiprotein 
assemblies, such as those described during cyclic reactions of chaperones (Ranson et al., 
2006), dynamic biomachines such as ribosomes (Mitra and Frank, 2006), spliceosomes 
(Stark and Luhrmann, 2006), and virus capsid assembly and maturation (Steven et al., 
2005). Structural studies have provided some clues as to how capsid proteins determine 
the conformation that they must adopt (Abrescia et al., 2004), although the underlying 
mechanism is not yet fully understood.  
 
The viral capsid structures provide a paradigm in the analysis of non-equivalent 
interactions among identical subunits. Structural polymorphism, together with the 
extensive use of symmetry, is an example of nature’s efficient use of limited coding 
capacity (Harrison, 2001). We have analyzed the molecular basis of the conformational 
polymorphism of the IBDV coat protein VP2. IBDV has a single T=13 levo capsid 
(Böttcher et al., 1997; Coulibaly et al., 2005; Saugar et al., 2005) formed by 260 VP2 
trimers, making 12 pentamers and 120 hexamers. The IBDV capsid is a fully quasi-
equivalent shell built of a single protein. From strict geometric considerations, VP2 
trimers adopt five distinct conformations (a-e) (Fig. 34). A number of T=13 capsids 
have been described for different dsRNA viruses.  
 
VP2 is synthesized as part of a large polyprotein (ca. 110 kDa) that is 
cotranslationally self-cleaved releasing three polypeptides, namely pVP2 (the VP2 
precursor), VP4 (the protease), and VP3 (a polypeptide with scaffolding activity among 
others). pVP2 (512 residues, 54,4 kDa) undergoes subsequent processing events 
mediated by VP4 at three secondary targets (positions 487, 494 and 501) (Sanchez and 
Rodriguez, 1999). The resulting intermediates are further cleaved twice between 
Arg452-Arg453 and Ala441-Phe442, probably in this order, to yield VP2 (47 kDa). The 
released C-terminal peptides (accounting for 7.4 kDa) remain inside the capsid (Da 
Costa et al., 2002) and appear to be involved in the entry mechanism by promoting the 
disruption of host cell membranes (Galloux et al., 2007). Here, we have also shed light 
on how these two late processing events occur, which are performed by a viral and, 
probably, by a cellular protease, respectively.  
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Fig. 34. Fit of the IBDV X-ray model into the virion cryo-EM map. (A) Complete capsid virion 
(white), rendered at ~10 Å. The five VP2 trimer types are indicated by letters a to e; the blue triangle 
indicates the limits of a G4 triangle. The locations of fivefold, threefold, and twofold axes are also 
indicated. Bar = 100 Å. (B) View from inside the capsid of the asymmetric unit X-ray model fitted into 
the corresponding region of the cryo-EM map. White surfaces show densities according to the X-ray 
model, displayed at a contour slightly lower than that of the cryo-EM map. Even at this threshold for the 
filtered atomic model, with P and S domains being well matched, the solid yellow densities correspond to 
empty cryo-EM virion densities; these densities probably arise from disordered VP2 N-terminal 
segments. A scheme of the asymmetric unit, seen from the inner surface, is shown in the inset. The first 
and last residues visible in the X-ray model are indicated for each of the 13 VP2 chains (A to M). 
 
5.1. Conformational polymorphism of the IBDV major coat protein 
 
Studies of the structures resulting from the expression of VP2 or pVP2 alone 
showed that VP2 spontaneously forms T=1 subviral particles (SVP), an all-pentamer 
capsid. In contrast pVP2 or intermediate pVP2 variants assemble into tubular structures 
with a hexagonal lattice (Caston et al., 2001). These IBDV-related structures are 
nevertheless formed by the same structural building block, (p)VP2 trimers. These 
results suggested that the inherent molecular switch controlling VP2 polymorphism 
resides in the temporally bound, 71-residue C-terminal sequence, which is removed 
when its function is completed. For this reason, no vestige remains in the mature capsid 
indicating how this event occurred. In addition, it has been shown that VP3 plays an 
essential role allowing pVP2 to acquire different conformations through its interaction 
with the pVP2 C-terminal end (Ona et al., 2004).  
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The role of the pVP2 C-terminal end was analyzed by generating a series of pVP2 
C-terminal deletion mutants. These molecular forms were also expressed with a His tag 
bound covalently at their N-termini. Interestingly, some VP2 C-terminal deletions could 
correspond to naturally occurring intermediates involved in virus assembly (Saugar et 
al., 2005). The primary sequence, circular dichroism, and NMR analyses indicate that 
residues 443-GFKDIIRAIR-452 of pVP2 C-terminal domain, forms an amphiphilic α-
helix. In the absence of VP3, efficient T=13 capsid-like assembly can be restored by the 
presence of a His tag at the VP2 N-terminus, suggesting that the His tag mimics VP3 
function during virion assembly (Saugar et al., 2005). Comparative three-dimensional 
cryo-EM analyses of virions and chimeric His-tagged VP2 proteins (e.g., His-VP2-466 
capsid) revealed that VP3 acts as a canonical scaffolding protein rather than as a 
permanent component of the mature capsid, and its function is successfully restored by 
the His tag. The pVP2 443-452 sequence is nearly identical to a LmTIM amphipathic α-
helix, whose hydrophobic side is buried, while leaving surface-exposed hydrophilic 
side-chains. The hydrophilic side of residues 443-452 is constituted of basic residues, 
although the same restrictions apply to the hydrophobic side of the VP2 peptide. 
Accordingly, this side would be buried by interaction with other VP2 region(s), 
although interactions with other protein(s) cannot be ruled out by the available data. 
 
Furthermore, more additional functions have been attributed to the VP2 C-terminal 
domain. IBDV presents four characteristic structural peptides derived from pVP2CTD, 
termed pep46, pep7a, pep7b and pep11 and being 46,7,7 or 11 amino acids in length, 
respectively, associated to the virus particle (Da Costa et al., 2002) (Fig. 35). Pep46 
deforms biological membranes, leading to the formation of pores. Its structure has been 
determined by NMR analysis (Galloux et al., 2007). In this peptide three different 
domains can be defined: a central hydrophobic domain flanked by two domains mainly 
constituted by both hydrophobic and charged residues. Whereas the N-terminal domain, 
is positively charged, where the amphiphatic α-helix is located, the C-terminal is 
somewhat negatively charged. The sequence similarity between pep46 of different 
IBDV strains and different birnaviruses is higher at the N-terminal than at the C-
terminal domain, suggesting an important role for this α-helix in the viral cycle as it has 
been established during the present work. Moreover, the identification of the 
membrane-active domain of pep46 has been mapped within its first 15 residues, which 
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includes the amphiphatic α-helix until residue 452. Correlating the results that we have 
reported, point mutations in this region, using reverse genetics, Lys-445 and Arg-452 
prevent the rescue of IBDV virus.  
 
 
Fig. 35. IBDV polyprotein and the four structural peptides pep46, pep7a, pep7b, and pep11 derived from 
the C-terminal domain of pVP2, are represented. Numbering refers to the residue positions in the 
polyprotein. Hydrophobic residues are red, acidic in blue and basic in pink. The main characteristics of 
the pep46 domains are indicated.  
 
5.2.Molecular switch and triggering factors 
 
The distinct conformational states of capsid proteins may be controlled by flexible 
protein regions (loops, N- and C-termini), ds- or ssRNA, metal ions, pH, or 
combinations of these (Johnson, 1996). These factors, referred to as molecular 
switches, may be insufficient, especially when large T number capsids are considered, 
and might require one or more auxiliary proteins that acting as a molecular effectors 
(scaffold, minor capsid or enzymatic proteins) (Dokland, 2000). The presence of a His 
tag in different pVP2 variants is essential for assembly of genuine virus-like structures. 
His tag and VP3 sequence comparisons show that the last five residues in the VP3 C-
terminal align with the similar His tag region. No other similarities are found, 
confirming the importance and uniqueness of this region. We have shown that the 
substitution of the His tag by the VP3 C-terminal domain also yields T=13 VLP 
indicating that the His tag is really emulating this VP3 region. Moreover, the deletion 
of the acid region (residues 11 to 25) in HT-VP2-466 prevents the VLP formation thus 
confirming the previous observations suggesting that the acidic segment of the VP3 C-
terminal region was essential for correct capsid assembly. Hence, VP3 mutants with 
altered or deleted C-terminal residues (Chevalier et al., 2004), or entirely lacking the 
 114 
——————————————————————————————Discussion 
last 13 residues (Maraver et al., 2003b) fail to assemble into T=13 capsids, and 
hexagonal tubular or aberrant assemblies are formed.  
It is also noticeable, that both acidic segments in the His tag and the VP3 C-
terminal residues are preceded by a basic segment that could also have an additional 
function. In the HT-VP2-466 construct, the deletion of the basic region, which includes 
all His residues, abolishes the T=13 VLP formation. This indicates that the basic region 
of VP3 C-terminal domain is necessary for the correct assembly of viral capsids. 
Moreover, point mutations in Arg residues of this basic region yields partially collapsed 
structures (VP3 Arg-245) or the production of a majority of T=7 capsids (VP3 Arg-
242), reinforcing the importance of the VP3 basic region in virions. 
Following these results, a charge complementarity between basic residues of the 
VP2 amphiphatic α-helix and the acid region of VP3 Ct domain could be necessary for 
the correct T=13 VLP assembly. In view of the alignment, it is tempting to suggest that 
electrostatic interactions may be the initial event in the adoption of different 
conformational states. Structural polymorphism might be achieved by electrostatic 
interactions between these two separate polypeptide elements that can be disengaged in 
the recombinant baculovirus system, with the HT-VP2-466 and CtVP3-VP2-466 gene. 
It has been established that an electrostatic interaction is established between VP2 Arg-
449 and VP3 Asp-254 and a possible interaction between VP2 Lys-445 and VP3 Asp-
252. 
 
We postulate that this electrostatic interaction is transmitted to the rest of VP2, 
inducing the correct conformational change. Similar changes have been described at 
atomic detail for the allosteric regulation of integrins, which transmit conformational 
changes after activation by ligand binding (Xiao et al., 2004). We are currently focused 
on modifications of the His tag and the proposed counterpart to obtain new VP2 
chimerical proteins able to successfully assemble T=13 shells with higher efficiency. 
In addition, a possible electrostatic interaction between the basic region of VP3 
C-terminal domain and the acid domain of pVP2 C-terminal domain corresponding to 
helix-α6 (Galloux et al., 2007) can not be ruled out at this point. 
 
 115 
——————————————————————————————Discussion 
It is nonetheless intriguing that VP3 stoichiometry inside the virion remains 
constant at ~600 copies, in our purifications and those of others (Dobos et al., 1979). A 
plausible reason may be its temporal stabilizing role, carried out by a non-icosahedral 
but regular scaffold structure (Zandi et al., 2004; Zlotnick, 2004), capable of 
maintaining an unstable capsid made up of 780 (p)VP2 copies, i.e., a procapsid-like 
assembly. 
 
5.3. Proteolytic processing of the capsid protein precursor 
 
The progressive processing of pVP2 seems to avoid the natural tendency of mature 
VP2 to assemble into all-pentameric T=1 SVP. An effective assembly pathway that 
avoids the dominance of aberrant assemblies would be provided by a post-assembly 
maturation step, in which virions are initially assembled as a procapsid that matures 
through structural transitions. Biochemical studies of IPNV, a closely related birnavirus, 
showed the existence of a provirion (Villanueva et al., 2004) that matures by pVP2 
processing.  
Post assembly maturation has been described for noda- and tetraviruses, which 
assemble as provirions with a T=3 (Schneemann et al., 1998) and T=4 (Canady et al., 
2000) lattice composed of a single α-protein, respectively. Provirion maturation is 
relatively slow, and takes place through the autocatalytic cleavage of the α-protein 
(Zlotnick et al., 1994), mediated by a single acidic residue. This yields the mature CP 
β−protein and the γ-peptide, and leads to the rearrangement of the capsid subunits. 
Considering the functional links (Ahlquist, 2005), and the unexpectedly high structural 
similarity between the CP of IBDV and noda- and tetravirus (Coulibaly et al., 2005), as 
well as their similarities in the assembly pathway, it was postulated that VP2 
autoproteolysis is the final processing event rendering the mature VP2 protein. Based on 
the VP2 X-ray structure, we examined the role of two likely candidate residues, Asp-
391 and Asp-431, for catalyzing the last proteolytic event that occurs during capsid 
maturation. These residues were selected taking into account the existing structural 
similarities of domains S and B CP from IBDV, noda- and tetraviruses (Fig. 36). 
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Fig. 36. Structural relationships between capsid proteins of (+) ssRNA and dsRNA viruses. 
Structural comparison of the crystallographic structure of protein β of FHV, a nodavirus (PDB 2Q26) 
(coloured in red), with VP2 of IBDV (PDB 2GSY) (coloured in green). Autoproteolytic residues are 
marked in balls and spheres, Asp-75 for FHV and Asp-431 for IBDV, as it can be observed both residues, 
although lacking of a sequence similarity, posses a similar localization in the S domain of the CP. 
 
Our results indicate that the D431N mutation blocks the pVP2→VP2 proteolytic 
trimming and affects the assembly of stable IBDV particles. Assembly of VLPs with the 
proper size and morphology, i.e. the T=13 capsid, was not detected in cells expressing 
the polyprotein gene harbouring the D431N mutation. Expression of pVP2 intermediate 
polypeptides carrying the D431N point mutation nonetheless leads to the assembly of 
either as pentameric (T=1 SVP), or tubular structures with a hexagonal lattice. The 
isolation of these assembly products excluded a possible misfolding of the polypeptide 
since they are built by the same structural block, VP2 trimers (Saugar et al., 2005). The 
crystal structure of the mutant D431N VP2 protein provides additional experimental 
evidence supporting this interpretation. Similarly, mutations on the scissile bond Ala-
441-Phe-442 yielded no production of particles. Furthermore, combinations of VP2 
polypeptides containing mutations affecting either the scissile bond or the catalytic site 
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revealed that pVP2 proteolytic processing is the result of a monomolecular cis-cleavage 
reaction, similar to that previously described for the nodavirus CP (Zlotnick et al., 
1994). Moreover, reverse genetics analyses demonstrate that pVP2 self-processing is 
essential for the assembly of an infectious IBDV progeny (Chevalier et al., 2002). 
 
In this context, it is easily envisioned how the D431N mutation is not only 
unable to cleavage the Ala-441-Phe-442 scissile bond, but also might preclude or alter 
the interaction of VP3 with the helical region of VP2 at the inner basement of the VP2 S 
domain. Furthermore, we believe that the interaction of the VP3 C-terminal segment 
with the pVP2 amphipathic α-helix might be necessary to temporally inhibit the last 
proteolytic event since, probably being the Asp-431 blocked by one or more basic 
residues of the Ct domain of VP3 until the icosahedral capsid has been correctly 
assembled. Moreover, it can not be discarded that an activation of Asp-431 promoted by 
the VP3 basic environment, may be required for its autocatalytic function. 
It should be also pointed out that CP, which ensures the successful propagation 
of viral genomes by sheltering them from a hostile environment, and guiding them 
through the interaction with specific cell receptors, in their journey to reach an 
appropriate milieu for a successful replication process, can also play other important 
roles. In addition to the Asp- or Glu-based proteolytic activities associated to birna-, 
noda- and tetravirus, other CP such that of Semliki Forest virus, an enveloped (+ss) 
RNA virus, exhibits a self-cleaving serine protease activity (Morillas et al., 2008). 
Enzymatic activities associated to CP, in most known examples found in fully 
assembled virus particles, are not exclusively restricted to protease activities. The CP of 
Leishmania RNA virus, a dsRNA virus that persistently infects the parasitic protozoan 
Leishmania, possesses a site specific RNA endoribonuclease activity that cleaves viral 
positive-sense RNA (MacBeth and Patterson, 1995a, MacBeth and Patterson, 1995b). 
L-A virus, another dsRNA virus that infects the yeast Saccharomyces cerevisiae, has a 
CP that removes the m7GMP caps from host cellular mRNAs and covalently attaches 
them to a His residue on the capsid outer surface (Blanc et al., 1994; Tang et al., 2005). 
Unfortunately, the lack of specific sequence consensus motifs complicates the search 
for CP-associated enzymatic activities. 
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5.4. IBDV assembly model 
 
Results from our group indicate that the amphipathic α-helix is bound to the 
flexible VP2 C-terminal end (Luque et al., 2007). In the IBDV assembly model the 
spatial conformation of the (p) VP2 C-terminal region defines whether a pentamer or a 
hexamer is formed. 
 
5.4.1. Pentamer assembly 
 
Although SVP pentamer assembly is independent from other viral components, the 
corresponding virion capsid pentamers are built in a more physiological context, and 
additional factors must be considered. Comparison of almost identical pentamers from 
the various structures analyzed (T=1, T=7 and T=13 capsids of VP2 and chimeric VP2 
monomers, (Caston et al., 2001; Luque et al., 2007; Saugar et al., 2005) suggests that 
the relatively large pVP2 C-terminal domain would interfere with the five-fold contacts. 
The structure of the T=13 His-VP2-466 capsid indicates that the VP2 C-terminal 
domain is processed sufficiently to allow contacts for those VP2 chains at the five-fold 
axis. In virion assembly, this rapid processing would preclude (or release) the VP3 
interaction, resulting in α-helical bundle formation. 
 
This is reminiscent of basic concepts from the well-established nodavirus 
assembly system (Schneemann et al., 1998b). The different lattice geometry (T=13 
versus T=3), together with increased complexity, indicates a more sophisticated 
assembly pathway for IBDV. The nodavirus capsid is formed by 60 trimers, and the CP 
forms two different contacts: (i) those related by icosahedral twofold symmetry axes 
form 60 flat contacts with a 180° dihedral angle, and (ii) those related by quasi-twofold 
symmetry axes form 120 bent contacts with a 144° dihedral angle. Flat contacts are due 
primarily to insertion of an ordered RNA duplex and, to a lesser extent, to the presence 
of an ordered N-terminal peptide arm in the groove between subunits (Fisher and 
Johnson, 1993). Kinetic studies suggested that 120 bent subunits are cleaved at a higher 
rate than the remaining 60 flat subunits (Gallagher and Rueckert, 1988). In the T=13 
lattice, the contacts between VP2 trimers at the fivefold axis are similarly bent, with a 
dihedral angle of ~140° (Fig. 37A and 37C). Rapid processing would lead to helical 
 119 
——————————————————————————————Discussion 
bundle formation that, once again, is similar to the pentameric helical bundle made by 
the γ-peptide in the nodavirus capsid (Cheng et al., 1994). In this model, VP2 pentamers 
could act as nucleating centres for capsid assembly after joining additional VP2 trimers 
with flat contacts (hexamers). 
 
Fig. 37. Structural conformations of pVP2 amphipathic α-helix. (A and B) Inner surfaces of a 
pentamer (A) and a hexamer (B). Surfaces are represented with electrostatic potentials calculated with the 
GRASP program, showing the distributions of negative (red) and positive (blue) charges. Note the narrow 
channel (diameter,~20 Å) formed by five α−3 helices around the five-fold axis, in contrast with the 
broader channel at the quasi-six-fold axis (diameter,~35 Å). The insets indicate the two classes of 
contacts between adjacent VP2 trimers, namely, bent at the five-fold axis (two pentameric trimers in red) 
or flat at the local six-fold axis (a pentameric red trimer and a hexameric green trimer). (C and D) Side 
views of ribbon diagrams of a VP2 pentamer (C) and a hexamer (D). For simplicity, the hexamer front 
half has been removed. The amphipathic α-helices are shown in blue. VP2 chains are shown in magenta, 
except for the last visible C-terminal amino acid, which is represented as an orange sphere.  
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Our current hypothesis is that the VP2 molecular form required for the correct 
formation of pentamers is provided by the cleavage of VP2 between residues 452-453 
by a cellular protease, the puromycin sensitive aminopeptidase (PSA). VP2-452 leads to 
an helical bundle formation by the amphiphatic α-helix in the pentameric axes. Finally, 
these amphiphatic helices would be partially removed when the correct capsid 
conformation has been set up as part of the maturation process. Some of the 
reminiscences of this process can be observed when an intermediate band of 452 amino 
acids can be detected in IBDV mature virions.  
  
The necessity of these helical bundles in pentamers by amphiphatic α-helices 443-
452 was shown when coinfections in insect cells with the rBV/Poly, as an hexamer 
donor, and the rBV/VP2-441, which provides pentamers, prevented the correct 
formation of T=13 capsid like structures; whereas with the rBV/VP2-452, IBDV VLPs 
were assembled. 
 
Aditionally, the VP3 proteolytic degradation in insect cells (Maraver et al., 
2003b) was prevented as the protein was interacting with VP2 and protected by its 
encapsidation. Although it has been reported that coexpression of VP1 prevents VP3 
trimming and restores VLP formation in insect cells (Maraver et al., 2003a), as the 
formation of VP3-VP1 complexes (Lombardo et al., 1999) might hinder the VP3 
cleavage site, and thus protect the VP3 C-terminal tail against proteolysis; the quantity 
of VLPs using this experimenta approach is less significant than that observed in cells 
coinfected with of rBV/Poly and rBV/VP2-452. It is also significant the absence of PSA 
RNA in H5 insect cells, where IBDV VLP formation is prevented when the polyprotein 
is expressed; suggesting the lack of this cellular protease in this cell line.  
 
PSA is an ubiquitous 100 kDa, Zn+2 metallopeptidase present at high 
concentrations in mammalian brain especially cerebellum; (Karsten et al., 2006) from 
which it was initially purified as an enkephalin-degrading aminopeptidase (Hersh et al., 
1980). PSA exists primarily in soluble form in the cytosol and nucleus, but is also found 
in a membrane-bound form, and associated with the microtubule-spindle apparatus 
during mitosis (Constam et al., 1995). It has been proposed that it plays a role in a 
number of processes including neuropeptide metabolism (Hersh and McKelvy, 1981; 
Hersh et al., 1980), regulation of the cell cycle (Constam et al., 1995), processing of 
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antigenic peptides for presentation on MHC Class I molecules (Stoltze et al., 2000) and 
hydrolysis of proteasomal products (Botbol and Scornik, 1983; Saric et al., 2004). PSA 
exhibits a broad specifity against various N-terminal residues with some preference for 
basic and hydrophobic amino acids (Constam et al., 1995; Johnson and Hersh, 1990; 
Stoltze et al., 2000). Silencing of the Caenorhabditis elegans ortholog of PSA causes 
defects in embryogenesis and reproduction (Brooks et al., 2003). The homozygous PSA 
knockout mice show dwarfism and impairment of reproductive functions in both sexes 
(Osada et al., 2001a; Osada et al., 2001b). Interestingly, the PSA-deficient mice also 
show altered locomotor activity, increased anxiety and impaired response to pain 
(Osada et al., 1999). Perhaps these behavioural and neurological abnormalities are 
related to the failure to metabolize polyQ proteins by PSA (Bhutani et al., 2007), which 
when overproduced can be toxic. 
 
Coinfections in H5 insect cells with rBV/Poly and rBV/PSA result in the 
recovery of T=13 VLP, suggesting that the polyprotein has a PSA-specific cleavage site 
in its sequence. When a mutant rBV/Poly was generated, in which Arg-453 was 
substituted by an Ala residue, PSA coexpression did not rescue VLP assembly, showing 
that the protease target must be this arginine dipeptide. Furthermore, the same mutation 
in the heterologous system of rVV, which leads to high production of VLPs, only 
yielded pVP2 type I tubules, suggesting that this residue is critical for proper pentamer 
assembly.  
 
The role of PSA in the viral infection context was analyzed using a RNA 
interference approach, showing that PSA silencing in DF1 cells (chicken fibroblasts) 
dramatically reduces the viral production over 90% with a large accumulation of VP2 
precursor (pVP2) forms. 
 
It should be also noticed the endopeptidase PSA activity, which has always been 
described as an exopeptidase, acting against various N-terminal residues, with some 
preference for basic and hydrophobic amino acids (Constam et al., 1995; Johnson and 
Hersh, 1990; Stoltze et al., 2000). This is not the only peptidase that having been 
described as an exopeptidase can degrade proteins “from inside”. Some other examples 
like the tripeptidyl peptidase II (TPPII), a cytosolic subtilisin-like peptidase that exhibits 
enhanced activity in proteasome inhibitor-adapted cells and degrades polypeptides by 
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exo- as well as predominantly trypsin-like endoproteolytic cleavage (Geier et al., 1999; 
Wang et al., 2000) and aminopeptidase N (PepN), characterized as the sole alanine 
aminopeptidase in Escherichia coli (Chandu et al., 2003), have been found. 
 
PepN is very efficient as an aminopeptidase in cleaving after alanine, leucine, 
tyrosine and phenylalanine. The cleavage of endopeptidase substrates by PepN was 
much slower than aminopeptidase substrates, revealing a preference for hydrophobic 
and basic residues. PepN belongs to the M1 family of metallopeptidases (Hooper, 1994; 
Rawlings and Barrett, 1995) and its homologues are ubiquitous and present in all 
kingdoms, as PSA (Fig. 38). PepN and its homologues possess the conserved 
exopeptidase, GXMEN motif (Vazeux et al., 1998) and three Zn2+- binding ligands 
present within the HEXXHX18E motif (Hooper, 1994; Rawlings and Barrett, 1995; 
Rudberg et al., 2002), which is the metallopeptidase one. Although the endopeptidase 
motif has not been determined yet, the deletion of 312 bp encompassing catalytically 
important residues in the M1 family disrupts endopeptidase activity. 
 
 
Fig. 38. Sequence alignment of the region harbouring the catalytically important residues from 
PepN E.coli and PSA Gallus gallus. Asterisks represent identical residues, whereas colons and single 
dots represent conserved and semi-conserved substitutions. Boxes highlight the exopeptidase motif (in 
green) and the M1 family metallopeptidase motif (in blue); the glutamate residue important in catalysis is 
also shown in blue. Gen Bank™ accession numbers of sequences are as follows: PepN, E. coli (M15273) 
and PSA, Gallus gallus (AJ851657). 
 
As described above, the cleavage site of the cellular protease is Arg-452-Arg-
453. This motif of dibasic amino acids in this position is highly conserved in all 
analyzed IBDV strains (Fig. 39A) as well as in different members of the Birnaviridae 
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family (Fig. 39B). This also suggests a kind of host dependence, as IBDV VLP are not 
correctly assembled in cell lines that are not susceptible to infection, as insect cells. 
 
Fig. 39. Sequence alignment of protein VP2 of the region harbouring the cleavage site of the 
cellular protease. A. Alignment of different IBDV strains: Soroa (accession number AAD30136), 
PBG98 (BAA00741), D78 (AA015768), Variant E (AAD32617), UK661 (NP690838), CU (AAK51522), 
52/70 (BAA00745), STC (BAA00391), OH (AAC55351), 23/82 (CAI4863) B. Alignment of different 
Birnaviridae members: IBDV (accession number AAD30136), Infectious Pancreatic Necrosis Virus 
(IPNV; AJ622822), Marine Aquabirnavirus (MABV; BAA31999), Yellowtail Ascites Virus (YAV; 
NP690805), Paralichthys olivaceus birnavirus (PoBV, YP001514404), Aquabirnavirus TAB 98 
(AqBVTAB98, ACD64976), Blotched Snakehead Virus (BSNV; AJ459382) and Drosophila X Virus 
(DrXV, U60650). The scissile bond is highlighted in blue. Asterisks represent identical residues, whereas 
colons and single dots represent conserved and semi- conserved substitutions. 
 
Although it has not been reported previously the implication of a cellular 
protease in the assembly of the birnaviruses. This is a common strategy used by some 
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viruses. Some recent findings report that for example, during the course of Hepatitis A 
virus particle assembly and RNA packaging, immature procapsids might be targeted to 
early lysosomes where they encounter cellular proteases including cathepsin L that 
remove 2A peptide, and thereby fully mature the particles (Morace et al., 2008). In 
flavivirus, just prior to release, the proteolytic cleavage of prM protein by furin triggers 
the conversion of the immature virions into slightly smaller mature particles with high 
infectivity (Junjhon et al., 2008). Hepatitis C virus, with a positive-sense ssRNA 
genome, that encodes a polyprotein of ca. 3000 amino acids, which is cleaved both co- 
and post-translationally by viral and cellular proteases to render mature viral proteins 
(Moradpour et al., 2007; Penin et al., 2004). In the case of core protein, complete 
maturation requires further cleavage within the core-E1 signal peptide by signal peptide 
peptidase (SPP) (Targett-Adams et al., 2008). 
 
5.4.2. Hexamer assembly 
 
Coplanar contacts are formed by VP2 trimers within a G4 triangle and those made 
by the e trimer. In our model, insertion of the VP2 amphipatic α-helix into the highly 
hydrophobic grooves that form the broad cavity at the quasi six-fold axes would 
preclude the bending of these contacts. The amphipathic α-helix has an Asp residue 
(Asp-446) between its hydrophobic and enriched basic residue sides, which could 
further stabilize the dominant hydrophobic interactions (Fig. 37A and 37D). 
Amphipathic α-helix behaviour would resemble that of the ordered N-terminal peptide 
arm of the nodavirus CP. Previous analysis of pVP2 polypeptides with C-terminal 
extensions of variable length showed that the longer the C-terminal domain the more 
probable is hexamer formation which would produce primarily tubular structures 
(Saugar et al., 2005a). Accordingly, the C-terminal domain cleavage would be slower, 
and would be stabilized by its interaction with VP3.  
 
Furthermore, analysis restricted to His-VP2-466 capsid particles. similar in size to 
IBDV virions, from a sample containing heterogeneous assemblies in equilibrium, 
represents an arrested morphogenetic intermediate, and may constitute a set of 
conformationally metastable particles. This interpretation is reflected in the density 
 125 
——————————————————————————————Discussion 
arms around the quasi six-fold axis, which are not identical and one of which is absent 
(Fig. 37A). 
 
We show a scheme that summarizes our model for the IBDV assembly pathway 
(Fig. 40). Structural analysis of CP topology, virion architecture, and assembly between 
evolutionally distant viruses reveal unexpected similarities (Bamford et al., 2005). Our 
data for the IBDV assembly pathway reinforces the recently suggested evolutionary 
relationships between birnavirus and positive-strand ssRNA viruses. The IBDV capsid 
assembly is controlled by scaffolding (VP3) and proteolytic proteins (VP4, VP2 and a 
cellular protease, PSA) that degrade short CP-specific sequences in consecutive events. 
This, together with the VP2 C-terminal flexibility, triggers interactions of the 
amphipathic α-helix for VP2 assembly into hexamers and pentamers. Interactions via 
amphipathic α-helices may be a common feature of macromolecular complex activation 
(Johnston et al., 2005) and, as found in HIV assembly (Ternois et al., 2005), may serve 
as an attractive target for future antiviral strategies. 
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Fig. 39. Hypothetical scheme of IBDV assembly. After the release of pVP2, VP3 and VP4 by the 
cleavage of the polyprotein; some pVP2 peptides are further cleaved by PSA in Arg-452-Arg-453 scissile 
bond. Amphiphatic α-helices (443-452) interact with themselves forming a helical bundle forming the 
pentameric conformation; these α-helices can probably interact with VP3 C-terminal domain stabilizing 
the pentamers. On the other hand, pVP2 will probably interact with VP3 leading to coplanar contacts that 
form hexamers. Preformed pentamers and hexamers could interact by VP3 oligomerization domain 
assembling a “procapsid” intermediate. Another possibility is that the pentamer could act as a nucleation 
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factor with which pVP2-VP3 complexes could interact by VP3 contacts. Similar to noda- and tetravirus 
assembly model, this spherical “procapsid” intermediate could adopt a reversible state (“immature 
capsid”) depending on pH until a CP small amount has been cleaved. Finally, the capsid matures when 
VP2 C-terminal domain is released by the cleavage of Ala-441-Phe-442 by Asp-431, rendering VP3 
inside the capsid. Which is the signal that originates the cleavage of the CP still unknown, probably the 
higher density of dsRNA and their interaction with VP3 forming the RNP complexes provokes the 
dissociation of pVP2 and VP3 and the further maturation of the CP. 
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1. VP2 structural polymorphism is based on two peptide components: the pVP2 C-
terminal amphipathic α-helix, acting as a conformational molecular switch, and 
the VP3 C-terminal domain, acting as a molecular triggering factor. Acid and 
basic residues of VP3 C-terminal domain are required for the correct assembly 
of IBDV capsid. Structural polymorphism is achieved by electrostatic 
interactions between these two peptide components. 
 
2. VP2 Asp-431, lying in a flexible loop preceding the C-terminal (helix α-4), is 
responsible for the endopeptidase activity that cleaves the Ala-441-Phe-442 
bond to generate the mature VP2 polypeptide. pVP2 proteolytic processing is 
the result of a monomolecular cis-cleavage reaction.  
 
3. VP2 self-processing is essential for the assembly of an infectious IBDV 
progeny.VP2-452 intermediate precursors are essential to pentamer assembly, 
which act as capsid nucleation factors. A cellular protease, puromycin sensitive 
aminopeptidase, is responsible in vivo to provide VP2-452 polypeptide. 
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1. El polimorfismo estructural de VP2 se basa en dos componentes peptídicos: la 
hélice-α anfipática del dominio C-terminal de VP2 que actúa como un 
interruptor molecular conformacional, y el dominio C-terminal de VP3, que 
actúa como un factor efector molecular. Los residuos ácidos y básicos del 
dominio C-terminal de VP3 se requieren para el correcto ensamblaje de la 
cápsida de IBDV. El polimorfismo estructural se consigue debido a una 
interacción electrostática entre estos dos componentes peptídicos. 
 
2. Asp-431 de VP2, localizado en un “loop” flexible (hélice α-4), es responsable 
de la actividad endopeptidasa que procesa el enlace Ala-441-Phe-442 para 
generar el polipéptido maduro de VP2. El proceso proteolítico de pVP2 es el 
resultado de una reacción monomolecular de corte en cis. 
 
3. El autoprocesamiento de pVP2 es esencial para el ensamblaje de una progenie 
infecciosa de IBDV: 
4. Los precursores intermedios de VP2-452 son esenciales para el ensamblaje de 
pentámeros, los cuales actúan como factores nucleadores de la cápsida. Una 
proteasa celular, una aminopeptidasa sensible a puromicina (PSA), es la 
responsable in vivo de proveer el polipéptido VP2-452. 
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Viral capsids are envisioned as vehicles to deliver the viral
genome to the host cell. They are nonetheless dynamic pro-
tective shells, as they participate in numerous processes of
the virus cycle such as assembly, genome packaging, binding
to receptors, and uncoating among others. In so doing, they
undergo large scale conformational changes. Capsid proteins
with essential enzymatic activities are being described more
frequently. Here we show that the precursor (pVP2) of the
capsid protein VP2 of the infectious bursal disease virus
(IBDV), an avian double-stranded RNA virus, has autopro-
teolytic activity. The pVP2 C-terminal region is first pro-
cessed by the viral protease VP4. VP2 Asp-431, lying in a
flexible loop preceding the C-terminal most -helix, is
responsible for the endopeptidase activity that cleaves the
Ala-441—Phe-442 bond to generate themature VP2 polypep-
tide. The D431N substitution abrogates the endopeptidase
activity without introducing a significant conformational
change, as deduced from the three-dimensional structure of
the mutant protein at 3.1 A˚ resolution. Combinations of VP2
polypeptides containing mutations affecting either the cleav-
age or the catalytic site revealed that pVP2 proteolytic proc-
essing is the result of a monomolecular cis-cleavage reaction.
The D431N mutation does not affect the assembly of the VP2
trimers that constitute the capsid building block. Although
VP2 D431N trimers are capable of assembling both pentam-
ers and hexamers, expression of a polyprotein gene harboring
the D431N mutation does not result in the assembly of IBDV
virus-like particles. Reverse genetics analyses demonstrate
that pVP2 self-processing is essential for the assembly of an
infectious IBDV progeny.
Multiprotein assemblies are the basic cellular entities con-
trolling fundamental biological processes. Viral capsids rep-
resent an excellent framework for the analysis of “built-in”
features such as structural polymorphism and transient con-
formations. In addition, complex capsids may require one or
more auxiliary proteins (scaffold, accessory, and proteolytic
proteins) to trigger structural and functional changes. In this
context, assembly of birnavirus capsid has resulted in an appro-
priate process for studying the coordination of molecular fac-
tors involved that, like in many other viruses, rarely leads to
aberrant assemblies in vivo.
Birnaviruses are a family of naked icosahedral viruses infect-
ing rotifers, insects, fishes, and birds (1). Their genome, formed
by two segments of double-stranded RNA (dsRNA),4 encodes
only five mature polypeptides. Although most of the research
has been focused on the infectious bursal disease virus (IBDV),
an important avian pathogen (2), available information sug-
gests that all members of the family share similar replication
strategies.
The IBDVparticle possesses a relatively complex icosahedral
capsid based on a triangulation number T  13 levo lattice
composed by a single polypeptide known as VP2. Whereas the
simplest capsids are built from60 identical subunits and assem-
bled into pentamers (T 1), those with more than 60 subunits
are assembled into pentamers and hexamers and cannot have
identical but “quasi-equivalent” environments (T 1) (3). The
T number also describes the number of different environments
occupied by the protein subunit (4). TheVP2 protein assembles
into 260 trimers that form 12 pentamers and 120 hexamers
(5–7). From strict geometric considerations, VP2 trimers have
five distinct conformations.
VP2 is synthesized as part of a polyprotein (110 kDa) that is
cotranslationally self-cleaved, releasing three polypeptides,
namely pVP2 (the VP2 precursor), VP4 (the protease), and VP3
(a polypeptide with scaffolding activity among others). pVP2
(512 residues, 54.4 kDa) undergoes subsequent, and much
slower, processing events mediated by VP4 at three secondary
targets (positions 487, 494, and 501) (8), and the resulting inter-
mediates are further cleaved between residues Ala-441 and
Phe-442 to yield VP2 (47 kDa) and several C-terminal frag-
ments (accounting for 7.4 kDa). Both the mechanism and the
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executor of the last pVP2 3 VP2 proteolytic maturation
remain unknown and are associated with the pVP2 assembly
into a procapsid-like structure (9). The released C-terminal
segments remain associated to the capsid (10) and appear to be
involved in the entry mechanism by promoting the disruption
of host cell membranes (11).
Studies carried out with another birnavirus, infectious pan-
creatic necrosis virus (IPNV), a pathogen of the aquatic fauna
(12), suggest that the pVP23 VP2 conversion is required for
thematuration of quasi-spherical provirions intomature icosa-
hedral virions (13). This maturation mechanism is reminiscent
of the post-assembly proteolytic maturation that takes place
during the morphogenesis of some ssRNA icosahedral viruses,
and in particular to those of noda- and tetraviruses (14, 15). The
capsid protein (CP) precursor, the -protein, associates as a
trimer, building a quasi-spherical provirion (16). At low pH, the
-protein is autocatalytically processed, rendering the mature
CP, known as -protein, and the C-terminal -peptide (17).
This reaction is slow anddependent on a conservedAsp residue
located in close proximity of the CP scissile bond (18). Matura-
tion of the -protein is accompanied by large conformational
changes on theCP that irreversibly transforms the quasi-spher-
ical (non-infectious) provirions into icosahedral infective viri-
ons (14, 17).
The molecular mechanisms that define the multimeric state
of the mature VP2 as hexamers or pentamers have been inten-
sively analyzed (7, 19–21). Expression of VP2 alone results in
the spontaneous assembly of icosahedral T  1 subviral parti-
cles (SVP), an all-pentamer capsid 23 nm in diameter com-
posed of 20 trimeric clusters of VP2. On the other hand, pVP2
expression leads to the assembly of tubular structures with a
hexagonal lattice (7, 19). The pVP2 C-terminal processing
events are abolished when this protein is expressed using a
baculovirus-based system. Notably,
the pVP2 C-terminal region con-
tains an amphipathic -helix that
plays an important role in allowing
the formation of multiple VP2 con-
formations. VP3 also participates in
the inherent conformational poly-
morphismof pVP2 through interac-
tion with the pVP2 C-terminal end,
working as a canonical scaffolding
protein.
The atomic structure of the VP2
polypeptide has been recently so-
lved fromT 1 SVP (5, 22, 23). The
VP2 subunit folds into three do-
mains termed projection (P), shell
(S), and base (B). Domains S and P
are  barrels with a jelly roll topol-
ogy, whereas the B domain is
formed by -helices facing the inte-
rior of the shell, corresponding to its
N and C termini. The helical C-ter-
minal arm of VP2 establishes a
domain swapping and mediates
interactions between adjacent VP2
trimers increasing their stability. S and B domains share a high
degree of structural similarity with noda- and tetravirus -pro-
tein. pVP2 and-protein cleavage sites are deeply buried inside
the capsid shell, thus sheltered from possible attacks by cellular
proteases. Fitting the VP2 atomic structure into the three-di-
mensional cryo-electron microscopy map of IBDV T  1 SVP
allowed us to identify at least two conformations for its C-ter-
minal region (19, 21). These structural considerations tempted
us to suggest Asp-391 and/or Asp-431 as candidate catalytic
residues capable of triggering a hydrolytic cleavage either on its
own scissile bond or on that from a neighboring pVP2molecule
(Fig. 1). The results presented here demonstrate that residue
Asp-431 is essential for pVP2proteolyticmaturation, thus lead-
ing us to propose that birnavirus pVP2 polypeptides are auto-
catalytically processed. This finding provides yet another piece
of evidence reinforcing the hypothesis about a common ances-
tor linking icosahedral ssRNA and dsRNA viruses.
EXPERIMENTAL PROCEDURES
Cells and Viruses—Recombinant vaccinia virus (rVV)
VT7LacOI/POLY and recombinant baculoviruses (rBV)
FB/VP2–452 andFB/VP2-501were previously described (7, 24,
25). Expression experiments were carried out with BSC-1
mammalian cells or QM7 quail muscle cells for rVV infections
andTrichoplusia ni (H5) insect cells (Invitrogen) for rBV infec-
tions. BSC-1 andQM7 cells were grown inDulbecco’smodified
Eagle’s medium (DMEM) containing 10% fetal calf serum. H5
cells were grown in TC-100 medium (Invitrogen) containing
10% fetal calf serum. rVVs and rBVs were grown and titrated as
previously described (25, 26).
Generation of the Recombinant Viruses VT7/LacOI—Using
PCR overlap extension five mutant pVP2 genes were con-
structed containing the following single and double muta-
FIGURE 1. Conformational flexibility of the VP2 C-terminal -helix around its cleavage site. A, bottom
view, facing the inner surface of the viral capsid, of the VP2 protein x-ray model (PDB entry 2GSY). -Helices
(1–4) of domain B (green) are indicated for a VP2 chain; the candidate catalytic residues Asp-391 and Asp-431
are also indicated. 3 and 4 helices of the closer neighboring VP2 chain (magenta) that projects toward the
3-fold axis of the trimer are shown, and to simplify the view, only its Asp-391 residue is indicated. The locations
of 5-, 3-, and2-fold axes of icosahedral symmetry are indicated.B, sameaspanel A, but theC-terminal4helices
of VP2 chains were remodeled after fitting the x-ray model into an equivalent cryo-electron microscopy map
(21).
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tions: A441G, F442G, A441G/F442G, D431N, and D391N.
PCR reactions were carried out using the pVP2 gene, cloned
in the pFB/POLY plasmid as template, and the set of mutator
primers (supplemental Table 1) in combination with primers
5-GCCATCACAAGCCTCAGCGTTGG and 5-GTGCACC-
GCGGAGTACCCCAG for A441G, F442G, and A441G/
F442G. Primers 5-GATGCCATCACAAGCCTCAGC and 5-
CGCAGTCGAGGTTGTGTGCACwere used for D431N and
D391N. The resulting DNA fragments were digested with
NdeI and SphI and used to replace the original NdeI-SphI
fragment of the pVOTE.2/POLY plasmid previously de-
scribed (25). The plasmids pVOTE/A441G, pVOTE/F442G,
pVOTE/A441G/F442G, pVOTE/D391N, and pVOTE/D431N
were used to obtain the recombinant vaccinia viruses
VT7LacOI/A441G, VT7LacOI/F442G, VT7LacOI/A441G/
F442G, VT7LacOI/D391N, and VT7LacOI/D431N. For this,
BSC-1 cells were infected with the vaccinia virus recombinant
VT7LacOI (27) and transfected with the previous plasmids.
Selection and amplification of VT7LacOI/A441G, VT7LacOI/
F442G, VT7LacOI/A441G/F442G, VT7LacOI/D391N, and
VT7LacOI/D431N were carried out as previously described
(28).
Construction of Recombinant Baculoviruses—rBV FB/VP2–
452 and FB/VP2-501 were previously described (7, 19). The
pVOTE.2/D431N and pVOTE.2/D391N plasmids were used as
a template for PCR synthesis to generate rBV/VP2–452D431N,
rBV/VP2–452D391N, and rBV/VP2-501D431N. PCRwas per-
formed with Vent DNA polymerase (New England Biolabs)
with common 5 and 3 end primer (5-GCGCAGATCTATG-
ACAAACCTGTCAGATCAAACCC and 5-GCGCAAGCT-
TACCTTATGGCCCGGATTATGTCTTTGAAGC). BglII-
HindIII-digested PCR fragments were cloned into FastBac
(Invitrogen) BamH1-HindIII polylinker sites for protein
expression. Selection of derived bacmids from the DH10Bac
Escherichia coli strain and preparation for Lipofectine transfec-
tionwere performed according to themanufacturer’s protocols
(Invitrogen). The constructs were expressed in H5 insect cells
(29).
Immunoprecipitation of VP2—QM7 cell monolayers were
infected with the corresponding rVV at a multiplicity of infec-
tion of 2 plaque-forming units/cell and maintained in the pres-
ence of isopropyl -D-thiogalactosidase. At 18 h postinfection
(pi), cells were washed twice and metabolically labeled with
methionine-free DMEM containing 125 Ci/ml [35S]Met and
isopropyl -D-thiogalactosidase for 1 h. After this period cells
were washed 3 times with DMEMcontaining a 10-fold concen-
tration of coldmethionine and thenmaintained inDMEMsup-
plemented with isopropyl -D-thiogalactosidase and 2% fetal
calf serum. At 0, 24, 48, and 72 h post-labeling, cells were har-
vested, washed twice with phosphate-buffered saline, and
resuspended in lysis buffer (50 mM Tris, pH 7.5, 100 mM NaCl,
5 mM EDTA, 0.5% IGEPAL CA-630). Immunoprecipitations
were carried as described elsewhere (26). Immunoprecipitated
samples were resuspended in Laemmli sample buffer to a 1
final concentration and subjected to 11% SDS-PAGE followed
by autoradiography.
ReverseGenetic Analysis—DNA fragments containing cDNA
versions corresponding to the complete positive strand RNAs
of to the IBDV Soroa strain segments A and B, fused to the T7
bacteriophage promoter (in 5 position with respect of the
IBDV cDNAs), and a cDNA corresponding to the hepatitis
delta virus ribozyme (in 3 position with respect of the IBDV
cDNAs) sequences were generated by in vitro gene synthesis
(Genescript Co.) and inserted into the multiple cloning site of
the pUC57 cloning plasmid (GenBankTM/EMBL). These plas-
mids were named pT7-SA-Rz and pT7-SB-Rz, containing the
cDNA corresponding to segment A and B, respectively.
Plasmid pVOTE/D431N, described above, was digested with
SphI and NdeI and ligated to pT7-SA-Rz previously digested
with the same enzymes. The resulting plasmid, pT7-
SA(D431N)-Rz, was sequenced to determine the correctness of
its sequence.
QM7 cells were transfected with a combination of either
pT7-SA-Rz and pT7-SB-Rz or pT7-SA(D431N)-Rz and pT7-
SB-Rz, respectively, using Lipofectamine (Invitrogen). 6 h after
transfection cultures were infectedwith 1 plaque-forming unit/
cell of VT7LacOI, an rVV inducibly expressing the T7 RNA
polymerase. After infection, cultures were maintained at 37 °C
inDMEMcontaining 10% fetal calf serum supplementedwith 1
mM isopropyl -D-thiogalactosidase. At 72 h pi, cultures were
harvested and subjected to three freeze-thawing cycles. After
removing cell debris by low speed centrifugation, supernatants
were recovered and passed through 0.1-m filters (Millipore)
to eliminate contaminant rVV particles and used to infect fresh
QM7 cell monolayers. Infections were performed in triplicate
with undiluted and 101–105 serial dilutions of the initial
stocks. A set of infected cells was used to determine the IBDV
titer at 72 h pi. Another set was harvested at 72 h pi, and the
corresponding extracts were analyzed for the presence of VP1
and VP2 proteins. The absence of contaminant infecting rVV
particleswas alsomonitored byWestern blot using themAbC3.
The third set was also harvested at 72 h pi and used to collect
cells originally infected with the undiluted stocks. These sam-
ples were subjected to three freeze-thawing cycles, and the pro-
cedure described abovewas repeated, thus allowing the analysis
of the initial virus stock and two subsequent virus amplification
rounds.
Purification of IBDV Polyprotein-derived Structures—QM7
and H5 cells (2–5  108 cells) were infected with appropriate
rVVor rBV (multiplicity of infection 1–5plaque-formingunits/
cell). At 72 h pi in rVV assays and at 48 h pi in rBV assays, cells
were harvested, lysed in PES buffer (25 mM piperazine-N,N-
bis(2-ethanesulfonic acid), pH 6.2, 150 mM NaCl, and 20 mM
CaCl2) plus 1% IGEPAL CA-630 (Sigma) on ice, and processed
on a 25% sucrose cushion and a linear 20–50% sucrose gradient
(19). The particulate material containing polyprotein-derived
structures was concentrated 20-fold by ultracentrifugation and
used for SDS-PAGE, Western blot, and electron microscopy
analysis.
SDS-PAGE and Western Blot—Infected cell extracts (25 l)
or concentrated sucrose gradient fractions (10 l) were added
to Laemmli’ s sample buffer to a 1 final concentration and
heated at 100 °C for 3 min. Electrophoresis was performed in
11% polyacrylamide gels. Western blot analyses were carried
out using an anti-VP2 serum as described (26).
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Electron Microscopy—2–5-l samples of concentrated
sucrose gradient fractionswere applied to glow-discharged car-
bon-coated grids for 2min andnegatively stainedwith 2%aque-
ous uranyl acetate. Micrographs were recorded with a JEOL
1200 EXII electron microscope operating at 100 kV at a nomi-
nal magnification of 40,000.
Crystallization and Data Collection—Cubic crystals belong-
ing to space group P213 (a b c 326.72 Å) were obtained
by the vapor diffusion method in hanging drops at room tem-
perature by mixing 2 volumes of VP2–452_D431N-derived
SVP (1.6 mg/ml) and 1 volume of the reservoir solution con-
taining 14–17% polyethylene glycol 4000, 0.1 M Tris, pH 9.0,
and 5% isopropanol. Crystals were transferred to a cryoprotect-
ing solution containing 20% glycerol in the crystallization
buffer and incubated for 1min before they were flash-frozen by
immersion in liquid nitrogen. X-ray data were collected from a
single crystal using synchrotron radiation at the European Syn-
chrotron Radiation Facility, Grenoble, France (beamline
ID14-2) to 3.1 Å resolution. Diffraction images were processed
using MOSFLM (30) and internally scaled with SCALA (31).
Structure Refinement—Crystals of D431N-mutated SVP
were isomorphous to the previously obtained of native VP2
SVPs (PDB code 2GSY (22)). The initial maps for D431N-mu-
tantwere obtained after a rigid body fitting of the coordinates of
native SVPs (PDB code 2GSY) to the new unit cell. The D431N
mutation and other subtle changes weremanually rebuilt using
Coot (32), and the structure was then refined with CNS (33)
using the 20-fold non crystallographic symmetry as a restraint.
The final refinement statistics are summarized in supplemental
Table 2. The coordinates and structure factors have been
deposited into the Protein Data Bank (code 3FBM).
RESULTS
Effect of Mutations on Asp Residues Potentially Involved on
pVP2 3 VP2 Proteolytic Maturation—(p)VP2 residues Asp-
391 and Asp-431 appeared to be likely candidates to trigger a
nucleophilic attack on the pVP2 441–442 scissile bond. The
IBDV polyprotein expressed by an inducible rVV provided an
excellent framework to analyzing the possible role of residues
Asp-391 and Asp-431 on pVP2 proteolytic maturation. As
described above, the use of this system allows the accumulation
of pVP2 and VP2 and the efficient assembly of virus-like parti-
cles (VLP), structurally undistinguishable from purified IBDV
virions (26, 34). Hence, two single-point mutant versions of the
IBDV polyprotein gene were generated and used to construct
two rVV, called VT7LacOI/D431N and VT7LacOI/D391N, in
which Asp residues under study at positions 431 and 391 were
replaced by Asn residues, respectively. Cultures infected with
these two rVV were harvested at different times pi (24, 48, and
72 h), and the corresponding extracts were analyzed by West-
ern blot using VP2-specific serum. As a control for this exper-
iment, cultures were also infected with VT7LacOI/POLY, a
rVV expressing the wild-type polyprotein gene (26).
Although expression of wild-type and D391N polyproteins
led to accumulation of both pVP2 and VP2 polypeptides, sam-
ples from cells expressing polyprotein D431N showed equiva-
lent pVP2 levels but did not contain detectable VP2 (Fig. 2A).
These results strongly suggested that the D431N substitution
specifically abrogated pVP2 proteolytic processing and were
further confirmed using an alternative experimental approach.
QM7 cells were infected with the three described rVV and, at
19 h pi, the cultures were metabolically labeled with [35S]me-
thionine for 1 h. Thereafter, cultures were extensively washed
and incubated with fresh medium supplemented with an
excess of cold methionine. At different times post-labeling
(0, 24, 48, and 72 h), cells were harvested, and the corre-
sponding extracts were subjected to immune precipitation
using anti-VP2 antiserum. The results of this analysis (Fig.
2B) demonstrate that whereas in cells infected with
VT7LacOI/POLY and VT7LacOI/D391N, the pVP2 polypep-
tide is progressively processed to mature VP2, the pVP2
polypeptide encoded by VT7LacOI/D431N remains intact for
the duration of the experiment (72 h after its synthesis). Taken
together, these results demonstrate that the conservative
D431N substitution causes a complete blockade on pVP2 3
VP2 proteolytic maturation.
D431N Substitution Allows the Assembly of VP2 Trimers—
VP2 trimers constitute the building block of the IBDV-related
icosahedral capsids with different T as well as different tubular
structures with helical symmetry (19, 21). Therefore, it seemed
likely that the results described above might be caused by defi-
ciency on trimer assembly induced by a VP2 conformational
change generated in theD431Nmutant. Such a conformational
change might prevent both the assembly of IBDV provirions
and the subsequent pVP2 proteolytic processing event.
Expression of chimerical VP2 genes in insect cells leads to the
spontaneous assembly of T  1 SVP built by 20 VP2 trimers
arranged into pentamers. We have exploited this system to
determine the effect of the D431Nmutation on the assembly of
VP2 trimers. A VP2 gene with the N-terminal 452 residues
FIGURE 2. Effect of conservativemutations of residues Asp-431 and Asp-
391 on pVP2/VP2 proteolytic maturation. A, Western blot analysis of pro-
teins expressed in cells infected with rVV VT7LacOI/POLY, VT7LacOI/D431N,
or VT7LacOI/D391N, respectively. Infected cultures were harvested at 24, 48,
and 72 h pi, respectively. The corresponding extracts were subjected to SDS-
PAGE and Western blot using anti-VP2 serum. B, QM7 cells infected with rVV
VT7LacOI/POLY, VT7LacOI/D431N, or VT7LacOI/D391N were metabolically
pulse-labeled with [35S]Met for 1 h at 19 h pi (hpi). The radioactivity was
chased with by adding fresh medium containing an excess of cold methio-
nine. Cultures were harvested at 0, 24, 48, and 72 h post-labeling, and the
corresponding extracts were immunoprecipitated using anti-VP2 serum. The
resulting sampleswere subjected to SDS-PAGE followedby autoradiography.
Molecular weight markers (expressed in kDa, left) and bands corresponding
to proteins pVP2 and VP2 (right) are indicated.
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harboring the D431N substitution was generated, VP2–
452_D431N, inserted into the pFastBac1 transfer vector, and
then used to generate the corresponding rBV, rBV/VP2–
452_D431N. Extracts from cells infected with rBV/VP2–
452_D431Nwere used for SVP purification. As shown in Fig. 3,
expression of the VP2–452D431N gene results in the assembly
of T 1 SVP that is undistinguishable under electron micros-
copy observation by negative staining from those produced by
wild-type protein and D391N mutant (data not shown).
The possibility nevertheless existed that the mutation
D431N might somehow affect the formation of VP2 hexamers
formed by six VP2 trimers. To analyze this possibility we took
advantage of a previous observation. As described above, we
have shown that expression of VP2 long forms in a rBV expres-
sion system leads to the assembly of tubular structures
formed exclusively by hexamers built by pVP2 intermediate
precursor trimers (7, 19). Therefore, the D431N gene was
subcloned into pFB/VP2-501, and the resulting plasmid, pFB/
VP2-501_D431N, was used to generate the corresponding rBV.
As shown in Fig. 4, expression of VP2-501 _D431N in insect
cells results in the assembly of rigid tubules with an identical
morphology to that of tubules purified from cells expressing
wild-type VP2-501 gene. The results of this series of experi-
ments demonstrate that theD431N substitution do not prevent
either the trimer assembly or the subsequent formation of pen-
tamers and hexamers.
Finally, to rule out the possibility that the D431N substitu-
tionmight induce conformational changes on theVP2polypep-
tide undetectable by electron microscopy, the crystal structure
of VP2–452_D431N-derived SVP was determined at 3.1 Å res-
olution (supplemental Table S1). The root mean square devia-
tion of the superimposition of all 428 equivalent C atoms from
VP2 in the structures of native andD431N SVP is 0.20 Å, show-
ing that these structures are essentially identical in conforma-
tion. This similarity is alsomaintained within the flexible linker
between helices 3 and 4 (residues 428–435), containing the
D431N mutation (Fig. 5).
pVP2 Undergoes an Intramolecular Proteolytic Processing—
To get a better understanding of the pVP2 maturation mecha-
nism, it was important to determine whether the pVP23 VP2
cleavage is the result of an intra- (cis-cleavage) or intermolecu-
lar (trans-cleavage) event.
To discriminate between these two possibilities, a poly-
protein mutant containing an intact Asp-431 residue but
resistant to self-proteolytic processing was required. Such a
mutant would be used for co-expression analysis to provide
the pVP23 VP2 proteolytic activity in trans. With this aim,
three polyprotein genes containing one or two amino acid
substitutions affecting either one or both amino acids at the
pVP2 scissile bond (Ala-441—Phe-442) were generated. The
mutant genes contain the following substitutions: (i) A441G,
(ii) F442G, and (iii) A441G/F442G. Mutant genes were then
inserted within the vaccinia virus genome, giving rise to
rVV VT7LacOI/A441G, VT7LacOI/F442G, and VT7LacOI/
A441G/F442G, respectively. The effect of the described muta-
tions on pVP2 processing was analyzed by Western blot and
pulse-chase/immune precipitation analysis. As shown in Fig. 6,
whereas single substitutions cause a major but partial pVP23
VP2 blockade, the double mutation A441G/F442G completely
abolishes pVP2 processing. Accordingly, this mutant gene was
selected for subsequent experiments.
Next, cells were coinfected with VT7LacOI/POLY and
VT7LacOI/D431N, VT7LacOI/POLY and VT7LacOI/A441G/
F442G or VT7LacOI/D431N and VT7LacOI/A441G/F442G.
Cultures were harvested at 48 and 72 h pi, and the correspond-
ing extracts were analyzed byWestern blot. As shown in Fig. 7,
the presence ofmatureVP2was exclusively detected in samples
from cells expressing the wild-type polyprotein gene that pro-
vides both the catalytic Asp-431 residue and the intact cleavage
site. Coinfection with VT7LacOI/D431N and VT7LacOI/
A441G/F442G showed that pVP2-D431N remains uncleaved
and is not proteolytically processed in trans by the wild-type
pVP2, thus strongly suggesting that pVP2 processing is the
result of a monomolecular cis-cleavage reaction.
FIGURE 3. VP2 with the D431N substitution assembles as T 1 subviral
particleVP2 trimers.A, wild-typeVP2–452 SVPwerepurifiedbyultracentrif-
ugation on sucrose gradients. Gradientswere collected into 12 fractions, con-
centrated by ultracentrifugation, and analyzed by SDS-PAGE and Western
blot using anti-VP2 serum. The direction of sedimentation was right to left,
with fraction 12 representing the gradient top. The image shown on the right
corresponds to a representative electron microscopy micrograph (negative
staining) of wild-type SVP, present at the upper gradient fractions. B, mutant
VP2–452_D431N assemblies were analyzed as described above. The image
shown on the right corresponds to a representative electron microscopy
micrograph (negative staining) of mutant VP2–452_D431N SVP present at
the upper gradient fractions. Bars 100 nm.
FIGURE4.pVP2variantwith theD431Nsubstitutionassemblesas tubular
assemblies with hexagonal symmetry. A, wild-type p VP2-501 assemblies
were purified by ultracentrifugation on sucrose gradients. Gradients were
collected into 12 fractions, concentratedbyultracentrifugation, andanalyzed
by SDS-PAGE and Western blot using anti-VP2 serum. The direction of sedi-
mentation was right to left, with fraction 12 representing the gradient top.
The image shown on the right corresponds to a representative electron
microscopy micrograph (negative staining) of wild-type tubular structures
present at the lower fractions. B, mutant pVP2-501 _D431N assemblies were
analyzed as described above. The image shown on the right corresponds to a
representative electron microscopy micrograph (negative staining) of pVP2-
501 _D431N rigid tubules at the lower fractions. Bars 100 nm.
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D431N Substitution Completely Abolishes IBDV Infectivity—
It was important to assess the relevance of the Asp-431 on
IBDV infectivity. This analysis was carried out using a reverse
genetics approach using plasmids pT7_SA_Rz and B pT7_
SB_Rz containing the cDNA sequences corresponding to IBDV
segments A and B, respectively, and plasmid pT7_SA/
D431N_Rz, harboring a mutant version of segment A contain-
ing the D431N substitution.
The results obtained demon-
strate that the D431N substitution
completely abolishes the produc-
tion of an infectious IBDV progeny
(Table 1). Western blot analysis
indicated that cells transfected with
plasmids pT7_SA/D431N_Rz and
pT7_SB_Rz failed to trigger the gen-
eration of infectious IBDV. This
finding, in agreement with the
observations described above,
highlights the critical importance of
the VP2 D431N residue on IBDV
infectivity.
pVP23VP2MaturationBlockade
Prevents theAssemblyof Stable IBDV-
derived VLP—IPNV morphogenesis
involves the assembly of provirions
containing a high proportion of pVP2
molecules. Provirion maturation ap-
pears to be associated to pVP2 pro-
teolytic processing (13). Hence,
it seemed feasible that block-
ing pVP23 VP2 processing might
favor the accumulation and isolation of IBDV provirions. To
test this possibility, QM7 cultures were infected with
VT7LacOI/POLY or VT7LacOI/D431N. Expression of the
IBDV polyprotein in avian cells using an inducible rVV results
in the accumulation of abundant levels of VLP with similar size
and shape to those of authentic IBDV particles (26, 35).
Remarkably, the assemblies produced with the rBV system in
insect cells were nevertheless structurally varied, and in gen-
eral, the formation of IBDV-like particles was rather inefficient.
Insect cells might, therefore, have an important cellular fac-
tor(s) that interferes negatively with VLP assembly (e.g. cellular
proteins and/or host environment).
Cultures harvested at 2 different times, 36 and 72 h pi, and
the corresponding extracts were then used for the isolation of
IBDV-derived assemblies using a sucrose gradient-based puri-
fication protocol followed by electronmicroscopy andWestern
blot analyses of the collected fractions. As described previously,
extracts from cells infected with the rVV expressing the wild-
type polyprotein gene contained abundant icosahedral VLPs
with a relatively high VP2/pVP2 ratio (26). In contrast, no
IBDV-derived assemblies were detected in samples from
VT7LacOI/D431N-infected cells. The use of gentler extraction
conditions and/or alternative purification protocols yielded
similar results. The same results were observed with extracts
from cells infected with the three rVVs expressing polyprotein
genes containing mutations on the pVP2 cleavage site
described above.
DISCUSSION
We analyzed the protease activity of the IBDV CP VP2. The
IBDV polyprotein is a fusion of capsid precursor pVP2 with the
viral protease (VP4) and the scaffolding protein (VP3). pVP2, a
512-residue precursor, undergoes sequential C-terminal proc-
essing events mediated by the viral protease VP4 to render
FIGURE 5. Structure of the VP2 D431N T  1 SVP monomer. Ribbon diagrams of wild-type (yellow) and
mutant D431N (blue) VP2 proteins. The superposition was performed using all the 428 residues of both mole-
cules. Shown on the right is an electron density map of the VP2 C-terminal boxed region around residue
Asp-431 . Residues from Val-429 to Pro-435 are shown as sticks and explicitly labeled every two residues.
FIGURE 6.Analysis of the pVP2 cleavage site Ala-441-Phe-442. A, West-
ern blot analysis of proteins expressed in cells infected with rVV VT7LacOI/
POLY, VT7LacOI/A441G, VT7LacOI/F442G, and VT7LacOI/A441G/F442G.
Infected cultures were harvested at 24, 48, and 72 h pi (hpi). B, QM7 cells
were infected with different recombinants VT7LacOI/A441G, VT7LacOI/
F442G, or VT7LacOI/A441G/F442Gwere pulse-labeledwith [35S]Met for 1 h at
19 h pi. The radioactivity was chased with by adding with freshmedium con-
taininganexcessof coldmethionine. Cultureswereharvestedat 0, 24, 48, and
72 h post-labeling, and the corresponding extracts immunoprecipitated
using anti-VP2 serum. The resulting samples were subjected to SDS-PAGE
followed by autoradiography. Molecular weight markers (expressed in kDa,
left), and bands corresponding to proteins pVP2 and VP2 (right) are indicated.
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shorter pVP2 polypeptides. These pVP2 intermediates with
C-terminal extensions of variable length are further cleaved to
render the mature VP2 (441 residues). Based on the VP2 x-ray
structure, we examined the role of two likely candidate resi-
dues, Asp-391 and Asp-431, for catalyzing the last proteolytic
event that occurs during capsid maturation. These residues
were selected taking into account the structural analogies of
domains S and B of IBDV CP to their counterparts in some
positive-sense ssRNA viruses such as noda- and tetraviruses, in
which the cleavage is mediated by acid residues, specifically
Asp-75 of FlockHouse virus (FHV) (18) andGlu-103 ofNudau-
relia capensis  virus (36).
Our results indicate that he D431N mutation blocks the
pVP23 VP2 proteolytic trimming and affects the assembly of
stable IBDV particles. Assembly of VLPs with the proper size
andmorphology, i.e. theT 13 capsid, was not detected in cells
expressing the polyprotein gene harboring the D431N muta-
tion. Expression of pVP2 intermediate polypeptides with the
point mutation D431N nonetheless can assemble either as all-
pentamer structures (T 1 SVP) or tubular structures built of
pVP2 hexamers. The isolation of these assembly products
excluded a possible misfolding of the polypeptide as they are
built by the same structural block, VP2 trimers (19). The crystal
structure of the mutant D431N VP2 protein provides addi-
tional experimental evidence supporting this interpretation.
Similarly, mutations on the scissile bond Ala-441—Phe-442
yielded no production of particles.
We previously reported that the molecular switch control-
ling VP2 polymorphism resides in the C-terminal 443GFKDII-
RAIR452 segment that is organized as an amphipathic -helix
(19). In addition, most of the temporally bound 71-residue
C-terminal segment consists of -helices (11). Our working
model assumes that assembly control of the complex IBDVT
13 capsid requires the electrostatic interaction of the acidic
segment of the VP3 C-terminal region, whose importance was
previously established (29, 37), with the pVP2 amphipathic
-helix as an initial event in the adoption of different confor-
mational states. In this context it is easily envisioned how the
D431N mutation is not only unable to cleavage the Ala-441—
Pro-442 scissile bond but alsomight preclude or alter the inter-
action of VP3 with the helical region of VP2 at the inner base-
ment of the VP2 S domain. Furthermore, we believe that the
interaction of the C-terminal VP3 segment with the pVP2
amphipathic -helix might be necessary to temporally inhibit
the last proteolytic event because, as reported previously, the
pVP2 conformational state becomes irreversible (only able to
assemble as pentamers) when its C-terminal region has been
removed (21). Another fact that remains to be clarified in the
sophisticated succession of interactions between VP3 and
(p)VP2 refers to the high flexibility exhibited by the VP2 C-ter-
minal end (21). It is likely that the conformational change orig-
inates from a rearrangement of some helical regions in the pro-
capsid internal VP2 S domains as described for the Nudaurelia
capensis  virus conformational change (14, 17, 38).
Noda- and tetraviruses undergo a biphasic maturation proc-
ess. During the first step, triggered by a reduction in pH, the
procapsids undergo large scale structural rearrangements, thus
quickly evolving to smaller, less porous, capsids; the second step
is dependent on the first and consists of a relatively slow auto-
proteolytic cleavage of the precursor CP subunits. Maturation
of IPNV, a closely related birnavirus, also occurs by pVP2 proc-
essing to VP2 in which spherical provirions evolve to relatively
smaller icosahedral virions (13). Our attempts to isolate IBDV-
derived provirions using a wide variety of approaches have
failed at present. This could be due to several factors: (i) a com-
paratively faster pVP2 3 VP2 conversion rate for the IBDV
capsid than that of its IPNV counterpart; or (ii) a weaker inter-
action between the IBDV pVP2 with the scaffolding protein
VP3, thus leading to the assembly of more labile provirions.
In addition to the structural similarities between their CP
polypeptides described above, birna-, noda-, and tetravirus
share many other features at multiple levels (39). These viruses
possess bipartite genomes with a similar overall organization
(one segment coding for the RNA polymerase, and the other
one encoding the capsid precursor protein). Interestingly,
birna-, noda-, and tetravirus mRNA lack 3-terminal poly(A)
tails (15, 40). Their RNA-dependent RNA polymerases exhibit
a non-canonical organization exclusive of this three-virus
group containing a specific sequence permutation of the cata-
lytic palm subdomain (41–43). An additional similarity
between birnaviruses and positive-sense ssRNA viruses is the
protein priming of RNA synthesis, described for IPNV (44) and
originally discovered in picornaviruses (45). A further parallel
among noda-, tetra-, and birnaviruses refers to the presence of
active capsid-associated -helical peptides generated during
the proteolytic processing of the CP precursor C-terminal
region. These peptides form hydrophilic channels that perme-
abilize biological membranes, allowing genome translocation
during the virus entry process (11, 46). Finally, the multifunc-
FIGURE 7. pVP2 intramolecular proteolytic processing.Western blot anal-
ysis of proteins expressed in QM7 cells coinfected with VT7LacOI/POLY and
VT7LacOI/D431N, VT7LacOI/POLY andVT7LacOI/A441G/F442G, or VT7LacOI/
A441G/F442G and VT7LacOI/D431N. Infected cultures were harvested at 48
and 72 h pi (hpi). A scheme indicating the combinations of rVV used in this
experiment (mutated positions are crossed out) is shown at the bottom.
TABLE 1
Virus titers obtained by reverse genetics
Coinfections Virus titersFirst round Second round Third round
pfu/ml
pT7-SA-Rz/pT7-SB-Rz 1.3 0.5 102 9.0 1.3 104 6.0 1.5 107
pT7-SA(D431N)-Rz/
pT7-SB-Rz
0 0 0
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tional IBDVVP3 protein (involved in virus assembly as an scaf-
folding protein and RNA synthesis as an RNA-dependent RNA
polymerase activator) is mostly found associated to the dsRNA
segments forming ribonucleoprotein complexes (47). In this
sense, nodavirus also expresses a dsRNA-binding protein that
acts as a potent suppressor, inhibiting host RNA silencing (48,
49). Our finding that the IBDVCP precursor is self-cleaved in a
cis-processing event mediated by an aspartic acid residue adds
further experimental evidence reinforcing the structural and
functional relationships among icosahedral ssRNA and dsRNA
viruses.
Viral CPs ensure the successful propagation of viral genomes
by sheltering them from a hostile environment and guiding
them through the interaction with specific cell receptors in
their journey to reach an appropriate milieu for a successful
replication process. Nevertheless, there is increasing evidence
that CPs play other important roles. In addition to the Asp- or
Glu-based proteolytic activities associated to birna-, noda-, and
tetravirus, other CPs such that of Semliki Forest virus, an envel-
oped plus strand RNA virus, exhibits a self-cleaving serine pro-
tease activity (50). Enzymatic activities associated toCP inmost
known examples found in fully assembled virus particles are not
exclusively restricted to protease activities. The CP of Leishma-
nia RNA virus, a dsRNA virus that persistently infects the par-
asitic protozoan Leishmania, possesses a site-specific RNA
endoribonuclease activity that cleaves viral positive-sense RNA
(51, 52). L-A virus, another dsRNA virus that infects the yeast
Saccharomyces cerevisiae, has a CP that removes the m7GMP
caps fromhost cellularmRNAs and covalently attaches them to
a His residue on the capsid outer surface (53, 54). Unfortu-
nately, the lack of specific sequence consensus motifs compli-
cates the search for CP-associated enzymatic activities. Finally,
these studies might settle the basis for the future design of cap-
sid-targeted antiviral compounds trapping IBDV virion parti-
cles at an intermediate maturation stage rather than interrupt-
ing the assembly of capsid subunits, e.g. binding to trimers.
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